MICE - MHC class I polypeptide-related sequence E (pseudogene) Gene
Also Known as PERB11.5; dJ377H14.7
Species: Homo sapiens
Gene Type: pseudo
Gene ID: 4280
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(208)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13757A | Tamoxifen | 99.96% | Yes | |
| HY-B2176 | ATP | 99.88% | Unkown | |
| HY-16561 | Resveratrol | 99.95% | Yes | |
| HY-B0470 | Neomycin sulfate | Inhibitor | 99.86% | Unkown |
| HY-66005 | Acetaminophen | 99.97% | Unkown | |
| HY-14608 | L-Glutamic acid | 99.96% | Unkown | |
| HY-153192 | Nerandomilast | Inhibitor | 99.99% | Unkown |
| HY-Y0966 | Glycine | Inhibitor | 99.93% | Unkown |
| HY-13404 | Capmatinib | 99.71% | Yes | |
| HY-13757 | Tamoxifen Citrate | 99.88% | Yes | |
| HY-12678 | Entrectinib | 99.26% | Yes | |
| HY-109506 | DPPC | 99.91% | Unkown | |
| HY-15498 | Rimegepant | Antagonist | 99.99% | Unkown |
| HY-16985 | Darolutamide | Antagonist | 99.49% | Unkown |
| HY-N0469 | L-Lysine | Inhibitor | 99.94% | Unkown |
| HY-14608A | L-Glutamic acid monosodium salt | 98.0% | Unkown | |
| HY-114370 | Selpercatinib | Inhibitor | 99.83% | Yes |
| HY-B1192 | Estradiol benzoate | Agonist | 99.90% | Unkown |
| HY-109044 | Tapinarof | Agonist | 99.95% | Unkown |
| HY-B0190A | Nafamostat mesylate | Inhibitor | 99.94% | Yes |
| HY-B0561 | Spironolactone | 99.81% | Yes | |
| HY-66009 | Epalrestat | Inhibitor | 99.62% | Yes |
| HY-B1046 | Clofazimine | 99.79% | Unkown | |
| HY-N6972 | Cepharanthine | 99.87% | Yes | |
| HY-B1135 | Benzbromarone | 99.91% | Yes | |
| HY-132591A | Inclisiran sodium | 99.08% | Unkown | |
| HY-N0394 | L-Cystine | 99.84% | Unkown | |
| HY-B1640 | Ethacrynic acid | Inhibitor | 99.98% | Unkown |
| HY-12723 | Apomorphine | 99.48% | Unkown | |
| HY-B0227 | Ketoprofen | Inhibitor | 99.95% | Yes |
| HY-B0401 | Tolbutamide | Inhibitor | 99.96% | Unkown |
| HY-B0448 | Phenytoin | Inhibitor | 99.95% | Yes |
| HY-104081 | Cholestyramine | Activator | / | Unkown |
| HY-B0300 | Penicillamine | Inhibitor | 98.0% | Yes |
| HY-P1624 | Teduglutide | Activator | 99.85% | Unkown |
| HY-A0106 | Levamisole | 99.97% | Yes | |
| HY-A0134 | Isoflurane | Inhibitor | 99.27% | Unkown |
| HY-B1121 | Flunisolide | 99.87% | Unkown | |
| HY-119209 | Nefazodone | Inhibitor | 98.01% | Unkown |
| HY-B1923 | Piperacillin | Inhibitor | 98.37% | Yes |
| HY-B1005 | 8-Hydroxyquinoline | Inhibitor | 99.99% | Unkown |
| HY-A0081 | Fluphenazine dihydrochloride | Inhibitor | 99.91% | Unkown |
| HY-109120 | Odevixibat | Inhibitor | 99.88% | Yes |
| HY-108742 | Abaloparatide | Activator | 99.82% | Unkown |
| HY-B0648 | Medroxyprogesterone | Agonist | 98.82% | Unkown |
| HY-B1178 | Cotinine | Agonist | 99.98% | Unkown |
| HY-B0892 | Benzyl alcohol | 99.99% | Unkown | |
| HY-W018791 | Bifendate | 99.92% | Unkown | |
| HY-17403 | Manidipine dihydrochloride | Inhibitor | 99.84% | Unkown |
| HY-107916 | Thyrotropin | Inhibitor | / | Unkown |
| HY-A0042 | Rufinamide | Inhibitor | 99.88% | Yes |
| HY-108719 | Insulin glargine | Activator | 95.00% | Unkown |
| HY-B1462 | Chlorzoxazone | 99.77% | Unkown | |
| HY-B1286 | Piperacillin sodium | Inhibitor | 98.22% | Yes |
| HY-17015A | Peramivir | 99.94% | Unkown | |
| HY-B0693 | Ranitidine | Antagonist | 99.9% | Yes |
| HY-B1172 | Lactulose | 99.90% | Yes | |
| HY-B0448A | Phenytoin sodium | Inhibitor | 99.78% | Yes |
| HY-B0111 | Drospirenone | Agonist | 99.95% | Unkown |
| HY-N0283 | Diacerein | 99.42% | Yes | |
| HY-B2194 | γ-Oryzanol | Inhibitor | 99.66% | Unkown |
| HY-B1391 | D-Panthenol | 99.98% | Unkown | |
| HY-124290 | Carotegrast methyl | Antagonist | 99.24% | Unkown |
| HY-B0534 | Moclobemide | Inhibitor | 99.12% | Yes |
| HY-B0344 | Methscopolamine bromide | Inhibitor | 99.81% | Unkown |
| HY-N0700 | alpha-Asarone | Activator | 99.89% | Unkown |
| HY-B0723 | Ospemifene | 99.84% | Unkown | |
| HY-114277A | Sotorasib racemate | 98.99% | Unkown | |
| HY-17555 | Meclofenoxate hydrochloride | 98.33% | Unkown | |
| HY-A0021 | Palonosetron hydrochloride | Antagonist | 99.94% | Unkown |
| HY-B1266 | Physostigmine salicylate | Inhibitor | 99.74% | Unkown |
| HY-B1400 | Diiodohydroxyquinoline | Inhibitor | 98.0% | Unkown |
| HY-14668 | Lomitapide mesylate | 99.61% | Yes | |
| HY-B0330B | Levofloxacin hydrochloride | 99.99% | Yes | |
| HY-B1198 | Piperonyl butoxide | Inhibitor | 98.0% | Unkown |
| HY-17015 | Peramivir trihydrate | Inhibitor | 98.30% | Unkown |
| HY-B1190 | Cefadroxil | 99.54% | Yes | |
| HY-B0168A | Milnacipran hydrochloride | Inhibitor | 99.71% | Yes |
| HY-B0742 | Hydroxyprogesterone caproate | Ligand | 99.29% | Yes |
| HY-B1415 | Clofibric acid | 99.92% | Unkown | |
| HY-N0597 | Panaxatriol | 99.93% | Unkown | |
| HY-13404C | Capmatinib dihydrochloride hydrate | 99.67% | Yes | |
| HY-B0281A | Ranitidine hydrochloride | Antagonist | 99.86% | Yes |
| HY-B1817 | Zinc acetate | 99.44% | Unkown | |
| HY-101082 | N6,2′-O-Dimethyladenosine | Inhibitor | 99.87% | Unkown |
| HY-17549 | Adrafinil | Agonist | 99.85% | Unkown |
| HY-N0538 | Xylitol | 99.5% | Yes | |
| HY-106203 | Crinecerfont | Antagonist | 98.08% | Unkown |
| HY-D0211 | Phenolphthalein | 99.39% | Unkown | |
| HY-119980 | Fluphenazine | 98.70% | Unkown | |
| HY-108742A | Abaloparatide TFA | Activator | 98.80% | Unkown |
| HY-112974 | Inotersen | Inhibitor | 96.44% | Unkown |
| HY-B0696 | Tiagabine | Inhibitor | 99.20% | Unkown |
| HY-100375 | Diroximel fumarate | Activator | 99.60% | Yes |
| HY-108767 | Insulin aspart | ≥95.0% | Unkown | |
| HY-17426 | Famciclovir | Inhibitor | 99.69% | Yes |
| HY-17623 | Tegoprazan | Inhibitor | 99.71% | Unkown |
| HY-76938 | Actarit | Inhibitor | 99.58% | Unkown |
| HY-B0890 | Zomepirac sodium salt | Inhibitor | 99.63% | Unkown |
| HY-B1794 | Thiethylperazine | 99.91% | Unkown | |
| HY-B0417A | Lincomycin hydrochloride | Inhibitor | 99.59% | Unkown |
| HY-111603 | Calcium dobesilate | Inducer | 98.0% | Unkown |
| HY-17484 | Ampiroxicam | 98.73% | Unkown | |
| HY-B1245 | Salsalate | 99.61% | Yes | |
| HY-B1350A | Fusidic acid sodium salt | Inhibitor | 99.64% | Yes |
| HY-W040128 | Kanamycins sulfate | 99.22% | Unkown | |
| HY-107744 | Nalmefene | 99.94% | Yes | |
| HY-19696B | Tauroursodeoxycholate dihydrate | 99.96% | Yes | |
| HY-B1206 | Neostigmine (methyl sulfate) | Inhibitor | 99.50% | Yes |
| HY-B1177 | Crotamiton | Inhibitor | 98.07% | Unkown |
| HY-W013272 | Hydroxyflutamide | 99.77% | Unkown | |
| HY-90003 | Tianeptine | 99.84% | Unkown | |
| HY-A0069 | Doxylamine succinate | 99.76% | Unkown | |
| HY-B0226 | Nitrofurazone | Inhibitor | 99.96% | Unkown |
| HY-B0531 | Triflusal | 99.56% | Unkown | |
| HY-B2209B | Hydroxocobalamin acetate | 98.90% | Yes | |
| HY-W017113 | 2-Mercaptobenzothiazole | 99.85% | Yes | |
| HY-B1358 | Lincomycin hydrochloride monohydrate | Inhibitor | 99.74% | Unkown |
| HY-B1324 | Oxiconazole nitrate | 98.0% | Yes | |
| HY-B1640R | Ethacrynic acid (Standard) | Inhibitor | 98.78% | Unkown |
| HY-A0022A | Azaphen dihydrochloride monohydrate | Inhibitor | 99.94% | Unkown |
| HY-A0169A | Methyl aminolevulinate hydrochloride | Activator | 98.98% | Unkown |
| HY-W011522 | Taurolidine | 98.19% | Yes | |
| HY-117660 | Lincomycin | Inhibitor | 99.82% | Unkown |
| HY-17460A | Garenoxacin Mesylate hydrate | Inhibitor | 99.95% | Unkown |
| HY-B1429 | Chlorpropamide | Inhibitor | 99.79% | Unkown |
| HY-13859 | Clevudine | Inhibitor | 99.84% | Unkown |
| HY-14447 | Bilastine | Antagonist | 99.91% | Unkown |
| HY-17564 | 2'-Deoxycytidine (hydrochloride) | 99.98% | Unkown | |
| HY-B1127 | Betamipron | Inhibitor | 98.69% | Unkown |
| HY-B2117 | Valpromide | Inhibitor | 99.72% | Unkown |
| HY-B1268 | Docusate Sodium | Inhibitor | 98.0% | Unkown |
| HY-P0009 | Cetrorelix | Antagonist | 99.71% | Yes |
| HY-B1012 | Quinestrol | 99.72% | Unkown | |
| HY-13404A | Capmatinib dihydrochloride | 99.82% | Yes | |
| HY-108292 | Propacetamol hydrochloride | Inhibitor | 99.74% | Unkown |
| HY-112234 | L-Sepiapterin | ≥95.0% | Unkown | |
| HY-121235 | Clonixin | Inhibitor | 98.88% | Unkown |
| HY-122365 | Inositol nicotinate | 98.05% | Unkown | |
| HY-12752A | Alimemazine hemitartrate | 99.49% | Unkown | |
| HY-90003A | Tianeptine sodium salt | 99.90% | Unkown | |
| HY-N7065 | Dihydralazine sulfate | 98.0% | Unkown | |
| HY-13404B | Capmatinib hydrochloride | 99.48% | Unkown | |
| HY-14196 | Toloxatone | Inhibitor | 98.11% | Unkown |
| HY-B0921 | Succinylsulfathiazole | Inhibitor | 99.22% | Unkown |
| HY-B1017 | Molindone (hydrochloride) | Inhibitor | 99.81% | Unkown |
| HY-B1589A | Carbinoxamine maleate salt | 98.78% | Unkown | |
| HY-B1794A | Thiethylperazine dimaleate | 99.99% | Unkown | |
| HY-B0327 | Irsogladine | 99.88% | Unkown | |
| HY-13710A | Dimethindene maleate | Antagonist | 99.72% | Unkown |
| HY-B0170A | Azatadine dimaleate | Inhibitor | 99.85% | Unkown |
| HY-B0374 | Moxonidine | 99.72% | Unkown | |
| HY-B1451 | Imidapril hydrochloride | Inhibitor | 99.91% | Yes |
| HY-185373 | Paclitaxel liposome | / | Unkown | |
| HY-142240 | Crisugabalin | Inhibitor | 99.88% | Unkown |
| HY-B1341 | Norethynodrel | Activator | 90.53% | Unkown |
| HY-B0190 | Nafamostat | Inhibitor | / | Unkown |
| HY-109569 | Vitamin K2 | ≥98.0% | Unkown | |
| HY-17604 | Bexagliflozin | Inhibitor | 99.31% | Unkown |
| HY-B1265 | Hydrocortisone 17-valerate | 98.0% | Unkown | |
| HY-P1386 | D15 | Inhibitor | 99.02% | Unkown |
| HY-17460 | Garenoxacin | Inhibitor | 98.62% | Unkown |
| HY-A0022 | Azaphen | Inhibitor | / | Unkown |
| HY-A0124 | Sapropterin | / | Unkown | |
| HY-B0190AR | Nafamostat mesylate (Standard) | Inhibitor | 99.95% | Unkown |
| HY-B0190B | Nafamostat hydrochloride | Inhibitor | / | Unkown |
| HY-U00134 | Benzcyclane | Antagonist | 99.39% | Unkown |
| HY-B0227A | Ketoprofen (lysinate) | Inhibitor | / | Unkown |
| HY-150520 | Neomycin | Inhibitor | / | Unkown |
| HY-108790 | Peginterferon beta-1a | Inducer | / | Unkown |
| HY-19522C | Seladelpar (lysine dihydrate) | 99.51% | Unkown | |
| HY-106547 | Rilmazafone | / | Unkown | |
| HY-114833 | Bunolol | Antagonist | / | Unkown |
| HY-119980A | Fluphenazine dimaleate | / | Unkown | |
| HY-119980B | Fluphenazine hydrochloride | / | Unkown | |
| HY-17032 | Indeloxazine | / | Unkown | |
| HY-A0069A | Doxylamine | 99.21% | Unkown | |
| HY-A0069R | Doxylamine succinate (Standard) | / | Unkown | |
| HY-A0081R | Fluphenazine dihydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-A0169 | Methyl aminolevulinate | / | Unkown | |
| HY-B0693A | Ranitidine bismuth citrate | / | Unkown | |
| HY-B0890A | Zomepirac | Inhibitor | / | Unkown |
| HY-B1121A | Flunisolide hemihydrate | / | Unkown | |
| HY-B1198R | Piperonyl butoxide (Standard) | Inhibitor | / | Unkown |
| HY-B1239A | Drofenine | Inhibitor | / | Unkown |
| HY-B1324A | Oxiconazole | / | Unkown | |
| HY-B1589 | (±)-Carbinoxamine | Antagonist | / | Unkown |
| HY-B1640A | Ethacrynic acid sodium | Inhibitor | / | Unkown |
| HY-N0597R | Panaxatriol (Standard) | / | Unkown | |
| HY-P1624A | Teduglutide TFA | Activator | / | Unkown |
| HY-W018475 | Rizatriptan | Agonist | / | Unkown |
| HY-106203R | Crinecerfont (Standard) | Antagonist | / | Unkown |
| HY-117660R | Lincomycin (Standard) | Inhibitor | / | Unkown |
| HY-133171A | (S)-Norfluoxetine | Inhibitor | / | Unkown |
| HY-17484R | Ampiroxicam (Standard) | / | Unkown | |
| HY-A0139 | Thiothixene | Antagonist | / | Unkown |
| HY-A0169AR | Methyl aminolevulinate hydrochloride (Standard) | Activator | / | Unkown |
| HY-B0170 | Azatadine | Inhibitor | / | Unkown |
| HY-B0170AR | Azatadine dimaleate (Standard) | Inhibitor | / | Unkown |
| HY-B0281AR | Ranitidine hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-B0430B | (±)-Pantothenic acid | / | Unkown | |
| HY-B0771AR | Cefozopran hydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-B0890R | Zomepirac sodium salt (Standard) | Inhibitor | / | Unkown |
| HY-B0956A | Paromomycin | Inhibitor | / | Unkown |
| HY-B1177R | Crotamiton (Standard) | Inhibitor | / | Unkown |
| HY-B1358R | Lincomycin hydrochloride monohydrate (Standard) | Inhibitor | / | Unkown |
| HY-N7065R | Dihydralazine sulfate (Standard) | / | Unkown | |
| HY-U00134R | Benzcyclane (Standard) | Antagonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(15)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-108841 | Raleukin | Antagonist | 99.40% | Unkown |
| HY-P9944 | Palivizumab | Inhibitor | 99.63% | Unkown |
| HY-P9914 | Eculizumab | Inhibitor | 99.88% | Unkown |
| HY-P99720 | Luspatercept | Inhibitor | 98.92% | Unkown |
| HY-P99222 | Teplizumab | 99.73% | Unkown | |
| HY-P99048 | Sintilimab | Inhibitor | 99.1% | Unkown |
| HY-P99797 | Pabinafusp alfa | 98.89% | Unkown | |
| HY-P9960 | Ocrelizumab | Inhibitor | ≥99.0% | Unkown |
| HY-108786 | Asfotase alfa | 98.53% | Unkown | |
| HY-P99118 | Serplulimab | 99.30% | Unkown | |
| HY-P99194 | Evinacumab | Inhibitor | 99.24% | Unkown |
| HY-P99341 | Casirivimab | Inhibitor | 99.54% | Unkown |
| HY-P99345 | Dostarlimab | Inhibitor | 98.92% | Unkown |
| HY-P9987 | Crizanlizumab | Inhibitor | ≥95.0% | Unkown |
| HY-112998 | Efmoroctocog alfa | 95% | Unkown |
Clinical Phase
Bioactive Molecules
(242)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N0379 | D-Mannose | ≥98.0% | Phase 4 | |
| HY-B1820 | Zinc sulphate | Inhibitor | 99.85% | Phase 4 |
| HY-W007087 | Valerate sodium | Activator | 98.00% | Phase 4 |
| HY-N6608 | Physostigmine | Inhibitor | 99.92% | Phase 4 |
| HY-B0342 | Meglumine | 98.0% | Phase 4 | |
| HY-B1946 | Dimethoate | 99.91% | Phase 4 | |
| HY-136642 | Fluocinolone | Agonist | 98.48% | Phase 4 |
| HY-N3018 | Isomaltose | Inhibitor | 98.0% | Phase 4 |
| HY-W203683 | Perfluorononanoic acid | 99.9% | Phase 4 | |
| HY-148163 | Polystyrene sulfonic acid (30% in water) | / | Phase 4 | |
| HY-N2320 | Physostigmine hemisulfate | Inhibitor | 99.80% | Phase 4 |
| HY-N6869 | Dehydroabietic acid | 98.52% | Phase 4 | |
| HY-108882B | DNase I RNase & Protease free | / | Phase 4 | |
| HY-B1713A | DL-Ornithine hydrochloride | 99.78% | Phase 4 | |
| HY-B0168 | Milnacipran | Inhibitor | 99.69% | Phase 4 |
| HY-119468 | Medifoxamine | Inhibitor | 99.34% | Phase 4 |
| HY-114784 | Ingavirin | Inhibitor | 99.88% | Phase 4 |
| HY-163885 | SSZ | Inhibitor | 98.13% | Phase 4 |
| HY-70062 | Pevonedistat | 99.98% | Phase 3 | |
| HY-148273 | Setidegrasib | Inhibitor | 99.65% | Phase 3 |
| HY-10484 | Pevonedistat hydrochloride | 99.19% | Phase 3 | |
| HY-164734 | Raludotatug Deruxtecan | 99.29% | Phase 3 | |
| HY-113066C | Guanosine 5'-diphosphate sodium, 96% (HPLC) | 99.88% | Phase 3 | |
| HY-59291 | Levacetylleucine | Chemical | 98.0% | Phase 3 |
| HY-112137 | Trehalose-6,6'-dibehenate | Activator | 99.92% | Phase 3 |
| HY-19796 | Icomidocholic acid | 99.98% | Phase 3 | |
| HY-109008 | Nacubactam | Inhibitor | 99.06% | Phase 3 |
| HY-149555 | DNL343 | Activator | 99.94% | Phase 3 |
| HY-148410A | Zorevunersen sodium | Activator | 99.27% | Phase 3 |
| HY-NP006 | Protein A | Inducer | 93.27% | Phase 3 |
| HY-114440 | Belapectin | 98.94% | Phase 3 | |
| HY-153920 | Pimicotinib | Inhibitor | 99.92% | Phase 3 |
| HY-143230 | Custirsen | Inducer | 96.12% | Phase 3 |
| HY-148788 | Osivelotor | Inhibitor | 98.10% | Phase 3 |
| HY-153192A | Nerandomilast dihydrate | Inhibitor | 99.93% | Phase 3 |
| HY-145586 | Onradivir | Inhibitor | 99.53% | Phase 3 |
| HY-145721A | Mongersen sodium | 99.61% | Phase 3 | |
| HY-107661 | Arundic Acid | Activator | 98.0% | Phase 3 |
| HY-108022A | Azemiglitazone potassium | 98.94% | Phase 3 | |
| HY-P4154 | Bevonescein | Inhibitor | 99.11% | Phase 3 |
| HY-153492A | Olpasiran sodium | Inhibitor | 98.82% | Phase 3 |
| HY-139142B | Simufilam hydrochloride | 99.85% | Phase 3 | |
| HY-19720A | Emixustat hydrochloride | Inhibitor | 99.29% | Phase 3 |
| HY-14604 | Xaliproden hydrochloride | 98.40% | Phase 3 | |
| HY-14932 | Pafuramidine | Inhibitor | 99.28% | Phase 3 |
| HY-145119AS | Mindeudesivir hydrobromide | Inhibitor | 98.16% | Phase 3 |
| HY-132579 | Tominersen | 96.32% | Phase 3 | |
| HY-106203A | Crinecerfont hydrochloride | Antagonist | 98.82% | Phase 3 |
| HY-112597A | Mavodelpar | Agonist | 99.93% | Phase 3 |
| HY-19720 | Emixustat | 98.00% | Phase 3 | |
| HY-172581 | Clifutinib | 99.59% | Phase 3 | |
| HY-133894 | Bofutrelvir | Inhibitor | 95.0% | Phase 3 |
| HY-121872 | DP-b99 | Inhibitor | 95.0% | Phase 3 |
| HY-105063 | DiaPep277 | 99.44% | Phase 3 | |
| HY-13707 | Tin(IV) mesoporphyrin IX dichloride | 95.0% | Phase 3 | |
| HY-150364A | Farabursen sodium | Inhibitor | 93.56% | Phase 3 |
| HY-17445 | Muraglitazar | Agonist | 98.38% | Phase 3 |
| HY-139585 | Tigulixostat | Inhibitor | 99.18% | Phase 3 |
| HY-145721 | Mongersen | Inhibitor | 98.57% | Phase 3 |
| HY-176498 | NBM-T-BMX-OS01 | 99.74% | Phase 3 | |
| HY-113066 | Guanosine 5'-diphosphate | / | Phase 3 | |
| HY-14811 | Beloranib | 89.63% | Phase 3 | |
| HY-148511 | Vidutolimod | 93.85% | Phase 3 | |
| HY-139142A | Simufilam dihydrochloride | / | Phase 3 | |
| HY-145586A | Onradivir monohydrate | Inhibitor | / | Phase 3 |
| HY-106203C | Crinecerfont tosylate | Antagonist | / | Phase 3 |
| HY-106204 | Nelipepimut-S | / | Phase 3 | |
| HY-125475 | Rivipansel | Antagonist | / | Phase 3 |
| HY-13554 | Annamycin | / | Phase 3 | |
| HY-143744 | Suraxavir marboxil | Inhibitor | / | Phase 3 |
| HY-P10653 | C5A | Inhibitor | / | Phase 3 |
| HY-148410 | Zorevunersen | Activator | 98.50% | Phase 3 |
| HY-175254 | Antibiofilm agent-17 | / | Phase 3 | |
| HY-16950 | 4-Hydroxytamoxifen | Modulator | 99.96% | Phase 2 |
| HY-100442 | Paquinimod | Inhibitor | 99.90% | Phase 2 |
| HY-16900 | Rolipram | Inhibitor | 99.87% | Phase 2 |
| HY-111784 | Inobrodib | Inhibitor | 99.95% | Phase 2 |
| HY-112288 | C188-9 | 99.84% | Phase 2 | |
| HY-101563 | GSK3326595 | Inhibitor | 99.83% | Phase 2 |
| HY-W015828 | Ompenaclid | Inducer | 99.94% | Phase 2 |
| HY-110133 | JTE-607 | Inhibitor | 99.27% | Phase 2 |
| HY-13513 | U-104 | Inhibitor | 99.95% | Phase 2 |
| HY-15096 | MKT-077 | Inhibitor | 98.49% | Phase 2 |
| HY-Y1275 | N-Methylpyrrolidone | 99.99% | Phase 2 | |
| HY-100113 | Buloxibutid | 98.94% | Phase 2 | |
| HY-150724 | ODN 1018 | Agonist | 99.28% | Phase 2 |
| HY-B0504 | Creatinine | Modulator | 99.92% | Phase 2 |
| HY-P3211A | Nangibotide TFA | Inhibitor | 99.86% | Phase 2 |
| HY-101194 | Tin protoporphyrin IX dichloride | Inhibitor | 96.2% | Phase 2 |
| HY-N9481 | Lipoteichoic acid | / | Phase 2 | |
| HY-P1333 | Dynorphin A | 99.09% | Phase 2 | |
| HY-10367 | Canertinib | Inhibitor | 99.74% | Phase 2 |
| HY-148669 | Bleximenib | 99.36% | Phase 2 | |
| HY-133898 | Danavorexton | Activator | 99.56% | Phase 2 |
| HY-128850 | N-Acetyl-D-mannosamine | 99.99% | Phase 2 | |
| HY-141523 | Vociprotafib | Inhibitor | 99.70% | Phase 2 |
| HY-128973 | Pyropheophorbide-a | 98.0% | Phase 2 | |
| HY-152857 | Muvalaplin | Inhibitor | 99.96% | Phase 2 |
| HY-148669A | Bleximenib oxalate | 98.97% | Phase 2 | |
| HY-14530 | Pelitrexol | 98.07% | Phase 2 | |
| HY-129239 | Farudodstat | 99.68% | Phase 2 | |
| HY-153358 | TNG260 | Inhibitor | 99.33% | Phase 2 |
| HY-12472 | Balipodect | Inhibitor | 99.47% | Phase 2 |
| HY-108039 | Bezisterim | Inhibitor | 95.0% | Phase 2 |
| HY-108022 | Azemiglitazone | 97.35% | Phase 2 | |
| HY-160004 | PXL770 | Activator | 99.56% | Phase 2 |
| HY-P5128 | DOTA-JR11 | Antagonist | 99.14% | Phase 2 |
| HY-136789 | Tuxobertinib | Inhibitor | 99.88% | Phase 2 |
| HY-14674 | CP-724714 | 98.72% | Phase 2 | |
| HY-18099A | S1RA hydrochloride | Antagonist | 99.76% | Phase 2 |
| HY-107581 | MK-1903 | 99.68% | Phase 2 | |
| HY-W008491 | TK-112690 | Inhibitor | 99.91% | Phase 2 |
| HY-148794 | Risvodetinib | Inhibitor | 99.21% | Phase 2 |
| HY-123475 | Sisunatovir | Inhibitor | 99.40% | Phase 2 |
| HY-17553 | Coluracetam | Activator | 99.87% | Phase 2 |
| HY-109086 | Edicotinib | Inhibitor | 99.68% | Phase 2 |
| HY-137442 | Inupadenant | Antagonist | 98.27% | Phase 2 |
| HY-16361A | Omigapil maleate | Inhibitor | 99.84% | Phase 2 |
| HY-19480 | Ulodesine | 99.32% | Phase 2 | |
| HY-145608 | Zilurgisertib | Inhibitor | 98.25% | Phase 2 |
| HY-156618 | Irpagratinib | Inhibitor | 99.61% | Phase 2 |
| HY-132579A | Tominersen sodium | 97.36% | Phase 2 | |
| HY-149478 | JT002 | Inhibitor | 99.54% | Phase 2 |
| HY-B0340 | Nefiracetam | Activator | 99.87% | Phase 2 |
| HY-10367A | Canertinib dihydrochloride | Inhibitor | 99.68% | Phase 2 |
| HY-172437 | Secutrelvir | Inhibitor | 99.64% | Phase 2 |
| HY-18099 | S1RA | Antagonist | 98.96% | Phase 2 |
| HY-13241A | Ralimetinib | Inhibitor | 98.58% | Phase 2 |
| HY-15163 | Zotiraciclib | Inhibitor | 99.88% | Phase 2 |
| HY-119264 | PRLX-93936 | 98.31% | Phase 2 | |
| HY-137440 | Firazorexton | 99.56% | Phase 2 | |
| HY-159834 | Progerinin | Inhibitor | 99.74% | Phase 2 |
| HY-16758 | Verosudil | Inhibitor | 98.22% | Phase 2 |
| HY-14423 | Velneperit | Antagonist | 98.25% | Phase 2 |
| HY-16785 | Veledimex | Activator | 98.77% | Phase 2 |
| HY-19893 | Antroquinonol | Activator | 98.48% | Phase 2 |
| HY-100365 | Remetinostat | Inhibitor | 98.0% | Phase 2 |
| HY-100428 | Netoglitazone | Modulator | 99.92% | Phase 2 |
| HY-116228 | Cadrofloxacin | Inhibitor | 98.21% | Phase 2 |
| HY-101954A | Inarigivir ammonium | Inhibitor | 99.04% | Phase 2 |
| HY-16446 | SAR125844 | Inhibitor | 98.17% | Phase 2 |
| HY-19490 | VQW-765 | Agonist | 99.58% | Phase 2 |
| HY-17617 | Nastorazepide | 99.95% | Phase 2 | |
| HY-18006 | NKP608 | 99.88% | Phase 2 | |
| HY-125999 | EPI-589 | Inhibitor | 99.34% | Phase 2 |
| HY-148100 | Emapticap pegol | Inhibitor | 91.38% | Phase 2 |
| HY-P0107 | RC-3095 | Antagonist | 99.43% | Phase 2 |
| HY-12142 | Vofopitant | Antagonist | 99.82% | Phase 2 |
| HY-147403S | Tebideutorexant | Antagonist | 98.95% | Phase 2 |
| HY-137941 | Roxatidine | 98.25% | Phase 2 | |
| HY-109754 | Sulopenem etzadroxil | Inhibitor | 99.82% | Phase 2 |
| HY-137440A | Firazorexton hydrate | 99.94% | Phase 2 | |
| HY-14866 | Raseglurant | Modulator | 99.65% | Phase 2 |
| HY-B1202 | Alrestatin | Inhibitor | 99.67% | Phase 2 |
| HY-P99789 | Praluzatamab ravtansine | 99.07% | Phase 2 | |
| HY-101954 | Inarigivir | Inhibitor | 99.20% | Phase 2 |
| HY-128866 | TBAJ-876 | Inhibitor | / | Phase 2 |
| HY-121212 | Icosabutate | 97.28% | Phase 2 | |
| HY-100827 | Safotibant | Antagonist | 98.88% | Phase 2 |
| HY-106103 | Seglitide | Modulator | 99.30% | Phase 2 |
| HY-106887 | SCH 32615 | 99.68% | Phase 2 | |
| HY-12301 | MK-3697 | Antagonist | 98.83% | Phase 2 |
| HY-13225A | Rivanicline | Agonist | / | Phase 2 |
| HY-100426A | Osemozotan hydrochloride | Agonist | / | Phase 2 |
| HY-10289 | Carmegliptin | / | Phase 2 | |
| HY-105181 | T 588 | Activator | / | Phase 2 |
| HY-106129 | Izonsteride | Inhibitor | / | Phase 2 |
| HY-106185 | BMS-188797 | / | Phase 2 | |
| HY-106194 | SLV310 | / | Phase 2 | |
| HY-10823 | OSI-7904L | Inhibitor | / | Phase 2 |
| HY-109086A | Edicotinib hydrochloride | Inhibitor | / | Phase 2 |
| HY-115314 | Mequitamium iodide | Inhibitor | / | Phase 2 |
| HY-125327 | YM-543 | Inhibitor | / | Phase 2 |
| HY-13703 | Nimustine | / | Phase 2 | |
| HY-14316 | Tebanicline | Modulator | / | Phase 2 |
| HY-145996 | STC314 | / | Phase 2 | |
| HY-15074 | SPD-502 | / | Phase 2 | |
| HY-15076 | SPD-502 sodium | / | Phase 2 | |
| HY-16361 | Omigapil | Inducer | / | Phase 2 |
| HY-16758A | Verosudil hydrochloride | Inhibitor | / | Phase 2 |
| HY-168739 | Topoisomerase I inhibitor 17 | / | Phase 2 | |
| HY-P10868 | Pegtarazimod | Inducer | / | Phase 2 |
| HY-W011890A | Cridanimod sodium | Activator | / | Phase 2 |
| HY-114724 | HSR-609 | / | Phase 2 | |
| HY-16950R | 4-Hydroxytamoxifen (Standard) | Modulator | / | Phase 2 |
| HY-B1202R | Alrestatin (Standard) | Inhibitor | / | Phase 2 |
| HY-173629 | RMC-5127 | 99.96% | Phase 1 | |
| HY-164535 | Maridebart cafraglutide | 99.24% | Phase 1 | |
| HY-153810 | Mosnodenvir | Inhibitor | 99.94% | Phase 1 |
| HY-101144 | RSM-932A | Inhibitor | 98.77% | Phase 1 |
| HY-N2037 | Higenamine | 99.31% | Phase 1 | |
| HY-15340 | LG100268 | 99.39% | Phase 1 | |
| HY-W017540 | Cyclocreatine | Activator | 99.78% | Phase 1 |
| HY-167874 | ASP-8731 | Inhibitor | 98.42% | Phase 1 |
| HY-19307 | SB-273005 | 99.94% | Phase 1 | |
| HY-162877 | AZD4144 | Inhibitor | 99.67% | Phase 1 |
| HY-15698 | CRT0066101 | 99.88% | Phase 1 | |
| HY-W011641 | (±)-Naringenin | 99.83% | Phase 1 | |
| HY-102020 | RG3039 | 99.30% | Phase 1 | |
| HY-N1420A | Rhamnose monohydrate | 99.95% | Phase 1 | |
| HY-10081 | GS-6201 | Antagonist | 98.47% | Phase 1 |
| HY-101024 | PF-06263276 | Inhibitor | ≥99.0% | Phase 1 |
| HY-101478 | Fenobam | 99.91% | Phase 1 | |
| HY-116175 | BIBB 515 | 99.56% | Phase 1 | |
| HY-125639 | (rac)-AR-13503 | Inhibitor | 99.08% | Phase 1 |
| HY-109968 | Irdabisant | Antagonist | 99.58% | Phase 1 |
| HY-10080 | Teglarinad chloride | Inhibitor | 99.67% | Phase 1 |
| HY-19393 | SCH 351591 | Inhibitor | 99.22% | Phase 1 |
| HY-115552 | Simmiparib | Inhibitor | 99.01% | Phase 1 |
| HY-114256 | EC1169 | Ligand | 98.06% | Phase 1 |
| HY-115681 | (2R/S)-6-PNG | Inhibitor | 99.96% | Phase 1 |
| HY-122604 | PF-DcpSi | 98.0% | Phase 1 | |
| HY-111792 | GSK1795091 | Agonist | 94.48% | Phase 1 |
| HY-114356 | BPI-9016M | Inhibitor | 97.13% | Phase 1 |
| HY-P99595 | Sirtratumab vedotin | 97.38% | Phase 1 | |
| HY-136220 | AHR antagonist 5 | Antagonist | 98.05% | Phase 1 |
| HY-105762 | Etamiphyllin | 99.90% | Phase 1 | |
| HY-148348 | AB-836 | Inhibitor | 99.13% | Phase 1 |
| HY-147426 | Zifcasiran | Inhibitor | / | Phase 1 |
| HY-19876 | PL37 | / | Phase 1 | |
| HY-101122 | LX2761 | / | Phase 1 | |
| HY-106317 | Glutathione monoisopropyl ester | / | Phase 1 | |
| HY-106925 | Cetefloxacin | Inhibitor | / | Phase 1 |
| HY-107044 | DK 507k | / | Phase 1 | |
| HY-114214 | CKD-712 | / | Phase 1 | |
| HY-117630 | RB-6145 | / | Phase 1 | |
| HY-121111 | Agaritine | Inhibitor | / | Phase 1 |
| HY-121659 | DCFBC | Inhibitor | / | Phase 1 |
| HY-123765 | JTT-553 | Inhibitor | / | Phase 1 |
| HY-150191 | IMA-1 | / | Phase 1 | |
| HY-16121 | CAA-0225 | Inhibitor | / | Phase 1 |
| HY-164429 | VIP236 | / | Phase 1 | |
| HY-16656 | BMS-767778 | Inhibitor | / | Phase 1 |
| HY-172661 | Kylo-0603 | / | Phase 1 | |
| HY-19372 | SSR-181507 hydrochloride | / | Phase 1 | |
| HY-P10586 | Macrophage-activating lipopeptide 2 | / | Phase 1 | |
| HY-W040555 | Norquetiapine dihydrochloride | 99.91% | Phase 1 | |
| HY-102020R | RG3039 (Standard) | / | Phase 1 | |
| HY-105110 | SCH 39304 | Inhibitor | / | Phase 1 |
| HY-117236 | GSI-136 | Inhibitor | / | Phase 1 |
| HY-120726 | BF844 | / | Phase 1 | |
| HY-12104 | PF-514273 | Antagonist | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(62)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99156 | Relatlimab | 98.00% | Phase 4 | |
| HY-P99048A | Sintilimab (Anti-PD-1) | Inhibitor | / | Phase 4 |
| HY-P991883 | Metuzumab | / | Phase 4 | |
| HY-P99022 | Gantenerumab | Inhibitor | 99.724% | Phase 3 |
| HY-P99721 | Lutikizumab | Inhibitor | 96.54% | Phase 3 |
| HY-P9983 | Lintuzumab | Inhibitor | 98.09% | Phase 3 |
| HY-P99155 | Zalutumumab | 98.34% | Phase 3 | |
| HY-P99351 | Andecaliximab | Inhibitor | 98.57% | Phase 3 |
| HY-P99708 | Livmoniplimab | Inhibitor | 99.25% | Phase 3 |
| HY-P99252 | Itolizumab | ≥99.0% | Phase 3 | |
| HY-P99725 | Marstacimab | 96.27% | Phase 3 | |
| HY-P99583 | Suvratoxumab | Inhibitor | 98.79% | Phase 3 |
| HY-P99884 | Sasanlimab | Inhibitor | 99.75% | Phase 3 |
| HY-P991214 | Tucotuzumab celmoleukin | 98.797% | Phase 3 | |
| HY-P99155A | Zalutumumab (powder) | Inhibitor | / | Phase 3 |
| HY-P991595 | HB-0017 | Inhibitor | / | Phase 3 |
| HY-P99554 | Topsalysin | / | Phase 3 | |
| HY-P99692 | Lenercept | Inhibitor | / | Phase 3 |
| HY-P99388 | Trevogrumab | Inhibitor | ≥99.0% | Phase 2 |
| HY-P99244 | Fezakinumab | 99.9% | Phase 2 | |
| HY-P99370 | Landogrozumab | Inhibitor | 99.79% | Phase 2 |
| HY-P99555 | Tomaralimab | Inhibitor | 99.42% | Phase 2 |
| HY-P99199 | Foralumab | 98.08% | Phase 2 | |
| HY-P99399 | Semorinemab | Inhibitor | 99.36% | Phase 2 |
| HY-P99414 | Prezalumab | Inhibitor | 99.41% | Phase 2 |
| HY-P99778 | Ontuxizumab | 99.85% | Phase 2 | |
| HY-P990914 | Denikitug | 99.00% | Phase 2 | |
| HY-P991069 | VRC-01 | Inhibitor | 99.805% | Phase 2 |
| HY-P99588 | Stamulumab | Inhibitor | 95.07% | Phase 2 |
| HY-P99959 | Unasnemab | 99.00% | Phase 2 | |
| HY-P99216 | Ponezumab | Inhibitor | 97.89% | Phase 2 |
| HY-P991571 | GC1118 | Inhibitor | 99.22% | Phase 2 |
| HY-P990953 | Zubotamig | Inhibitor | 96.46% | Phase 2 |
| HY-P99744 | Modakafusp alfa | Inhibitor | 96.22% | Phase 2 |
| HY-P99618 | Fidasimtamab | Inhibitor | 95.00% | Phase 2 |
| HY-P991059 | VIS-410 | Inhibitor | 99% | Phase 2 |
| HY-P991900 | LY3541860 | Inhibitor | ≥99.0% | Phase 2 |
| HY-P991016 | Peluntamig | 99.9% | Phase 2 | |
| HY-P991637 | REGN7999 | Inhibitor | / | Phase 2 |
| HY-P991566 | KD6001 | Inhibitor | / | Phase 2 |
| HY-P991639 | BIW-8962 | Inducer | / | Phase 2 |
| HY-P991867 | SHR-1707 | Degrader | / | Phase 2 |
| HY-P991272 | ATR-107 | Inhibitor | 99.9% | Phase 1 |
| HY-P991201 | REGN-7257 | Inhibitor | 95.34% | Phase 1 |
| HY-P991669 | IGN523 | 97.47% | Phase 1 | |
| HY-P99814 | Pavurutamab | Inhibitor | 99.9% | Phase 1 |
| HY-P991193 | NGM-438 | Activator | 99.74% | Phase 1 |
| HY-P99699 | Lesofavumab | Inhibitor | 98.27% | Phase 1 |
| HY-P99836 | Cudarolimab | Inhibitor | 95.00% | Phase 1 |
| HY-P991373 | APNmAb005 | Inhibitor | 97.64% | Phase 1 |
| HY-P99911 | Efizonerimod alfa | Agonist | 98.57% | Phase 1 |
| HY-P991176 | RG-6333 | Agonist | 98.05% | Phase 1 |
| HY-P991641 | IMC-EB10 | Inhibitor | 98% | Phase 1 |
| HY-P991664 | AG01 | Inhibitor | 95.10% | Phase 1 |
| HY-P991888 | INCA033989 | Inhibitor | / | Phase 1 |
| HY-P991587 | SAR-446523 | Inhibitor | / | Phase 1 |
| HY-P991445 | REGN3051 | Inhibitor | / | Phase 1 |
| HY-P991528 | PE0116 | Activator | / | Phase 1 |
| HY-P991535 | PMN310 | Inhibitor | / | Phase 1 |
| HY-P991634 | IBI-325 | Inhibitor | / | Phase 1 |
| HY-P991961 | REGN4659 | Inhibitor | / | Phase 1 |
| HY-P99881 | Rolinsatamab talirine | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(3780)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-E0264 | Rodent Gnawing Blocks | / | Unkown | |
| HY-13818 | Stattic | 99.96% | Unkown | |
| HY-107202 | Polyinosinic-polycytidylic acid | 99.40% | Unkown | |
| HY-101840 | EIPA | 99.73% | Unkown | |
| HY-10231 | PX-478 | 99.58% | Unkown | |
| HY-153808 | Complete Freund's adjuvant (CFA) | / | Unkown | |
| HY-P1645 | Papain | / | Unkown | |
| HY-14452 | Fatostatin | Inhibitor | 99.85% | Unkown |
| HY-107632 | GYY4137 | 98.64% | Unkown | |
| HY-15648B | GSK-J4 | 99.45% | Unkown | |
| HY-N0171A | Beta-Sitosterol (purity>98%) | 99.74% | Unkown | |
| HY-N0219 | Bicuculline | Antagonist | 99.98% | Unkown |
| HY-101966 | NCT-503 | Inhibitor | 99.69% | Unkown |
| HY-10626 | T0901317 | 99.85% | Unkown | |
| HY-14393 | Emodin | Inhibitor | 99.25% | Yes |
| HY-141644 | PY-60 | Activator | 99.42% | Unkown |
| HY-N6693 | Valinomycin | 99.05% | Unkown | |
| HY-112683 | V-9302 | Antagonist | 99.46% | Unkown |
| HY-134901 | WM-3835 | 99.78% | Unkown | |
| HY-101903 | BMS-309403 | Inhibitor | 99.91% | Unkown |
| HY-139414 | Lysophosphatidylcholines | 99.9% | Unkown | |
| HY-160769 | NIBR-LTSi | 99.97% | Unkown | |
| HY-P10925 | Zolucatetide | Inhibitor | 99.31% | Unkown |
| HY-N0088 | Apocynin | Inhibitor | 99.94% | Unkown |
| HY-13687 | IKK 16 | Inhibitor | 99.88% | Unkown |
| HY-101117 | EED226 | Inhibitor | 99.56% | Unkown |
| HY-122022 | JR-AB2-011 | Inhibitor | 98.15% | Unkown |
| HY-131042 | NNMTi | Inhibitor | 99.70% | Unkown |
| HY-132295 | Azenosertib | Inhibitor | 99.96% | Unkown |
| HY-107999 | CADD522 | Agonist | 98.23% | Unkown |
| HY-P2329 | Lysostaphin | Inhibitor | 90% | Unkown |
| HY-W250113 | Zymosan A | Agonist | 82.2% | Unkown |
| HY-123942 | Diprovocim | Agonist | 98.82% | Unkown |
| HY-N0931 | Santacruzamate A | Inhibitor | 99.54% | Unkown |
| HY-103312 | Xestospongin C | Inhibitor | 99.9% | Unkown |
| HY-N0028 | Forsythiaside A | 99.79% | Unkown | |
| HY-103259 | Sodium metatungstate | Inhibitor | 93.4% | Unkown |
| HY-13817 | IU1 | 99.30% | Unkown | |
| HY-110171 | iMDK | Inhibitor | 99.35% | Unkown |
| HY-P2300 | Cyclo(Arg-Gly-Asp-D-Phe-Cys) | 98.08% | Unkown | |
| HY-N0171 | Beta-Sitosterol (purity>80%) | Inducer | ≥98.0% | Unkown |
| HY-106224 | Orexin A (human, rat, mouse) | Agonist | 99.93% | Unkown |
| HY-163731 | EGR-1-IN-1 | Inhibitor | 99.07% | Unkown |
| HY-134923 | CA77.1 | Inducer | 99.92% | Unkown |
| HY-100001 | SKF-96365 (hydrochloride) | 99.93% | Unkown | |
| HY-153306 | Zovegalisib | Inhibitor | 98.80% | Unkown |
| HY-126124 | AP39 | 96.35% | Unkown | |
| HY-101840A | EIPA hydrochloride | 98.01% | Unkown | |
| HY-112680A | Carboxy pyridostatin trifluoroacetate salt | 99.49% | Unkown | |
| HY-113354 | Anserine | 99.85% | Unkown | |
| HY-18100A | PRE-084 hydrochloride | 99.92% | Unkown | |
| HY-N0401A | (Z)-Ligustilide | 99.11% | Unkown | |
| HY-128144 | Lalistat 2 | 99.88% | Unkown | |
| HY-160818 | MC3138 | Activator | 99.92% | Unkown |
| HY-N2342 | Procyanidin C1 | Inducer | 99.54% | Unkown |
| HY-B0172A | Isoallolithocholic acid | 99.9% | Unkown | |
| HY-120912 | Gingerenone A | Activator | 99.95% | Unkown |
| HY-12336 | NIBR189 | Inhibitor | 99.71% | Unkown |
| HY-15648F | GSK-J4 hydrochloride | Inhibitor | 99.01% | Unkown |
| HY-W587486 | N-Acetyltaurine | 99.91% | Unkown | |
| HY-113308A | Taurolithocholic acid sodium salt | 99.81% | Unkown | |
| HY-112683A | V-9302 hydrochloride | Antagonist | 99.10% | Unkown |
| HY-103124 | DOI hydrochloride | Agonist | 99.61% | Unkown |
| HY-W088065 | Sodium formate | Inhibitor | 99.7% | Unkown |
| HY-W115718 | Cuprizone | 99.61% | Unkown | |
| HY-W010155 | Tryptophol | 99.96% | Unkown | |
| HY-14452A | Fatostatin hydrobromide | Inhibitor | 99.52% | Unkown |
| HY-101903A | BMS-309403 sodium | Inhibitor | 99.89% | Unkown |
| HY-136964 | Sulfo-NHS-Biotin sodium | 95.0% | Unkown | |
| HY-B0413 | Fenbendazole | 99.94% | Unkown | |
| HY-157646 | MZ-101 | 99.42% | Unkown | |
| HY-107202A | Poly (I:C):Kanamycin (1:1) | 48.6% | Unkown | |
| HY-N0058 | 4,5-Dicaffeoylquinic acid | 99.65% | Unkown | |
| HY-168374 | DSPE-PEG2000-Mannose | 90.0% | Unkown | |
| HY-P5912 | GluN1(356-385) | Inhibitor | 99.95% | Unkown |
| HY-P0267 | Melanotan (MT)-II | Agonist | 99.97% | Unkown |
| HY-13991 | CCG-1423 | 99.88% | Unkown | |
| HY-110126 | AR-C118925XX | Antagonist | ≥99.0% | Unkown |
| HY-NP141 | NP-BSA | / | Unkown | |
| HY-142295 | GNF2133 | Inhibitor | 99.67% | Unkown |
| HY-100433 | PACMA 31 | 99.32% | Unkown | |
| HY-123606 | GSK484 | Inhibitor | 99.14% | Unkown |
| HY-100367 | ES 936 | Inhibitor | 98.66% | Unkown |
| HY-143228 | SH-42 | Inhibitor | 99.87% | Unkown |
| HY-103157 | PD146176 | 99.59% | Unkown | |
| HY-126477 | NNK | 99.97% | Unkown | |
| HY-W140439 | 1-Oleoyl-sn-glycero-3-phosphocholine | 99.58% | Unkown | |
| HY-108065A | 3'-Sialyllactose sodium | Inhibitor | 99.89% | Unkown |
| HY-P2818 | Alkaline phosphatase, Bovine intestine | Inhibitor | / | Unkown |
| HY-150743 | ODN 2395 | Agonist | 98.39% | Unkown |
| HY-P2232 | Conalbumin | Inhibitor | / | Unkown |
| HY-W615108B | β-Nicotinamide mononucleotide, reduced form disodium | 99.55% | Unkown | |
| HY-107859 | Tris(2-chloroethyl) phosphate | 97.07% | Unkown | |
| HY-142035 | N-Propargylglycine | 99.70% | Unkown | |
| HY-N8518 | Malabaricone C | 99.46% | Unkown | |
| HY-P3479 | Insulin (swine) | 99.90% | Unkown | |
| HY-16561R | Resveratrol (Standard) | 99.95% | Unkown | |
| HY-P10746 | EB1002 | Agonist | 99.98% | Unkown |
| HY-112205 | RR-11a | Inhibitor | 96.20% | Unkown |
| HY-155489 | DDO-2728 | 98.64% | Unkown | |
| HY-P2260 | Tat-beclin 1 | 99.89% | Unkown | |
| HY-15217 | CHR-6494 | Inhibitor | 99.28% | Unkown |
| HY-P11274A | Zenagamtide sodium | Agonist | 99.96% | Unkown |
| HY-107855 | DL-Mevalonolactone | 99.15% | Unkown | |
| HY-119981 | Ani9 | Inhibitor | 99.12% | Unkown |
| HY-P1291 | PKI 14-22 amide,myristoylated | Inhibitor | 98.96% | Unkown |
| HY-W012980 | Isovaleric acid | Activator | ≥98.0% | Unkown |
| HY-157941 | ART0380 | Inhibitor | 99.90% | Unkown |
| HY-156856 | FL118-14-Propanol | 99.56% | Unkown | |
| HY-E70076 | Subtilisin, bacillus licheniformis | / | Unkown | |
| HY-158113 | CBPD-409 | Degrader | 99.38% | Unkown |
| HY-18768 | NCT-501 | 99.59% | Unkown | |
| HY-N1420 | Rhamnose | 99.35% | Yes | |
| HY-P10102 | Kp7-6 | 99.28% | Unkown | |
| HY-103450 | G36 | Antagonist | 99.35% | Unkown |
| HY-13631J | (1R,9R)-Exatecan mesylate | 99.49% | Unkown | |
| HY-N0528 | Linarin | 98.02% | Unkown | |
| HY-W071746 | Linolelaidic acid | Inhibitor | 99.96% | Unkown |
| HY-120110 | IOX4 | Antagonist | 99.96% | Unkown |
| HY-145319 | FPFT-2216 | Inhibitor | 99.75% | Unkown |
| HY-113308 | Taurolithocholic acid | 99.7% | Unkown | |
| HY-120782 | Yhhu-3792 | Activator | 99.34% | Unkown |
| HY-135747 | Gut restricted-7 | Inhibitor | 99.54% | Unkown |
| HY-P1924 | IRBP(651-670) human, mouse | Activator | 99.64% | Unkown |
| HY-W019599 | 4-Chloro-L-phenylalanine | Inhibitor | 98.19% | Unkown |
| HY-124675 | MYCMI-6 | 98.57% | Unkown | |
| HY-116330A | Hyperforin dicyclohexylammonium salt | 99.48% | Unkown | |
| HY-126573 | Trilaurin | 99.78% | Unkown | |
| HY-14414 | GSK4112 | Inhibitor | 99.87% | Unkown |
| HY-402361 | TERT activator-1 | 99.91% | Unkown | |
| HY-W016814 | (Z)-Aconitic acid | Inhibitor | 99.28% | Unkown |
| HY-113227 | Oxoadipic acid | 99.86% | Unkown | |
| HY-P2542 | GIP (3-42), human | Antagonist | 99.75% | Unkown |
| HY-167036 | DMG-PEG2000-Mal | 99.58% | Unkown | |
| HY-13631I | (1S,9R)-Exatecan mesylate | 99.11% | Unkown | |
| HY-W009203 | L-Cystine dihydrochloride | 98.0% | Unkown | |
| HY-124798 | Rheb inhibitor NR1 | Inhibitor | 99.26% | Unkown |
| HY-126255 | SBI-797812 | Activator | 99.88% | Unkown |
| HY-P1925A | GO-203 TFA | 98.39% | Unkown | |
| HY-W001083 | 3-Hydroxyphenylacetic acid | 99.77% | Unkown | |
| HY-W269593 | Perfluorodecanoic acid | Inhibitor | 98.0% | Unkown |
| HY-151462 | RP-6685 | Inhibitor | 99.96% | Unkown |
| HY-117235 | Diallyl Trisulfide | 99.9% | Unkown | |
| HY-117771 | DO34 | Inhibitor | 99.30% | Unkown |
| HY-N1411 | Platycodin D | Activator | 99.34% | Unkown |
| HY-W145499 | Zinc Gluconate | 98.0% | Yes | |
| HY-W583749 | 6:2 Cl-PFAES | 99.98% | Unkown | |
| HY-12220 | MM-102 | Inhibitor | 99.09% | Unkown |
| HY-N0217 | Benzoylaconine | 99.92% | Unkown | |
| HY-100591 | SirReal2 | Inhibitor | 99.0% | Unkown |
| HY-113556 | Sappanone A | 99.87% | Unkown | |
| HY-117755 | PF-739 | Activator | 99.79% | Unkown |
| HY-P1241 | BAM(8-22) | 99.89% | Unkown | |
| HY-150203 | GLPG3970 | Inhibitor | 99.70% | Unkown |
| HY-15698A | CRT0066101 dihydrochloride | 99.97% | Unkown | |
| HY-117370 | USP25/28 inhibitor AZ1 | Inhibitor | 98.0% | Unkown |
| HY-N6727 | Gliotoxin | 99.51% | Unkown | |
| HY-137207 | MK-28 | Activator | 99.88% | Unkown |
| HY-103017A | JH-X-119-01 | Inhibitor | 99.65% | Unkown |
| HY-145765 | JQAD1 | 98.24% | Unkown | |
| HY-N0815 | Resibufogenin | 99.93% | Unkown | |
| HY-123972 | SEC inhibitor KL-2 | Inhibitor | 99.49% | Unkown |
| HY-160229 | ssRNA40 sodium | 98.34% | Unkown | |
| HY-114169 | WRG-28 | Inhibitor | 99.76% | Unkown |
| HY-110279 | Ogerin | Modulator | 99.94% | Unkown |
| HY-114360 | Taurohyodeoxycholic acid | Inhibitor | 99.73% | Unkown |
| HY-W081067 | Perfluoro(2-methyl-3-oxahexanoic) acid | Agonist | 99.41% | Unkown |
| HY-P5381 | gp91 ds-tat | 99.00% | Unkown | |
| HY-W012977 | 3,3-Dimethyl-1-butanol | Inhibitor | 99.56% | Unkown |
| HY-N0010 | Geniposidic acid | 98.87% | Unkown | |
| HY-125833 | Alpha-Naphthoflavone | 99.76% | Unkown | |
| HY-W019670 | N4-Acetylcytidine | 99.65% | Unkown | |
| HY-Z0283 | Benzamide | Inhibitor | 99.74% | Unkown |
| HY-131181 | LEI-401 | Inhibitor | 99.73% | Unkown |
| HY-108527 | CD1530 | 98.01% | Unkown | |
| HY-113486 | Lathosterol | 99.96% | Unkown | |
| HY-161834 | RG100204 | Inhibitor | 99.50% | Unkown |
| HY-N1441 | Afzelin | 99.62% | Unkown | |
| HY-N9914 | D-Psicose | Inhibitor | 99.99% | Unkown |
| HY-113365 | Cholestenone | 99.95% | Unkown | |
| HY-119024 | BCI-137 | 99.84% | Unkown | |
| HY-155033 | SSI-4 | 99.99% | Unkown | |
| HY-175023A | OncoACP3 TFA | Ligand | 99.87% | Unkown |
| HY-P1680 | Astin C | Inhibitor | 99.47% | Unkown |
| HY-103181 | N6-Cyclopentyladenosine | 99.95% | Unkown | |
| HY-162874 | diABZI-V/C-DBCO | 98.66% | Unkown | |
| HY-164561 | TASIN-30 | 99.96% | Unkown | |
| HY-W014233 | L-Histidinol dihydrochloride | Inhibitor | 99.97% | Unkown |
| HY-12756 | E6446 | 98.78% | Unkown | |
| HY-W614507 | Dihydronicotinamide riboside | 95.0% | Unkown | |
| HY-138669 | C004019 | Degrader | 99.72% | Unkown |
| HY-148819A | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride | Inhibitor | 98.46% | Unkown |
| HY-156698 | HJM-561 | Degrader | 99.26% | Unkown |
| HY-B1260 | Cetrimonium bromide | 98.0% | Unkown | |
| HY-D0195 | Acesulfame potassium | 99.83% | Unkown | |
| HY-N0212 | Peimine | 99.9% | Unkown | |
| HY-N6871 | Abietic acid | Inhibitor | 92.70% | Unkown |
| HY-125474 | Carrageenan | Inhibitor | / | Unkown |
| HY-155956 | GM-90257 | 99.90% | Unkown | |
| HY-N6973 | Boldine | 99.24% | Unkown | |
| HY-113413 | Imidazoleacetic acid | Agonist | 99.80% | Unkown |
| HY-164899 | 2A3 | 99.92% | Unkown | |
| HY-108559 | L-161982 | Inhibitor | 99.33% | Unkown |
| HY-12756A | E6446 dihydrochloride | 99.29% | Unkown | |
| HY-15908 | BCA | Inhibitor | 99.99% | Unkown |
| HY-170621 | STAT1/3-IN-1 | Inhibitor | 99.23% | Unkown |
| HY-B0413S | Fenbendazole-d3 | 99.70% | Unkown | |
| HY-NP0204 | Mouse Serum Albumin | 95% | Unkown | |
| HY-P10736A | AMG133 peptide payload TFA | Agonist | 99.70% | Unkown |
| HY-160421 | TREM2-IN-1 | Inducer | 99.34% | Unkown |
| HY-117427 | D5D-IN-326 | 99.90% | Unkown | |
| HY-135982 | GPR81 agonist 1 | Inhibitor | 99.73% | Unkown |
| HY-154918 | LysoPE(18:2/0:0) | 99.59% | Unkown | |
| HY-157839 | PROTAC α-Synuclein/Tau degrader 1 | Degrader | 99.28% | Unkown |
| HY-P1587 | IRBP (1-20), human | 99.58% | Unkown | |
| HY-W014901 | Bisphenol F | 99.93% | Unkown | |
| HY-Y0396 | N-Hydroxyphthalimide | 99.89% | Unkown | |
| HY-153065 | KIF18A-IN-6 | Inhibitor | 98.48% | Unkown |
| HY-155998 | NF-κB-IN-11 | Inhibitor | 98.42% | Unkown |
| HY-N0826 | Corynoline | 98.84% | Unkown | |
| HY-W011725 | N-6-Methyl-2-deoxyadenosine | Inhibitor | 99.83% | Unkown |
| HY-W012974 | 3-Aminoisobutyric acid | 98.0% | Unkown | |
| HY-113283 | Homogentisic acid | 99.68% | Unkown | |
| HY-129079 | TFMB-(R)-2-HG | Inhibitor | 98.26% | Unkown |
| HY-14229 | TGR5 Receptor Agonist | Agonist | 99.67% | Unkown |
| HY-14507 | YK-4-279 | 99.91% | Unkown | |
| HY-150725C | ODN 1585 sodium | Inducer | 93.90% | Unkown |
| HY-156117 | LB244 | Inhibitor | 98.45% | Unkown |
| HY-156815 | YL-365 | Antagonist | 99.96% | Unkown |
| HY-172158 | ALKBH5-IN-5 | 99.66% | Unkown | |
| HY-N0171R | Beta-Sitosterol (Standard) | Inducer | 98.18% | Unkown |
| HY-P2994 | 3-Hydroxybutyrate dehydrogenase | / | Unkown | |
| HY-Y1191 | EEDQ | Antagonist | 99.97% | Unkown |
| HY-130321 | Lauroyl-L-carnitine chloride | Activator | 99.92% | Unkown |
| HY-161176 | PROTAC KRAS G12D degrader 1 | 98.32% | Unkown | |
| HY-134494 | MS48107 | 99.90% | Unkown | |
| HY-113201 | Tetradecanoylcarnitine | 99.85% | Unkown | |
| HY-113205 | 15-keto-Prostaglandin E2 | ≥99.0% | Unkown | |
| HY-122614 | S29434 | Inducer | 99.29% | Unkown |
| HY-124284 | Hexamethylene bisacetamide | 99.56% | Unkown | |
| HY-129983 | 5-Hydroxymethyl-2'-deoxyuridine | Inhibitor | 99.93% | Unkown |
| HY-148764 | M47 | 99.96% | Unkown | |
| HY-153392 | TYA-018 | Inhibitor | 99.84% | Unkown |
| HY-156483 | TT-012 | Inhibitor | 99.76% | Unkown |
| HY-159099 | WIZ degrader 9 | Degrader | 99.29% | Unkown |
| HY-N0745 | Senkyunolide I | Inhibitor | 99.37% | Unkown |
| HY-P1181A | Pam2CSK4 TFA | 99.46% | Unkown | |
| HY-W018161 | Hexadecanedioic acid | Inhibitor | 98.0% | Unkown |
| HY-110195 | Smurf1-IN-A01 | 99.81% | Unkown | |
| HY-13467 | AM-1638 | Agonist | 99.71% | Unkown |
| HY-128574 | D927 | Activator | 99.46% | Unkown |
| HY-15815 | Bromosporine | 99.89% | Unkown | |
| HY-108448 | N-Oleoyldopamine | 99.47% | Unkown | |
| HY-120601 | Alizarin Red S sodium | 95.0% | Unkown | |
| HY-D0873 | HEPPS | Inhibitor | 99.04% | Unkown |
| HY-N0515 | Ophiopogonin D | 99.80% | Unkown | |
| HY-P1149 | Epitalon | Activator | 99.63% | Yes |
| HY-P1676A | cyclo(RLsKDK) TFA | Inhibitor | 99.66% | Unkown |
| HY-W096638A | Glycerophosphocholine | 98.89% | Unkown | |
| HY-111754 | DMX-5804 | Inhibitor | 99.83% | Unkown |
| HY-149004 | SLF1081851 | Inhibitor | 98.02% | Unkown |
| HY-151504 | Engasertib | Inhibitor | 99.65% | Unkown |
| HY-107811 | Harmol | 99.81% | Unkown | |
| HY-132969 | SBP-3264 | 98.50% | Unkown | |
| HY-148141 | JPE-1375 | Antagonist | 99.96% | Unkown |
| HY-15166 | (E/Z)-Zotiraciclib | Inhibitor | 99.96% | Unkown |
| HY-173158 | AUR1545 | Inhibitor | 99.58% | Unkown |
| HY-178018 | D574-0246 | 99.95% | Unkown | |
| HY-N0493 | Pectolinarigenin | 99.98% | Unkown | |
| HY-N2393 | Kukoamine B | Inhibitor | 99.87% | Unkown |
| HY-N7106 | Dimethyl phthalate | Inducer | 99.87% | Unkown |
| HY-110197 | 6bK TFA | Inhibitor | 99.68% | Unkown |
| HY-150725 | ODN 1585 | Inducer | 92.48% | Unkown |
| HY-P1291A | PKI 14-22 amide,myristoylated TFA | Inhibitor | 99.79% | Unkown |
| HY-P1852 | TIP 39, Tuberoinfundibular Neuropeptide | 99.84% | Unkown | |
| HY-W010042 | L-Glucose | 99.90% | Unkown | |
| HY-159835 | Oveporexton | Agonist | 99.68% | Unkown |
| HY-113161 | L-Octanoylcarnitine | ≥99.0% | Unkown | |
| HY-120657 | 9-PAHSA | 99.88% | Unkown | |
| HY-175282 | ASX-173 | 98.47% | Unkown | |
| HY-18555 | TMPA | 98.40% | Unkown | |
| HY-79139 | Pteroic acid | 98.05% | Unkown | |
| HY-N0447 | 8-Gingerol | 99.82% | Unkown | |
| HY-N1916 | Coniferyl ferulate | 98.73% | Unkown | |
| HY-P1130 | M871 | Antagonist | 99.98% | Unkown |
| HY-P2818E | Alkaline Phosphatase, Calf intestinal | Inhibitor | / | Unkown |
| HY-P4190 | Fsh receptor-binding inhibitor fragment(bi-10) | Antagonist | 99.19% | Unkown |
| HY-W016781 | D-Arginine | 98.0% | Unkown | |
| HY-Y0152 | Cinchonine | 99.71% | Unkown | |
| HY-12246 | XEN445 | Inhibitor | 99.63% | Unkown |
| HY-12363 | U-69593 | Agonist | 99.73% | Unkown |
| HY-12443 | PF-5006739 | Inhibitor | 99.70% | Unkown |
| HY-132182 | HPA-12 | 99.40% | Unkown | |
| HY-153066 | VLS-1272 | 99.63% | Unkown | |
| HY-153617 | FOXO1-IN-3 | 99.47% | Unkown | |
| HY-155663 | GPX4-IN-5 | 99.73% | Unkown | |
| HY-156617A | (αR)-Cyclopropaneacetamide-Exatecan | Inhibitor | 99.93% | Unkown |
| HY-N1472 | Levistolide A | 99.34% | Unkown | |
| HY-P1434 | [Pro3]-GIP (mouse) | Antagonist | 98.84% | Unkown |
| HY-N15721 | Tryptophan-cholic acid | 99.75% | Unkown | |
| HY-148016 | I-287 | Inhibitor | 99.36% | Unkown |
| HY-163387 | CHI3L1-IN-1 | Inhibitor | 99.68% | Unkown |
| HY-110171A | iMDK quarterhydrate | Inhibitor | 99.37% | Unkown |
| HY-110192 | ML 297 | Activator | 99.14% | Unkown |
| HY-112411 | PD 174265 | 98.35% | Unkown | |
| HY-125848 | Ginsenoside F2 | 99.92% | Unkown | |
| HY-137500 | NT1-014B | 98.43% | Unkown | |
| HY-145479 | PROTAC AR-V7 degrader-1 | Inhibitor | 98.19% | Unkown |
| HY-149874 | BMS-502 | Inhibitor | 99.31% | Unkown |
| HY-170872 | PT-129 | 98.66% | Unkown | |
| HY-172371 | Hypoxystat | 99.28% | Unkown | |
| HY-173591 | T0080 | 99.94% | Unkown | |
| HY-B0900 | Anethole | 99.81% | Unkown | |
| HY-158231 | Polyether F127 Diacrylate | Activator | / | Unkown |
| HY-161409 | SC912 | 99.13% | Unkown | |
| HY-N0668 | Rubusoside | Inhibitor | 98.05% | Unkown |
| HY-N12060 | Ginkgo biloba extract | Inhibitor | / | Unkown |
| HY-N6013 | Aloin (mixture of A&B) | 99.36% | Unkown | |
| HY-N8522 | 9,10-Dihydroxystearic acid | 98.0% | Unkown | |
| HY-W009123 | Erucamide | Inhibitor | 99.32% | Unkown |
| HY-W013579 | (S)-(+)-Carvone | 99.26% | Unkown | |
| HY-W017522 | Adipic acid | Inhibitor | 99.82% | Unkown |
| HY-W134301 | Aluminum potassium sulfate | 99.6% | Unkown | |
| HY-118594 | Diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate | Inhibitor | 99.83% | Unkown |
| HY-122895 | E64FC26 | 98.48% | Unkown | |
| HY-18711A | SCR-1481B1 | Inhibitor | 99.95% | Unkown |
| HY-107818 | 4-Hydroxychalcone | Inhibitor | 99.29% | Unkown |
| HY-145746 | Sulfo-Cy5 azide | Substrate | 98.97% | Unkown |
| HY-147557 | PA-915 | Antagonist | 99.17% | Unkown |
| HY-156418 | KY386 | 99.86% | Unkown | |
| HY-N0433 | Astragaloside II | 99.93% | Unkown | |
| HY-N3415 | Kumatakenin | 99.31% | Unkown | |
| HY-N4283 | Coniferyl alcohol | Inhibitor | 99.94% | Unkown |
| HY-P10736 | AMG133 peptide payload | 99.94% | Unkown | |
| HY-P11460 | Vectofusin-1 | 98.77% | Unkown | |
| HY-P1149A | Epitalon TFA | Activator | 99.46% | Unkown |
| HY-P1290A | PKA Inhibitor Fragment (6-22) amide TFA | Inhibitor | 99.77% | Unkown |
| HY-P1684 | Peptide P60 | Inhibitor | 98.39% | Unkown |
| HY-159069 | Zymosan (ZM), 95% | 96.11% | Unkown | |
| HY-D0723 | 5(6)-TAMRA SE | ≥95.0% | Unkown | |
| HY-160023 | Elisrasib | 98.50% | Unkown | |
| HY-139439 | SBI-581 | 98.17% | Unkown | |
| HY-148560 | ccc_R08 | Inhibitor | 98.87% | Unkown |
| HY-116439 | Diisononyl phthalate | Inhibitor | 98.0% | Unkown |
| HY-121615 | α-Phellandrene | Activator | 85.70% | Unkown |
| HY-131034 | LP-922056 | Activator | 99.63% | Unkown |
| HY-162809 | XMU-MP-9 | 99.12% | Unkown | |
| HY-N0592A | Demethyleneberberine chloride | 98.90% | Unkown | |
| HY-N0663 | Talatisamine | 99.77% | Unkown | |
| HY-N0912 | Rehmannioside D | 99.89% | Unkown | |
| HY-N6257 | Cafestol | 99.91% | Unkown | |
| HY-P1136C | TAT-Gap19 TFA | 99.41% | Unkown | |
| HY-W008151 | Diphenyl Phosphate | Activator | 99.94% | Unkown |
| HY-W012732 | Isoquinoline | Inhibitor | 99.58% | Unkown |
| HY-W170255 | Sodium mercaptopyruvate | Inhibitor | / | Unkown |
| HY-128700 | Nicotinic acid mononucleotide | Activator | 98.08% | Unkown |
| HY-P1676 | cyclo(RLsKDK) | Inhibitor | 98.85% | Unkown |
| HY-P5322 | Thrombospondin (TSP-1)-derived CD36 binding motif | 99.58% | Unkown | |
| HY-168016 | PROTAC YAP degrader-1 | 99.77% | Unkown | |
| HY-13687A | IKK 16 hydrochloride | Inhibitor | 99.95% | Unkown |
| HY-103111 | MMPIP hydrochloride | Antagonist | 99.10% | Unkown |
| HY-113158 | 4-Hydroxyhippuric acid | 99.68% | Unkown | |
| HY-113421 | Linoleoyl ethanolamide | 99.98% | Unkown | |
| HY-156112 | LM2I | Activator | 99.78% | Unkown |
| HY-172208 | PROTAC cGAS degrader-1 | Degrader | 99.07% | Unkown |
| HY-N0468 | Rebaudioside D | 98.48% | Unkown | |
| HY-N0660 | Jujuboside B | 99.92% | Unkown | |
| HY-P10580 | Vasculotide | Activator | 99.84% | Unkown |
| HY-P1408 | Obtustatin | 99.94% | Unkown | |
| HY-P3343A | hFSH-β-(33-53) TFA | Antagonist | 99.56% | Unkown |
| HY-P5762 | Phoenixin-14 | 99.28% | Unkown | |
| HY-Y1139 | Pimelic acid | ≥98.0% | Unkown | |
| HY-W111581 | Copper(II) diethyldithiocarbamate | Inducer | 98.5% | Unkown |
| HY-101404A | L-Homocysteine thiolactone hydrochloride | 99.99% | Unkown | |
| HY-103151 | CP94253 hydrochloride | Agonist | 98.00% | Unkown |
| HY-103400 | 8-Chloroadenosine | 99.75% | Unkown | |
| HY-110120 | DSR-6434 | Agonist | 99.32% | Unkown |
| HY-124373 | ND-336 | Inhibitor | 97.16% | Unkown |
| HY-124717 | YC-001 | Antagonist | 99.43% | Unkown |
| HY-147323 | Ferulic acid 4-O-sulfate | 98.86% | Unkown | |
| HY-151902 | SJ988497 | Degrader | 99.03% | Unkown |
| HY-N1990 | Gypenoside XLIX | 99.88% | Unkown | |
| HY-N2127 | Pinostrobin | 99.98% | Unkown | |
| HY-N2345 | Procyanidin B3 | Inhibitor | 99.92% | Unkown |
| HY-P1108A | Astressin 2B TFA | Antagonist | 99.75% | Unkown |
| HY-P1422 | Spadin | 99.84% | Unkown | |
| HY-149648 | JNJ-8003 | Inhibitor | 99.84% | Unkown |
| HY-150364 | Farabursen | 99.74% | Unkown | |
| HY-101448 | TMI-1 | 99.57% | Unkown | |
| HY-105174A | BPC 157 acetate | Activator | 99.78% | Unkown |
| HY-107202GL | Polyinosinic-polycytidylic acid (GMP Like) | 90.5% | Unkown | |
| HY-110190 | VU0422288 | Modulator | 99.94% | Unkown |
| HY-121360 | Cylindrospermopsin | 98.76% | Unkown | |
| HY-122258 | NSC-370284 | Inhibitor | 99.27% | Unkown |
| HY-139534 | ARI-1 | 99.16% | Unkown | |
| HY-150654 | WDR5-IN-5 | Inhibitor | 99.56% | Unkown |
| HY-152670 | JC2-11 | Inhibitor | 98.03% | Unkown |
| HY-N0777 | Isorhamnetin-3-O-glucoside | 99.96% | Unkown | |
| HY-N1388 | Tussilagone | 99.52% | Unkown | |
| HY-P0132 | YIGSR | Inhibitor | 99.38% | Unkown |
| HY-P10586A | Macrophage-activating lipopeptide 2 TFA | 99.83% | Unkown | |
| HY-P1136B | TAT-Gap19 | 99.60% | Unkown | |
| HY-P5522A | TriDAP dihydrochloride | 99.16% | Unkown | |
| HY-W016145 | L-Glutamic acid monosodium hydrate | 98.0% | Unkown | |
| HY-Y0946 | Acetamide | 99.95% | Yes | |
| HY-13283 | MF63 | Inhibitor | 99.55% | Unkown |
| HY-114332 | GNE-8505 | Inhibitor | 99.53% | Unkown |
| HY-175701 | CT-996 | 99.97% | Unkown | |
| HY-145733 | DI-1859 | Inhibitor | 99.62% | Unkown |
| HY-145938 | OncoFAP | 99.77% | Unkown | |
| HY-106224A | Orexin A (human, rat, mouse) TFA | Agonist | 98.13% | Unkown |
| HY-107825 | Flavonol | Inhibitor | 99.86% | Unkown |
| HY-120597 | SAK3 | Activator | 99.80% | Unkown |
| HY-121675 | 2-Bromo-LSD | 97.26% | Unkown | |
| HY-12928 | ML336 | 99.65% | Unkown | |
| HY-132187 | Sphingosylphosphorylcholine | 99.50% | Unkown | |
| HY-150270A | NP-1815-PX sodium | 99.51% | Unkown | |
| HY-155994 | PIK5-12d | 99.15% | Unkown | |
| HY-168022 | CAM2602 | Inhibitor | 99.85% | Unkown |
| HY-169841 | IHCH-7086 | Agonist | 98.96% | Unkown |
| HY-B0708 | β-Estradiol 17-acetate | Agonist | 99.93% | Unkown |
| HY-N0541 | Pseudoginsenoside F11 | 99.87% | Unkown | |
| HY-N2173 | Forsythoside E | 99.01% | Unkown | |
| HY-P10218A | MANS peptide TFA | Inhibitor | 99.88% | Unkown |
| HY-P1192 | GR-73632 | Agonist | 99.89% | Unkown |
| HY-Y0624 | 4-Pentenoic acid | 99.93% | Unkown | |
| HY-157536 | SMT-738 | Inhibitor | 98.47% | Unkown |
| HY-P4846 | Ac-Pro-Gly-Pro-OH | 99.49% | Unkown | |
| HY-130602 | MS432 | Degrader | 99.72% | Unkown |
| HY-17598 | Rafoxanide | 98.60% | Unkown | |
| HY-W013411A | Locostatin | 99.88% | Unkown | |
| HY-114340 | LEM-14 | 98.02% | Unkown | |
| HY-115581A | Thymidine 3',5'-diphosphate tetrasodium | 98.75% | Unkown | |
| HY-119264A | PRLX-93936 dihydrochloride | 99.83% | Unkown | |
| HY-119684 | Maresin 2 | Inhibitor | 97.20% | Unkown |
| HY-129297 | CMPF | 99.64% | Unkown | |
| HY-147322 | YAP/TAZ inhibitor-2 | Inhibitor | 99.11% | Unkown |
| HY-156397 | HTH-02-006 | Inhibitor | 99.42% | Unkown |
| HY-170506 | KB-208 | Agonist | 98.00% | Unkown |
| HY-175232 | GL64 | 98.80% | Unkown | |
| HY-19350 | BML-210 | 98.04% | Unkown | |
| HY-B1002 | Oxolinic acid | Inhibitor | 98.97% | Unkown |
| HY-B1199 | Nialamide | 96.29% | Unkown | |
| HY-N3266 | Methyl rosmarinate | 99.89% | Unkown | |
| HY-N3519 | Platycodin D3 | 98.91% | Unkown | |
| HY-P0107A | RC-3095 TFA | Antagonist | 99.66% | Unkown |
| HY-P1907 | Human Papillomavirus (HPV) E7 protein (49-57) | 98.30% | Unkown | |
| HY-W009356 | L-Cystine hydrochloride | 98.0% | Unkown | |
| HY-W015464 | N-Isovaleroylglycine | 99.86% | Unkown | |
| HY-W015635 | Diallyl disulfide | Inhibitor | 99.8% | Unkown |
| HY-W016414 | Triethyl phosphate | 99.95% | Unkown | |
| HY-112812 | SCD1 inhibitor-1 | Inhibitor | 99.91% | Unkown |
| HY-147395 | GPR52 agonist-1 | Agonist | 99.76% | Unkown |
| HY-175603 | NCGC00685960 | Inhibitor | 99.97% | Unkown |
| HY-B2176I | ATP disodium salt, 100 mM Solution, PCR Grade | / | Unkown | |
| HY-N6987 | Licraside | 99.95% | Unkown | |
| HY-P10927 | BRP | 95.15% | Unkown | |
| HY-P1108 | Astressin 2B | Antagonist | 97.81% | Unkown |
| HY-P4070 | Insulin icodec | 95.00% | Unkown | |
| HY-W014421 | AP-18 | Inhibitor | 99.61% | Unkown |
| HY-101029 | MBM-55 | 99.94% | Unkown | |
| HY-117280 | GN25 | Activator | 98.55% | Unkown |
| HY-103316 | trans-Ned 19 | Inhibitor | 99.33% | Unkown |
| HY-124529 | Lunularin | Inhibitor | 99.87% | Unkown |
| HY-125961 | T3Inh-1 | Inhibitor | 99.93% | Unkown |
| HY-127034 | Antipain dihydrochloride | Inhibitor | 99.9% | Unkown |
| HY-135190 | (-)-Cedrene | Inhibitor | 98.0% | Unkown |
| HY-154946 | SUCNR1-IN-1 | Inhibitor | 99.39% | Unkown |
| HY-155193 | XY-52 | Inhibitor | 99.77% | Unkown |
| HY-160236 | 3-(3-Sulfooxyphenyl)propanoic acid | 99.11% | Unkown | |
| HY-19900 | ITX5061 | Inhibitor | 99.69% | Unkown |
| HY-N0754 | Eupalinolide A | 99.92% | Unkown | |
| HY-N2189 | Swertisin | 99.54% | Unkown | |
| HY-NP159 | House Dust Mite Extract, from D.farinae | Activator | / | Unkown |
| HY-P10302A | GLP-1R/GIPR agonist-1 (soduim) | Agonist | 98.24% | Unkown |
| HY-P3304 | MR 409 | Agonist | 99.98% | Unkown |
| HY-W001538 | S-Propargylcysteine | 97.0% | Unkown | |
| HY-W250574 | NOTA-bis(tBu)ester | 98.0% | Unkown | |
| HY-Y1212 | Celite | 98% | Unkown | |
| HY-110218 | CW 008 | Agonist | 98.15% | Unkown |
| HY-114918 | MS438 | Agonist | 99.85% | Unkown |
| HY-W075903 | Hexaamminecobalt(III) chloride | Activator | 99.50% | Unkown |
| HY-179078 | CT-179 | 99.79% | Unkown | |
| HY-103175 | PSB36 | Antagonist | 99.94% | Unkown |
| HY-103316A | Ned 19 | Inhibitor | 99.92% | Unkown |
| HY-108882C | DNase I (filtered) | / | Unkown | |
| HY-113236 | p-Synephrine | 99.90% | Unkown | |
| HY-116514 | (S)-(−)-Perillyl alcohol | 98.0% | Unkown | |
| HY-125130 | Hesperetin 7-O-glucoside | Inhibitor | 99.38% | Unkown |
| HY-131881 | JHU37160 | Agonist | 99.98% | Unkown |
| HY-136750 | Z-LLY-FMK | Inhibitor | 98.65% | Unkown |
| HY-147943 | PROTAC BTK Degrader-1 | 99.92% | Unkown | |
| HY-162312 | LLK203 | 98.58% | Unkown | |
| HY-164288 | TDI-6570 | Inhibitor | 99.64% | Unkown |
| HY-173522 | KIF2C-IN-1 | 98.08% | Unkown | |
| HY-N0120 | (E/Z)-Polydatin | 98.13% | Unkown | |
| HY-N0534 | Vitexin-2"-O-rhamnoside | 99.78% | Unkown | |
| HY-N0894 | Octahydrocurcumin | 99.25% | Unkown | |
| HY-N2877 | Annonacin | 98.09% | Unkown | |
| HY-P10086 | TREM-1 inhibitory peptide GF9 | Inhibitor | 99.41% | Unkown |
| HY-P1823 | C-Reactive Protein (CRP) (174-185) | 99.88% | Unkown | |
| HY-W013762 | Tributyl citrate | 98.33% | Unkown | |
| HY-W016969 | 2-Undecanone | 99.90% | Unkown | |
| HY-120601A | Alizarin Red S | 95.0% | Unkown | |
| HY-171034 | PQA-18 | Inhibitor | 99.62% | Unkown |
| HY-103017 | JH-X-119-01 hydrochloride | Inhibitor | 99.14% | Unkown |
| HY-116649 | CB1 antagonist 2 | Antagonist | 99.91% | Unkown |
| HY-13495 | ML281 | 98.04% | Unkown | |
| HY-161305 | SE-7552 | Inhibitor | 99.48% | Unkown |
| HY-162919 | YK-2168 | 98.05% | Unkown | |
| HY-N0434 | Astragaloside III | 99.70% | Unkown | |
| HY-P2455 | LLO (91-99) | 99.24% | Unkown | |
| HY-118424 | JNJ-55511118 | Inhibitor | 99.85% | Unkown |
| HY-119347 | Cirsilineol | Inhibitor | 98.0% | Unkown |
| HY-119678 | Fortunellin | Activator | 98.31% | Unkown |
| HY-125366 | ARI-3099 | Inhibitor | 99.95% | Unkown |
| HY-126146 | PKC-iota inhibitor 1 | Inhibitor | 99.60% | Unkown |
| HY-146754 | MMP2-IN-1 | 99.24% | Unkown | |
| HY-161246 | uPSEM792 | Agonist | 98.02% | Unkown |
| HY-161724 | TFEB activator 2 | 98.84% | Unkown | |
| HY-164027 | MyoMed 205 | Inhibitor | 99.31% | Unkown |
| HY-175465 | SMI-10B13 | Inhibitor | 99.30% | Unkown |
| HY-76228 | 1H-pyrazole | 99.78% | Unkown | |
| HY-B0854 | Mancozeb | 85.50% | Unkown | |
| HY-N0392 | Polygalasaponin F | 99.85% | Unkown | |
| HY-N0631 | Cornuside | Inhibitor | 99.99% | Unkown |
| HY-N0909 | Notoginsenoside R2 | 99.80% | Unkown | |
| HY-N2542 | Tubeimoside III | Inhibitor | 99.91% | Unkown |
| HY-N6066 | Praeruptorin E | 99.83% | Unkown | |
| HY-N6605 | Kaempferol 3-O-β-D-galactopyranoside | 99.58% | Unkown | |
| HY-N6893 | Ergolide | 99.48% | Unkown | |
| HY-N6924 | Zingibroside R1 | 99.75% | Unkown | |
| HY-N6983 | Licoricesaponin G2 | 99.87% | Unkown | |
| HY-N8307 | Syringaresinol | 99.66% | Unkown | |
| HY-P10271 | RG7697 | Agonist | 99.90% | Unkown |
| HY-W052508 | Norquetiapine | 99.95% | Unkown | |
| HY-16639 | ML314 | Agonist | 99.52% | Unkown |
| HY-101005 | N-Methylhistamine dihydrochloride | 99.99% | Unkown | |
| HY-105416 | Calphostin C | Inhibitor | 99.9% | Unkown |
| HY-107648 | McN-A-343 | Agonist | 99.89% | Unkown |
| HY-113412A | 3-Methylhistamine dihydrochloride | 99.80% | Unkown | |
| HY-113440 | 5-Methoxytryptophol | 99.95% | Unkown | |
| HY-120813 | ARN 077 | Inhibitor | 99.82% | Unkown |
| HY-12736A | GSK143 dihydrochloride | Inhibitor | 99.37% | Unkown |
| HY-131904A | Hex | Inhibitor | 99.62% | Unkown |
| HY-135042 | CAY10614 | Antagonist | 98.87% | Unkown |
| HY-145313 | TTBK1-IN-2 | Inhibitor | 99.91% | Unkown |
| HY-151852 | 9AzNue5Ac | ≥95.0% | Unkown | |
| HY-15805 | KIN-8194 | Inhibitor | 99.26% | Unkown |
| HY-159124 | YZL-51N | Inhibitor | 95.0% | Unkown |
| HY-160768 | OTUB2-IN-1 | Inhibitor | 98.79% | Unkown |
| HY-162495 | IDOR-1117-2520 | 99.94% | Unkown | |
| HY-162938 | Skp2 inhibitor 3 | Inhibitor | 98.07% | Unkown |
| HY-163436 | F44-A13 | 96.73% | Unkown | |
| HY-177105 | JNJ-6640 | Inhibitor | 99.72% | Unkown |
| HY-N0026 | 2'-Acetylacteoside | Inhibitor | 99.73% | Unkown |
| HY-N2067 | Vanillyl alcohol | Inhibitor | 99.68% | Unkown |
| HY-N2108 | 7-Ethylcamptothecin | Inhibitor | 99.58% | Unkown |
| HY-N2673 | 5-Heptadecylresorcinol | Activator | 99.83% | Unkown |
| HY-N4110 | Friedelin | Inhibitor | 99.0% | Unkown |
| HY-N4183 | Licoflavone C | 99.83% | Unkown | |
| HY-N5106 | (E)-Flavokawain A | Inducer | 99.53% | Unkown |
| HY-N6715 | Tenuazonic acid | Inhibitor | 99.58% | Unkown |
| HY-N9536 | Cinnamtannin A2 | 97.66% | Unkown | |
| HY-P2260B | Tat-beclin 1 scrambled | 99.10% | Unkown | |
| HY-W018171 | 3,5,6-Trichloro-2-pyridinol | 99.85% | Unkown | |
| HY-W072025 | CYP2E1-IN-1 | 99.95% | Unkown | |
| HY-Y1217 | 1-Cyclohexanol | 99.94% | Unkown | |
| HY-12184 | ONO-AE 248 | Agonist | 98.27% | Unkown |
| HY-135700 | Mevalonolactone | 98.0% | Unkown | |
| HY-N0204 | Pulchinenoside A | Activator | 98.81% | Unkown |
| HY-W419700 | L-Glutamic acid ammonium | 98.0% | Unkown | |
| HY-126328 | PKC-theta inhibitor 1 | Inhibitor | 99.45% | Unkown |
| HY-152142 | DN-1289 | Inhibitor | 99.63% | Unkown |
| HY-155351 | PARP7-IN-15 | Inhibitor | 99.03% | Unkown |
| HY-156856S | FL118-14-Propanol-d5 | 97.86% | Unkown | |
| HY-125858 | MI-1061 | 99.08% | Unkown | |
| HY-15157 | Calcitetrol | Activator | 99.94% | Unkown |
| HY-114557 | NSC 90469 | 99.41% | Unkown | |
| HY-124813 | PDZ1i | Inhibitor | 99.29% | Unkown |
| HY-125039 | N-Acetyl lysyltyrosylcysteine amide | Inhibitor | 99.81% | Unkown |
| HY-125138 | ω-Muricholic Acid | 99.24% | Unkown | |
| HY-128387 | 2,3-Butanediol | 99.96% | Unkown | |
| HY-131605B | Ganciclovir triphosphate disodium solution (100 mM ± 3 mM) | Inhibitor | 98.65% | Unkown |
| HY-143889 | Senexin C | Inhibitor | 99.19% | Unkown |
| HY-148488 | A18-Iso5-2DC18 | Activator | 95.0% | Unkown |
| HY-15166A | (E/Z)-Zotiraciclib hydrochloride | Inhibitor | 99.90% | Unkown |
| HY-155157 | PF-07247685 | Inhibitor | 98.66% | Unkown |
| HY-15800A | CZC-25146 | Inhibitor | 99.10% | Unkown |
| HY-159120 | ZG-2291 | Inhibitor | 98.08% | Unkown |
| HY-164373 | SC428 | 98.0% | Unkown | |
| HY-16561S | Resveratrol-d4 | 99.9% | Unkown | |
| HY-173268 | UNC9426 | Inhibitor | 99.51% | Unkown |
| HY-177475 | LysoPC(20:4) | 96.74% | Unkown | |
| HY-177704 | ACSL5-IN-1 | Inhibitor | 99.88% | Unkown |
| HY-178159 | SA91-0178 | Inhibitor | 98.14% | Unkown |
| HY-21196A | Potassium perfluorohexanesulfonate | 98.0% | Unkown | |
| HY-B1169 | Timonacic | ≥98.0% | Unkown | |
| HY-N0237 | Atractyloside A | 98.11% | Unkown | |
| HY-N0914 | Ajugol | 99.80% | Unkown | |
| HY-N1570 | Pterosin B | Inhibitor | 99.98% | Unkown |
| HY-N6967 | Levomenol | Inhibitor | 99.22% | Unkown |
| HY-N7271 | Solanidine | 99.90% | Unkown | |
| HY-P3302 | Sialylglycopeptide | Inhibitor | 97.50% | Unkown |
| HY-P4086 | Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) | 99.36% | Unkown | |
| HY-W009417 | Cedryl acetate | Inhibitor | 99.43% | Unkown |
| HY-W010520 | Methylisothiazolinone | 99.07% | Unkown | |
| HY-W017100 | 2-Hydroxy-6-methoxybenzoic acid | 99.34% | Unkown | |
| HY-W018723 | 4-Aminobenzamidine dihydrochloride | Inhibitor | 99.97% | Unkown |
| HY-Y0850O | Polyvinyl alcohol (Mw 31000-50000, 87-89% hydrolyzed) | 88.3% | Unkown | |
| HY-19699 | 1-Naphthylacetamide | / | Unkown | |
| HY-W010989 | Gly-His-Lys acetate | Inhibitor | 99.68% | Unkown |
| HY-112056 | DIM-C-pPhCO2Me | 99.47% | Unkown | |
| HY-121246 | Fluorofenidone | Inhibitor | 99.78% | Unkown |
| HY-122895A | (E/Z)-E64FC26 | 99.80% | Unkown | |
| HY-144070 | ErSO-DFP | 99.56% | Unkown | |
| HY-100603 | GSK-F1 | Inhibitor | 95.06% | Unkown |
| HY-101018 | Propionyl-DL-carnitine chloride | 98.10% | Unkown | |
| HY-103290 | R715 | Antagonist | 99.67% | Unkown |
| HY-113314 | AFMK | 99.97% | Unkown | |
| HY-123936 | SR12343 | Inhibitor | 99.66% | Unkown |
| HY-125290 | MU1210 | Inhibitor | 99.50% | Unkown |
| HY-128129 | UT-B-IN-1 | Inhibitor | 99.68% | Unkown |
| HY-139192 | Brophenexin | 98.74% | Unkown | |
| HY-149091 | KDM5B-IN-4 | Inhibitor | 99.68% | Unkown |
| HY-149265 | ROS-generating agent 1 | 99.11% | Unkown | |
| HY-149766 | PB94 | Inhibitor | 98.02% | Unkown |
| HY-149923 | GPX4-IN-4 | Inhibitor | 98.94% | Unkown |
| HY-153261 | NLRP3-IN-17 | Inhibitor | 99.02% | Unkown |
| HY-156437 | NBI-961 | 99.73% | Unkown | |
| HY-157581 | MS39 | Degrader | 99.89% | Unkown |
| HY-160765 | WNTinib | 99.95% | Unkown | |
| HY-162565 | CDD-2807 | Inhibitor | 99.52% | Unkown |
| HY-163476 | PIP5K1C-IN-1 | Inhibitor | 98.71% | Unkown |
| HY-167832 | PT109 | 99.20% | Unkown | |
| HY-168035 | W4275 | Inhibitor | 98.93% | Unkown |
| HY-168162 | ZLC491 | Degrader | 98.51% | Unkown |
| HY-186096 | LP-856866 | 99.92% | Unkown | |
| HY-34596 | 4-Hydroxyindole | Inhibitor | 98.06% | Unkown |
| HY-B1835 | Benzylhydrazine | Inhibitor | 95.0% | Unkown |
| HY-N0167 | Gynostemma Extract | Inhibitor | 99.92% | Unkown |
| HY-N0778 | Isorhamnetin-3-O-neohespeidoside | Inhibitor | 99.93% | Unkown |
| HY-N0902 | Dihydrosanguinarine | Inhibitor | 99.98% | Unkown |
| HY-N0920 | Dihydrokavain | Inhibitor | 99.94% | Unkown |
| HY-N1109 | Uvaol | Inducer | 99.20% | Unkown |
| HY-N2255 | Crebanine | 99.83% | Unkown | |
| HY-N3389 | Licoisoflavone A | 99.53% | Unkown | |
| HY-P10234A | Poneratoxin acetate | Modulator | 98.35% | Unkown |
| HY-P2203 | SAHM1 | Inhibitor | 96.48% | Unkown |
| HY-116538 | (10E,12Z)-Octadeca-10,12-dienoic acid | Activator | 99.10% | Unkown |
| HY-12758 | YHO-13351 | Inhibitor | 99.16% | Unkown |
| HY-139410 | Sodium caseinates | Activator | / | Unkown |
| HY-160912 | ELOVL6-IN-5 | Inhibitor | 95.12% | Unkown |
| HY-B1847 | Terbuthylazine | 98.0% | Unkown | |
| HY-N10991 | Crocetin dialdehyde | 99.75% | Unkown | |
| HY-W142432 | Perfluoroundecanoic acid | Activator | 99.85% | Unkown |
| HY-W753791 | (±)-Perillaldehyde | 96.70% | Unkown | |
| HY-13207A | ONX-0914 TFA | 98.01% | Unkown | |
| HY-19337 | Ketodarolutamide | Antagonist | 98.72% | Unkown |
| HY-186095 | LP-911888 | Inhibitor | 99.83% | Unkown |
| HY-111358 | TLR7 agonist 1 | Agonist | 98.19% | Unkown |
| HY-101139A | Xanthine amine congener hydrochloride | Antagonist | 98.03% | Unkown |
| HY-107527 | Org 25543 hydrochloride | Inhibitor | 99.93% | Unkown |
| HY-109506S | DPPC-d62 | 99.0% | Unkown | |
| HY-110206 | AM6545 | Antagonist | 99.32% | Unkown |
| HY-111237 | Butyrolactone I | Inhibitor | 99.80% | Unkown |
| HY-113357 | m-Coumaric acid | 99.96% | Unkown | |
| HY-116193 | 5-PAHSA | 99.97% | Unkown | |
| HY-116568 | Prothioconazole | 99.52% | Unkown | |
| HY-121065 | BN-82685 | Inhibitor | 99.05% | Unkown |
| HY-124061 | GB83 | Antagonist | 99.80% | Unkown |
| HY-129421 | PA-9 | 99.73% | Unkown | |
| HY-131501 | Menaquinone 9 | 98.0% | Unkown | |
| HY-133079 | Ascorbyl tetra-2-hexyldecanoate | Inhibitor | 98.0% | Unkown |
| HY-141582 | Ceramide 3 | Inhibitor | 98.0% | Unkown |
| HY-141831 | STF-1084 | Inhibitor | 99.92% | Unkown |
| HY-145147 | AAA-10 | Inhibitor | 99.97% | Unkown |
| HY-148413 | Aprinocarsen sodium | Inhibitor | 98.42% | Unkown |
| HY-148422 | Rohinitib | 99.87% | Unkown | |
| HY-159102 | PVP-037.2 | Agonist | 99.18% | Unkown |
| HY-163087 | PT-91 | Agonist | 98.78% | Unkown |
| HY-163987 | SIRT3 activator 2 | Activator | 98.94% | Unkown |
| HY-171705 | KMS99220 | 99.48% | Unkown | |
| HY-173266A | TO-1187 TFA | Degrader | 98.41% | Unkown |
| HY-173396 | VU0467319 | Modulator | 98.53% | Unkown |
| HY-174802 | XL-3158 | Inhibitor | 99.55% | Unkown |
| HY-175341 | Rac1-IN-5 | Inhibitor | 99.84% | Unkown |
| HY-18775 | N6-(4-Hydroxybenzyl)adenosine | 99.84% | Unkown | |
| HY-B1941 | 4-tert-Octylphenol | 99.70% | Unkown | |
| HY-B2046 | Simazine | 99.44% | Unkown | |
| HY-N0241 | Rhodionin | Inhibitor | 99.73% | Unkown |
| HY-N0506 | Rosarin | 99.96% | Unkown | |
| HY-N0654 | Corypalmine | 99.51% | Unkown | |
| HY-N0670 | Tenacissoside H | Inhibitor | 99.89% | Unkown |
| HY-N10549 | Gigantol | 99.79% | Unkown | |
| HY-N2445 | Flavokawain C | 99.79% | Unkown | |
| HY-N6962 | α-Spinasterol | 99.90% | Unkown | |
| HY-N8210 | Homoeriodictyol | 99.86% | Unkown | |
| HY-P1106A | K41498 TFA | Antagonist | 98.71% | Unkown |
| HY-P11303 | PADRE peptide | Ligand | 98.28% | Unkown |
| HY-P1422A | Spadin TFA | 99.73% | Unkown | |
| HY-W044764 | 2-Benzylsuccinic acid | Inhibitor | 99.83% | Unkown |
| HY-W093416 | 3,3-Azo-1-butanol | / | Unkown | |
| HY-W354498 | L-Octanoylcarnitine hydrochloride | 98.0% | Unkown | |
| HY-W590549 | Dioleyldimethylammonium chloride | 95.88% | Unkown | |
| HY-125938 | Cycloartenyl ferulate | 99.15% | Unkown | |
| HY-134633 | Alpha-lipoic acid choline ester chloride | 99.72% | Unkown | |
| HY-164546 | WB436B | 99.93% | Unkown | |
| HY-B2241A | Potassiumalum, for cell culture | 98.01% | Unkown | |
| HY-N3015 | Bruceine E | 97.32% | Unkown | |
| HY-W011963 | Melevodopa hydrochloride | 99.76% | Unkown | |
| HY-W153159 | N-Methyltyramine hydrochloride | Agonist | 99.84% | Unkown |
| HY-W243408C | Calcium carbonate, 99% | 99.52% | Unkown | |
| HY-114311 | FGFR1/DDR2 inhibitor 1 | Inhibitor | 98.26% | Unkown |
| HY-12929 | NSC756093 | 99.58% | Unkown | |
| HY-112198 | AZ31 | Inhibitor | 98.22% | Unkown |
| HY-148859 | AA-T3A-C12 | 99.76% | Unkown | |
| HY-B0448S | Phenytoin-d10 | Inhibitor | 99.50% | Unkown |
| HY-108497 | L-803087 | Agonist | 99.66% | Unkown |
| HY-111432 | CCG-232601 | Inhibitor | 99.00% | Unkown |
| HY-114962 | S-22153 | Antagonist | 99.94% | Unkown |
| HY-128700A | Nicotinic acid mononucleotide triethylamine | Activator | 99.89% | Unkown |
| HY-144372 | TRPV1 antagonist 3 | Antagonist | 99.30% | Unkown |
| HY-163455 | pan-HCN-IN-1 | Inhibitor | 99.84% | Unkown |
| HY-169120 | FKB04 | Inhibitor | 99.98% | Unkown |
| HY-171160 | WYFA-15 | Inhibitor | 98.77% | Unkown |
| HY-172760 | CIM-834 | Inhibitor | 99.14% | Unkown |
| HY-174166 | AqF026 | Activator | 99.05% | Unkown |
| HY-174876 | PZ671 | 98.70% | Unkown | |
| HY-174976 | FHND5032 | Inhibitor | 99.49% | Unkown |
| HY-175222 | GlcNAc-MurNAc | Inhibitor | 95.37% | Unkown |
| HY-175416 | Yoda2 | Agonist | 99.57% | Unkown |
| HY-B1636 | Dithiazanine iodide | Inhibitor | 99.46% | Unkown |
| HY-N0757 | 8-O-Acetylharpagide | 99.75% | Unkown | |
| HY-N0930A | Galegine hemisulfate | 99.70% | Unkown | |
| HY-N1050 | Zederone | Inhibitor | 99.61% | Unkown |
| HY-N4107 | Phyllanthin | Inhibitor | 99.97% | Unkown |
| HY-N5025 | Bullatine A | Inhibitor | 98.0% | Unkown |
| HY-NP159A | House Dust Mite Extract, from D.pteronyssinus | Activator | / | Unkown |
| HY-P10218 | MANS peptide | Inhibitor | 99.66% | Unkown |
| HY-P11058 | OVA(250-264) | 98.14% | Unkown | |
| HY-W010516 | 2-Methylvaleric acid | 99.98% | Unkown | |
| HY-W014125 | Undecanedioic acid | 98.0% | Unkown | |
| HY-W015616 | Benzylacetone | Inhibitor | 99.98% | Unkown |
| HY-W018587 | TBPH | 95.0% | Unkown | |
| HY-W668775 | Quin-C7 | Antagonist | 99.76% | Unkown |
| HY-Y0850U6 | PVA (Mw 205000) | / | Unkown | |
| HY-117924 | AUTEN-67 | Inducer | 97.14% | Unkown |
| HY-136450 | Triclabendazole sulfoxide | Inhibitor | 98.34% | Unkown |
| HY-15266 | 24R-Calcipotriol | Activator | 94.85% | Unkown |
| HY-165035 | Glucosylceramide (gaucher's spleen) | 98.0% | Unkown | |
| HY-21197 | Perfluoroenanthic acid | Modulator | 98.0% | Unkown |
| HY-B1434 | 7-Aminocephalosporanic acid | Inhibitor | 98.0% | Unkown |
| HY-N10889 | Sominone | Activator | 99.96% | Unkown |
| HY-N2736 | 3′,4′,7-Trihydroxyflavone | Inhibitor | 99.04% | Unkown |
| HY-P5523A | iE-DAP dihydrochloride | 99.72% | Unkown | |
| HY-Y0498 | Aluminum oxide | 99% | Unkown | |
| HY-111751 | JNJ-61432059 | Modulator | 99.18% | Unkown |
| HY-112081 | BAY-707 | Inhibitor | 99.64% | Unkown |
| HY-128879A | VP3.15 dihydrobromide | Inhibitor | 98.0% | Unkown |
| HY-128914 | Tubulysin | 99.60% | Unkown | |
| HY-163198 | ASCT2-IN-1 | 98.21% | Unkown | |
| HY-15427 | GDC-0834 | Inhibitor | 98.05% | Unkown |
| HY-N0901A | Corynoxine B | Inhibitor | 99.76% | Unkown |
| HY-101230 | ICI 174864 | 98.84% | Unkown | |
| HY-103249 | Reutericyclin | Inhibitor | 98.11% | Unkown |
| HY-103505 | CL 218872 | Modulator | 99.25% | Unkown |
| HY-114170 | ML604440 | Inhibitor | 98.28% | Unkown |
| HY-116818 | Crebinostat | Inhibitor | 98.83% | Unkown |
| HY-120589 | VU0360172 | Agonist | 98.07% | Unkown |
| HY-121035 | 7BIO | Inhibitor | 99.20% | Unkown |
| HY-12143 | Vofopitant dihydrochloride | Antagonist | 99.56% | Unkown |
| HY-12242 | GBR 12935 dihydrochloride | Inhibitor | 99.80% | Unkown |
| HY-122830 | DD-03-171 | 98.72% | Unkown | |
| HY-122920 | Soyasaponin II | Inhibitor | 99.81% | Unkown |
| HY-123297 | TUG-469 | Agonist | 99.67% | Unkown |
| HY-125527A | 17(R)-Resolvin D1 | Inhibitor | 99.69% | Unkown |
| HY-139667 | PKM2-IN-3 | Inhibitor | 99.44% | Unkown |
| HY-142295A | GNF2133 hydrochloride | Inhibitor | 99.86% | Unkown |
| HY-143793 | RBP4 inhibitor 1 | Inhibitor | 99.49% | Unkown |
| HY-145119S | Mindeudesivir | 98.20% | Unkown | |
| HY-149862 | ARD-2051 | Degrader | 98.57% | Unkown |
| HY-15344 | Ketone monoester | 95.0% | Unkown | |
| HY-153999A | Rondaptivon pegol sodium | Inhibitor | 98.20% | Unkown |
| HY-15844 | AG-825 | 98.13% | Unkown | |
| HY-161059 | ZB-R-55 | Inhibitor | 99.39% | Unkown |
| HY-161723 | LH2-051 | Inhibitor | 99.85% | Unkown |
| HY-162596 | NRL-1049 | Inhibitor | 99.96% | Unkown |
| HY-163905 | EG-2184 | Inhibitor | 99.50% | Unkown |
| HY-167856A | RTI-122 dihydrochloride | Agonist | 99.36% | Unkown |
| HY-168894 | CT-1 | 99.90% | Unkown | |
| HY-172209 | PPIA-IN-1 | 96.90% | Unkown | |
| HY-172550 | MS7710 | Inhibitor | 98.86% | Unkown |
| HY-173425 | STING-IN-15 | Inhibitor | 99.04% | Unkown |
| HY-174346 | Skp2-IN-4 | 98.60% | Unkown | |
| HY-178500A | WCY-8-67 TFA | 99.40% | Unkown | |
| HY-18102 | GLPG0492 | Modulator | 99.85% | Unkown |
| HY-21193 | Perfluoropentanoic acid | 98.0% | Unkown | |
| HY-A0277 | Cyproconazole | Inhibitor | 98.72% | Unkown |
| HY-D2363 | DOTA.SA.FAPi TFA | Inhibitor | 99.26% | Unkown |
| HY-N0307 | Ciwujianoside B | Inhibitor | 99.68% | Unkown |
| HY-N1510 | Kaempferol 3-O-gentiobioside | Inhibitor | 99.88% | Unkown |
| HY-N8157 | 4'-O-Methylpyridoxine | 99.92% | Unkown | |
| HY-P10032 | NN1177 | 99.54% | Unkown | |
| HY-P10502A | L57 acetate | 99.01% | Unkown | |
| HY-P11005 | P259 | Inhibitor | 99.75% | Unkown |
| HY-P1259A | PR-39 TFA | Inhibitor | 99.89% | Unkown |
| HY-P2612 | WP9QY | 99.79% | Unkown | |
| HY-P4076 | MPG peptides, Pβ | 98.26% | Unkown | |
| HY-P5883 | TAT-M2NX | Inhibitor | 99.55% | Unkown |
| HY-W008951 | Ethylenediaminetetra(methylenephosphonic acid) | 99.9% | Unkown | |
| HY-W654264 | 2-Methylbutyrylcarnitine chloride | Activator | 98.92% | Unkown |
| HY-Y1809 | 1-Hydroxyoctadecane | 99.65% | Unkown | |
| HY-125539 | Roridin E | Inhibitor | 99.82% | Unkown |
| HY-176886 | LATS-IN-2 | Inhibitor | 99.45% | Unkown |
| HY-44178 | Diethyl butylmalonate | Inhibitor | 99.79% | Unkown |
| HY-W021450A | DL-Fluorocitric acid barium | / | Unkown | |
| HY-132302 | Hu7691 | Inhibitor | 99.91% | Unkown |
| HY-149480 | ERD-3111 | Degrader | 98.72% | Unkown |
| HY-16985S | Darolutamide-d4 | Antagonist | 98.58% | Unkown |
| HY-172918 | VV261 | Inhibitor | 99.92% | Unkown |
| HY-100968 | GBR 12783 dihydrochloride | Inhibitor | 99.14% | Unkown |
| HY-101248 | GR-46611 | Agonist | 99.86% | Unkown |
| HY-107734 | L 152804 | Antagonist | 99.89% | Unkown |
| HY-108485 | Damnacanthal | 99.40% | Unkown | |
| HY-110329 | ML179 | Agonist | 99.73% | Unkown |
| HY-112680 | Carboxypyridostatin | 99.41% | Unkown | |
| HY-12124 | BBS-4 | Inhibitor | 99.49% | Unkown |
| HY-128454 | Dimethyl trisulfide | 99.71% | Unkown | |
| HY-134858 | GSK716 | Inhibitor | 99.77% | Unkown |
| HY-138668 | JW-65 | Inhibitor | 99.05% | Unkown |
| HY-139178 | KVA-D-88 | Inhibitor | 99.81% | Unkown |
| HY-139401 | FAPI-34 | Ligand | 98.04% | Unkown |
| HY-139838 | Epyrifenacil | 99.04% | Unkown | |
| HY-143412 | MIR002 | 99.0% | Unkown | |
| HY-147204 | Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE | 99.82% | Unkown | |
| HY-147222 | SAE-14 | Antagonist | 98.60% | Unkown |
| HY-148152A | PSMA I&S TFA | 98.22% | Unkown | |
| HY-151425 | TDO-IN-1 | Inhibitor | 98.67% | Unkown |
| HY-153068 | CZL55 | Inhibitor | 98.92% | Unkown |
| HY-153695 | TXA707 | Inhibitor | 99.92% | Unkown |
| HY-153832 | MSU-42011 | 99.64% | Unkown | |
| HY-155478 | Androgen receptor-IN-6 | Inhibitor | 98.26% | Unkown |
| HY-158684 | YX-02-030 | 99.86% | Unkown | |
| HY-160237 | HYL001 | Inhibitor | 99.94% | Unkown |
| HY-164495 | Sob-AM2 | Agonist | 98.5% | Unkown |
| HY-172157 | HDAC11-IN-2 | 99.52% | Unkown | |
| HY-176428 | PROTAC MNK1 degrader-1 | 98.93% | Unkown | |
| HY-176533 | S1PR5-IN-1 | Inhibitor | 99.58% | Unkown |
| HY-19416 | AEOL-10150 pentachloride | 98.0% | Unkown | |
| HY-B2010 | Fomesafen | 99.81% | Unkown | |
| HY-N2135 | Puerarin 6''-O-Xyloside | 99.81% | Unkown | |
| HY-N6017 | Bakkenolide A | 99.99% | Unkown | |
| HY-N7144A | Citronellyl acetate | 98.0% | Unkown | |
| HY-N7515 | Pinocembrin chalcone | 98.74% | Unkown | |
| HY-P10109 | G6PI 325-339 (human) | Activator | 95.00% | Unkown |
| HY-P10235 | Cyclic AC253 | Antagonist | 99.83% | Unkown |
| HY-P10412 | A11 | Inhibitor | 98.49% | Unkown |
| HY-P3102 | GLP-1(32-36)amide | 98.44% | Unkown | |
| HY-P3134A | CPN-267 TFA | Agonist | 99.64% | Unkown |
| HY-W001925 | 7-Methoxy-1-tetralone | 99.93% | Unkown | |
| HY-W011168 | 8-Bromo-2'-deoxyguanosine | 98.0% | Unkown | |
| HY-W250121 | Tragacanth gum | / | Unkown | |
| HY-W923189 | Neral | 97.87% | Unkown | |
| HY-101393A | CGP 12177 hydrochloride | Modulator | 99.69% | Unkown |
| HY-13225B | Rivanicline hemioxalate | Agonist | 99.78% | Unkown |
| HY-148506 | 5'-ODMT cEt m5U Phosphoramidite (Amidite) | 99.76% | Unkown | |
| HY-149449 | Poly-L-γ-glutamic acid sodium | / | Unkown | |
| HY-33015A | 4-Chlorocinnamaldehyde | Inhibitor | 99.83% | Unkown |
| HY-B0973 | Dibenzothiophene | Inhibitor | 99.92% | Unkown |
| HY-W002199 | 6:2 Fluorotelomer alcohol | 99.96% | Unkown | |
| HY-W020246 | Tetramethylthiuram monosulfide | Inhibitor | 99.71% | Unkown |
| HY-W677042 | α-Androstenol | Activator | 99.85% | Unkown |
| HY-145119 | GS-621763 | Inhibitor | 99.72% | Unkown |
| HY-120000 | MS402 | Inhibitor | 98.36% | Unkown |
| HY-145774 | PD-1/PD-L1-IN-23 | Inhibitor | 99.98% | Unkown |
| HY-159692 | AZD8701 | Inhibitor | 96.61% | Unkown |
| HY-186028 | HOR1-C59 | Agonist | 99.89% | Unkown |
| HY-43521 | Ibrutinib-MPEA | Inhibitor | 99.71% | Unkown |
| HY-W587486R | N-Acetyltaurine (Standard) | Activator | 99.33% | Unkown |
| HY-103333 | Arvanil | 99.1% | Unkown | |
| HY-106755 | Tucaresol | Inhibitor | 97.50% | Unkown |
| HY-106929 | Moxilubant | Antagonist | 99.83% | Unkown |
| HY-107748 | 5'-Guanidinonaltrindole hydrochloride | Antagonist | 98.65% | Unkown |
| HY-114520 | TT01001 | Inhibitor | 99.93% | Unkown |
| HY-117006 | E1231 | Activator | 98.46% | Unkown |
| HY-118282 | mPGES1-IN-7 | Inhibitor | 99.78% | Unkown |
| HY-12095 | CB1 inverse agonist 2 | Agonist | 99.15% | Unkown |
| HY-125847 | Salvianolic acid F | 99.50% | Unkown | |
| HY-12678S1 | Entrectinib-d8 | 99.82% | Unkown | |
| HY-128371 | 2-Methylhexanoic acid | 98.0% | Unkown | |
| HY-129163 | HJ-PI01 | Inhibitor | 99.50% | Unkown |
| HY-131891 | JHU37152 | Agonist | 99.72% | Unkown |
| HY-136182 | YM-244769 dihydrochloride | Inhibitor | 98.57% | Unkown |
| HY-136182A | YM-244769 | Inhibitor | 99.22% | Unkown |
| HY-139659 | ARD-61 | 99.57% | Unkown | |
| HY-141638 | Me-IQ | 99.48% | Unkown | |
| HY-14393R | Emodin (Standard) | Inhibitor | 98.84% | Unkown |
| HY-151606 | Akt3 degrader 1 | 95.10% | Unkown | |
| HY-156374 | D359-0396 | Inhibitor | 99.98% | Unkown |
| HY-158991 | I1421 | Agonist | 99.15% | Unkown |
| HY-159579 | CW-3308 | 99.43% | Unkown | |
| HY-161671 | GAT2711 | Agonist | 98.00% | Unkown |
| HY-161759 | MS152 | Inhibitor | 99.36% | Unkown |
| HY-162387 | UK4b | Inhibitor | 96.17% | Unkown |
| HY-162428 | PTPN2/1-IN-3 | Inhibitor | 99.89% | Unkown |
| HY-163340 | GA32 | Inhibitor | 99.67% | Unkown |
| HY-163782 | SMIP-031 | 98.60% | Unkown | |
| HY-16936 | JH-II-127 | Inhibitor | 98.0% | Unkown |
| HY-172458 | Z-3578 | Inhibitor | 98.72% | Unkown |
| HY-175035 | HK-2-IN-1 | Inhibitor | 99.88% | Unkown |
| HY-178761 | PGK1-IN-1 | 99.78% | Unkown | |
| HY-178861 | dCDK9-202 | 99.25% | Unkown | |
| HY-179041 | SZ0232 | 99.25% | Unkown | |
| HY-186109 | ZY39 | 99.73% | Unkown | |
| HY-B1148 | Furaltadone hydrochloride | Inhibitor | 99.46% | Unkown |
| HY-D1707 | FDGlcU | 96.00% | Unkown | |
| HY-N0887 | Isoastragaloside I | 99.49% | Unkown | |
| HY-N0921 | Dihydromethysticin | 99.71% | Unkown | |
| HY-N1393 | 2-Methoxybenzoic acid | Inhibitor | 99.86% | Unkown |
| HY-N1407 | Polygalaxanthone III | 99.28% | Unkown | |
| HY-N1479 | Polygalic acid | 99.96% | Unkown | |
| HY-N1940 | β-Anhydroicaritin | Inhibitor | 99.69% | Unkown |
| HY-N2082 | Isorhamnetin 3-O-galactoside | Inhibitor | 99.64% | Unkown |
| HY-N2411 | Geissoschizine methyl ether | Agonist | 99.97% | Unkown |
| HY-N3522 | Platycoside E | Inhibitor | 99.40% | Unkown |
| HY-P10031 | SAR441255 | Agonist | 99.84% | Unkown |
| HY-P10269 | Bofanglutide | Agonist | 99.66% | Unkown |
| HY-P1302 | Orphanin FQ(1-11) | Agonist | 99.83% | Unkown |
| HY-P2264 | KYL peptide | Inhibitor | 99.65% | Unkown |
| HY-W012865 | Tartronic acid | ≥98.0% | Unkown | |
| HY-W097625 | 6-Methoxyflavone | 99.73% | Unkown | |
| HY-W248594 | IR 813 tosylate | 98.52% | Unkown | |
| HY-W348485 | WRX606 | Inhibitor | 95.65% | Unkown |
| HY-W674241 | 4-Ethylphenyl sulfate | Inducer | / | Unkown |
| HY-113354S | Anserine-d4 | 99.38% | Unkown | |
| HY-130687A | Psicose | 99.90% | Unkown | |
| HY-136782 | ST-148 maleate | Inhibitor | 99.4% | Unkown |
| HY-157039 | RIPK1-IN-17 | Inhibitor | 97.09% | Unkown |
| HY-174790 | Firefly Luciferase mRNA | 90% | Unkown | |
| HY-186113 | Cysteinocholic acid | 96.43% | Unkown | |
| HY-B1853 | Simetryn | 99.75% | Unkown | |
| HY-B1946S | Dimethoate-d6 | 99.86% | Unkown | |
| HY-N0853A | Alisol A 24-acetate | 98.0% | Unkown | |
| HY-N11908 | α-Santalol | 97.62% | Unkown | |
| HY-P10031A | SAR441255 TFA | Agonist | 99.93% | Unkown |
| HY-P10275 | Tat-NTS peptide | Inhibitor | 99.88% | Unkown |
| HY-P5489 | IGRP(206-214) | Agonist | 96.63% | Unkown |
| HY-Y1055A | Guanine hydrochloride | 98.78% | Unkown | |
| HY-Y1275S | N-Methylpyrrolidone-d9 | 98% | Unkown | |
| HY-100384 | NKL 22 | Inhibitor | 97.26% | Unkown |
| HY-128578 | KPLH1130 | Inhibitor | 99.86% | Unkown |
| HY-136093B | Lixumistat | 99.33% | Unkown | |
| HY-13836 | ELQ-300 | Inhibitor | 98.0% | Unkown |
| HY-173119 | SKLB-D18 | 98.06% | Unkown | |
| HY-175748 | MK-7337 | Ligand | 98.14% | Unkown |
| HY-120878 | CXCR2-IN-2 | Antagonist | 99.52% | Unkown |
| HY-123475A | Sisunatovir hydrochloride | Inhibitor | 98.61% | Unkown |
| HY-131334 | AMPK activator 4 | Activator | 98.64% | Unkown |
| HY-147149 | BPN-15477 | Modulator | 99.92% | Unkown |
| HY-150254A | SLB1122168 formic | Inhibitor | 99.91% | Unkown |
| HY-172811 | DA-302168S | Agonist | 98.01% | Unkown |
| HY-100555 | CH5138303 | Inhibitor | 99.05% | Unkown |
| HY-100935 | Cimaterol | Agonist | 99.13% | Unkown |
| HY-103511 | TCS1105 | 99.44% | Unkown | |
| HY-103566 | LY456236 | 99.57% | Unkown | |
| HY-111254 | GQ-16 | Modulator | 98.12% | Unkown |
| HY-118824A | N-Feruloylserotonin | Inhibitor | 99.93% | Unkown |
| HY-120793 | CMC2.24 | 97.11% | Unkown | |
| HY-121852 | SCH 336 | Agonist | 98.63% | Unkown |
| HY-122168 | AAT-008 | Antagonist | 98.03% | Unkown |
| HY-12392 | Iprindole | Agonist | 99.55% | Unkown |
| HY-125931 | Unifiram | Activator | 99.68% | Unkown |
| HY-126195 | Fluoflavine | Inhibitor | 98.47% | Unkown |
| HY-126426 | CBHcy | Inhibitor | 99.95% | Unkown |
| HY-128387S1 | 2,3-Butanediol-d8 | 99.28% | Unkown | |
| HY-131113 | N-Nitrosodibutylamine | Activator | 99.93% | Unkown |
| HY-133887 | Methotrexate α-tert-butyl ester | Inhibitor | 97.38% | Unkown |
| HY-137570 | Ethyl homovanillate | Inhibitor | 98.41% | Unkown |
| HY-143312E | (S)-V-0219 hydrochloride | Modulator | 99.71% | Unkown |
| HY-143411 | GEM144 | / | Unkown | |
| HY-143657 | Myoferlin inhibitor 1 | Inhibitor | 99.88% | Unkown |
| HY-144635 | Nrf2-ARE/hMAO-B/QR2 modulator 1 | Inhibitor | 98.42% | Unkown |
| HY-144899 | ASR-490 | Inhibitor | 99.20% | Unkown |
| HY-145794 | ZA3-Ep10 | 99.93% | Unkown | |
| HY-147128 | PY109 | Agonist | 99.15% | Unkown |
| HY-151799 | P62-RNF168 agonist-1 | 98.03% | Unkown | |
| HY-152148 | JZP-MA-11 | Inhibitor | 99.26% | Unkown |
| HY-153798 | GLP-1 receptor agonist 10 | Agonist | 99.63% | Unkown |
| HY-153999 | Rondaptivon pegol | Inhibitor | 98.20% | Unkown |
| HY-155463 | NLRP3-IN-25 | Inhibitor | 99.78% | Unkown |
| HY-156280 | RARα antagonist 1 | Antagonist | 99.07% | Unkown |
| HY-157269 | J10-1 | 99.92% | Unkown | |
| HY-162640 | LDR102 | Inhibitor | 99.78% | Unkown |
| HY-162866 | CXM102 | Activator | 99.36% | Unkown |
| HY-164102 | TNF-α-IN-18 | Inhibitor | 98.94% | Unkown |
| HY-168135 | PROTAC c-Met degrader-1 | Degrader | 98.48% | Unkown |
| HY-168710 | TLR4/NF-κB-IN-1 | Inhibitor | 99.92% | Unkown |
| HY-169092 | PF-07957472 | Inhibitor | 99.13% | Unkown |
| HY-173096 | NCATS-SM7270 | Inhibitor | 99.17% | Unkown |
| HY-174979 | Dac590 | 96.15% | Unkown | |
| HY-175022 | PROTAC IRAK4 degrader-13 | 99.47% | Unkown | |
| HY-175469 | VNT-101 | Inhibitor | 99.51% | Unkown |
| HY-175746 | AZD0233 | Antagonist | 98.66% | Unkown |
| HY-176205 | Ligritinib | Inhibitor | 98.08% | Unkown |
| HY-176763 | KZR-261 | Inhibitor | 99.39% | Unkown |
| HY-177008 | PROTAC HER2 degrader-1 | 98.0% | Unkown | |
| HY-179494 | M464 | Inhibitor | 99.58% | Unkown |
| HY-19870C | Setmelanotide monoacetate | 99.81% | Unkown | |
| HY-D0887 | Disodium 5'-inosinate | 99.74% | Unkown | |
| HY-N0772 | Isomangiferin | 99.60% | Unkown | |
| HY-N0899 | Wilforine | Inhibitor | 99.47% | Unkown |
| HY-N0930B | Galegine hydrochloride | 98.45% | Unkown | |
| HY-N1503 | Methyl deacetylasperulosidate | 98.49% | Unkown | |
| HY-N2129 | N-Nornuciferine | Inhibitor | 99.94% | Unkown |
| HY-N2163 | Mudanpioside C | Inhibitor | 98.20% | Unkown |
| HY-N2571 | Corydine | 99.93% | Unkown | |
| HY-N3001 | Isolinderalactone | 98.79% | Unkown | |
| HY-N6043 | Hydroxytyrosol acetate | 98.10% | Unkown | |
| HY-N7026 | Celosin I | 99.91% | Unkown | |
| HY-N7272 | Cirsimarin | Inhibitor | 99.95% | Unkown |
| HY-N8599 | Cichoriin | 99.9% | Unkown | |
| HY-N9182 | Zeaxanthin dipalmitate | Inducer | 99.9% | Unkown |
| HY-P10792 | HER2-targeted peptide H6F | 98.85% | Unkown | |
| HY-P1106 | K41498 | Antagonist | 99.66% | Unkown |
| HY-P11540 | CCKBR agonist-1 | 98.48% | Unkown | |
| HY-P1173 | L803-mts | Inhibitor | 99.98% | Unkown |
| HY-P1290 | PKA Inhibitor Fragment (6-22) amide | Inhibitor | 98.00% | Unkown |
| HY-P3012 | Cathepsin G | Activator | / | Unkown |
| HY-W040269 | Dehydrothio-p-toluidine | 99.91% | Unkown | |
| HY-W275039 | Phenylquinone | 97.26% | Unkown | |
| HY-W276164 | Sodium octadecyl sulfate | 99.86% | Unkown | |
| HY-101092B | QS-21-Xyl | 97.23% | Unkown | |
| HY-107859S | Tris(2-chloroethyl)phosphate-d12 | 99.15% | Unkown | |
| HY-168773 | (R)-AS-1 | Modulator | 99.90% | Unkown |
| HY-20176 | 2,4-Dichlorothieno[3,2-d]pyrimidine | / | Unkown | |
| HY-B1022 | Dimesna | 98.0% | Unkown | |
| HY-B1211 | Dehydroacetic acid | Inhibitor | 99.85% | Unkown |
| HY-N0854 | Alisol F | Inhibitor | 99.89% | Unkown |
| HY-N9484 | Menthofuran, 84% | 84.25% | Unkown | |
| HY-W341625 | Trihexosylceramide (d18:1/12:0) | 99.28% | Unkown | |
| HY-120083 | Rodatristat | Inhibitor | 98.41% | Unkown |
| HY-172930 | PVTX-405 | / | Unkown | |
| HY-100788C | 2-PMPA sodium | Inhibitor | 99.9% | Unkown |
| HY-132231 | FD223 | 98.05% | Unkown | |
| HY-101349 | L 741742 | 99.28% | Unkown | |
| HY-103325 | JTE-907 | 98.54% | Unkown | |
| HY-103639A | M62812 | Inhibitor | 99.86% | Unkown |
| HY-11053 | S 24795 | Agonist | 99.66% | Unkown |
| HY-111187 | KX2-361 | 99.09% | Unkown | |
| HY-113833 | N-Methylindan-2-amine hydrochloride | 99.94% | Unkown | |
| HY-114683 | KS370G | Inhibitor | 99.71% | Unkown |
| HY-120275 | CYD-2-11 | 98.05% | Unkown | |
| HY-122357 | Bestim | Inhibitor | 98.73% | Unkown |
| HY-122964 | URB447 | Antagonist | 99.5% | Unkown |
| HY-124187 | Pinolenic acid ethyl ester | ≥98.0% | Unkown | |
| HY-124727 | ZT55 | 99.51% | Unkown | |
| HY-125019 | iJak-381 | Inhibitor | 99.86% | Unkown |
| HY-125942 | SKF-96365 | 99.97% | Unkown | |
| HY-126193 | JS-K | 99.59% | Unkown | |
| HY-126367 | Light green SF yellowish | 75.0% | Unkown | |
| HY-139192A | Brophenexin free base | 99.24% | Unkown | |
| HY-139973 | OAB-14 | 99.21% | Unkown | |
| HY-149428 | AD4 | 98.01% | Unkown | |
| HY-151093 | IDO2-IN-1 | Inhibitor | 98.10% | Unkown |
| HY-155538 | Cisd2 agonist 1 | Agonist | 99.24% | Unkown |
| HY-156422 | KPZ560 | Inhibitor | 99.72% | Unkown |
| HY-158315 | NZ-97 | Inhibitor | 99.43% | Unkown |
| HY-159098 | dWIZ-1 | Degrader | / | Unkown |
| HY-162645 | BPR5K230 | Inhibitor | 99.82% | Unkown |
| HY-163540 | NP-BTA | Inhibitor | 99.15% | Unkown |
| HY-163729 | I-BET787 | Inhibitor | 99.88% | Unkown |
| HY-164397 | XMU-MP-5 | 99.00% | Unkown | |
| HY-165613 | Pam2Cys | 99.82% | Unkown | |
| HY-171030 | Pro-GA | Activator | 97.86% | Unkown |
| HY-173313 | Ferroptosis-IN-19 | Inhibitor | 98.92% | Unkown |
| HY-173444 | HDAC11-IN-3 | 99.70% | Unkown | |
| HY-174400 | SGLT2-IN-2 | Inhibitor | 99.57% | Unkown |
| HY-175208A | MST3-IN-1 TFA | 99.38% | Unkown | |
| HY-175231 | ST171 | Agonist | 99.34% | Unkown |
| HY-175247 | DDO-4033 | 99.11% | Unkown | |
| HY-175668 | IDOR-1104-0086 | Activator | 98.98% | Unkown |
| HY-176180 | PROTAC STING degrader-4 | 98.25% | Unkown | |
| HY-176184 | PROTAC DDR1 degrader-1 | 98.69% | Unkown | |
| HY-177435 | FAPI-800CW | Inhibitor | 99.40% | Unkown |
| HY-179537 | CKBA | Inhibitor | 98.97% | Unkown |
| HY-182757 | Y1693 | Inhibitor | 99.91% | Unkown |
| HY-186130 | CAST-calpain-2 stabilizer-1 | Inhibitor | / | Unkown |
| HY-24504 | MBA-m1 | Inhibitor | 98.20% | Unkown |
| HY-33009 | AS057278 | Inhibitor | 99.76% | Unkown |
| HY-B1309 | Metacetamol | Inhibitor | 99.97% | Unkown |
| HY-B1752 | Quinpirole | 98.95% | Unkown | |
| HY-D0193A | Ponceau 4R (85%) | 85.0% | Unkown | |
| HY-D1460 | Fluorescein Di-β-D-Glucuronide | 96.58% | Unkown | |
| HY-N0046 | Notoginsenoside Fe | Inhibitor | 99.99% | Unkown |
| HY-N10424 | Brazilein | 99.9% | Unkown | |
| HY-N11709 | Theasaponin E1 | 98.68% | Unkown | |
| HY-N11911 | Verazine | Inhibitor | 99.74% | Unkown |
| HY-N14001 | Naamidine J | 99.41% | Unkown | |
| HY-N2276 | Nodakenetin | Activator | 99.66% | Unkown |
| HY-N6020A | (+)-Butin | 99.54% | Unkown | |
| HY-N6579 | Arvenin I | 89.41% | Unkown | |
| HY-N6774 | Cytochalasin C | 99.85% | Unkown | |
| HY-N6928 | Mogroside III-E | Inhibitor | 99.30% | Unkown |
| HY-N9173 | Cupressuflavone | 99.32% | Unkown | |
| HY-P10032A | NN1177 TFA | 99.22% | Unkown | |
| HY-P10816 | PACE4 Inhibitory peptide C23 | 99.40% | Unkown | |
| HY-P11287A | DOTA-Pep-1L TFA | Ligand | 98.60% | Unkown |
| HY-P2818A | Alkaline phosphatase, Escherichia coli | Inhibitor | / | Unkown |
| HY-P2818C | Alkaline phosphatase, microorganism | Inhibitor | / | Unkown |
| HY-P6437 | Drp1 peptide inhibitor P110 | Inhibitor | 96.77% | Unkown |
| HY-W002942 | Ferroptosis-IN-21 | Inhibitor | 99.88% | Unkown |
| HY-W010243S | Methylisothiazolinone-d3 hydrochloride | 99.42% | Unkown | |
| HY-W419589 | Xanthomicrol | 97.68% | Unkown | |
| HY-W540123 | Fmoc-PNA-A(Bhoc)-OH | / | Unkown | |
| HY-W841438 | Lithium orotate | Inhibitor | / | Unkown |
| HY-W996116 | AZM198 | Inhibitor | 98.40% | Unkown |
| HY-Y0106 | 2,6-Dihydroxyacetophenone | 99.85% | Unkown | |
| HY-Y0496 | 1,4-Dichlorobenzene | Inducer | 99.71% | Unkown |
| HY-113086 | CE(16:1(9Z)) | 99.8% | Unkown | |
| HY-113421S | Linoleoyl ethanolamide-d4 | 99.2% | Unkown | |
| HY-114853 | BVT.13 | Agonist | 98.44% | Unkown |
| HY-114992 | 2-Propyl-2-pentenoic acid | 95.0% | Unkown | |
| HY-125677 | SHetA2 | 99.70% | Unkown | |
| HY-160554 | C12-113 | 98.67% | Unkown | |
| HY-179565 | NM102 | Inhibitor | 99.77% | Unkown |
| HY-45854 | GWP-042 | Inhibitor | 95.63% | Unkown |
| HY-B1870 | Metaldehyde | 98.0% | Unkown | |
| HY-D2481 | Asante potassium green-2 TMA | 93.3% | Unkown | |
| HY-N10508 | Calcitroic acid | Agonist | 85.0% | Unkown |
| HY-N1414A | 3′,6-Disinapoylsucrose | Inhibitor | 98.88% | Unkown |
| HY-N16040 | DMG-pSar25 | 99.0% | Unkown | |
| HY-N16499 | Hericene A | 99.08% | Unkown | |
| HY-P6083 | RTSPSSR | 99.38% | Unkown | |
| HY-W013331 | Deoxyartemisinin | Inhibitor | 99.9% | Unkown |
| HY-W109613 | Methyl dehydroabietate | 99.89% | Unkown | |
| HY-W1113135 | Carboxymethyl-β-cyclodextrin sodium salt | 99.6% | Unkown | |
| HY-W747072 | 3-Sulfo-taurocholic Acid Disodium Salt | 99.9% | Unkown | |
| HY-W782079 | Geraniol-d6 (Major) | 95.25% | Unkown | |
| HY-P99719 | Lupartumab Amadotin | 99.61% | Unkown | |
| HY-12761 | A-836339 | Agonist | 99.84% | Unkown |
| HY-135319 | Strictinin | 97.15% | Unkown | |
| HY-146223 | AZD4625 | 98.44% | Unkown | |
| HY-179591 | BGT-002 | 99.35% | Unkown | |
| HY-136522 | S2116 | 98.05% | Unkown | |
| HY-144868 | Glutathione synthesis-IN-1 | 98.46% | Unkown | |
| HY-151881 | SOS1-IN-15 | Inhibitor | 98.04% | Unkown |
| HY-206259 | CCG-203586 | Inhibitor | / | Unkown |
| HY-P3491 | Pegloxenatide | 90.00% | Unkown | |
| HY-B1198S | Piperonyl butoxide-d9 | Inhibitor | 98.68% | Unkown |
| HY-100442S1 | Paquinimod-d5-1 | Inhibitor | 98.19% | Unkown |
| HY-101170 | BU224 hydrochloride | 96.96% | Unkown | |
| HY-102020A | RG3039 hydrochloride | 98.15% | Unkown | |
| HY-106181 | Rivoglitazone | Agonist | 98.59% | Unkown |
| HY-10620 | PI3K-IN-22 | Inhibitor | 99.50% | Unkown |
| HY-106224AS1 | Orexin A-13C18,15N3 (human, rat, mouse) TFA | 98.60% | Unkown | |
| HY-106892 | BW 348U87 | Inhibitor | 99.62% | Unkown |
| HY-106947 | SY-640 | 99.77% | Unkown | |
| HY-107503 | MMPIP | Antagonist | 99.38% | Unkown |
| HY-108623 | Atizoram | Inhibitor | 96.3% | Unkown |
| HY-110201 | Estrogen receptor modulator 1 | Modulator | 99.91% | Unkown |
| HY-111837 | BI1071 | / | Unkown | |
| HY-114750 | Mebendazole-amine | 98.35% | Unkown | |
| HY-117081 | C30(ω-hydroxy) Ceramide (d18:1/30:0) | 99.46% | Unkown | |
| HY-117408 | VU6004256 | Modulator | 99.61% | Unkown |
| HY-117482 | BPN-15606 | Modulator | 99.95% | Unkown |
| HY-117912 | TRC210258 | 99.55% | Unkown | |
| HY-118388 | AS604872 | Antagonist | / | Unkown |
| HY-120692 | Cyclanoline chloride | 96.27% | Unkown | |
| HY-121495 | BKI-1369 | Inhibitor | 99.37% | Unkown |
| HY-121675A | 2-Bromo-LSD D-Tartrate | 99.91% | Unkown | |
| HY-124157 | AA41612 | Antagonist | 99.78% | Unkown |
| HY-124609 | CAD031 | 99.39% | Unkown | |
| HY-125172 | PolyQ aggregation inhibitor C2-8 | Inhibitor | 99.9% | Unkown |
| HY-125516 | MCTR3 | 98.40% | Unkown | |
| HY-125726 | Sulfo galactosylceramide | Activator | 98% | Unkown |
| HY-129087 | BC-1258 | Inducer | 99.85% | Unkown |
| HY-130136A | TMPRSS6-IN-1 TFA | Inhibitor | / | Unkown |
| HY-130437 | p-nitro-Pifithrin-α | 97.0% | Unkown | |
| HY-131885 | RuBi-Glutamate hexafluorophosphate sodium | Inhibitor | 82.94% | Unkown |
| HY-132126 | SPHINX | Inhibitor | 99.87% | Unkown |
| HY-135555 | 5-Carboxamidotryptamine | Agonist | 98.74% | Unkown |
| HY-136855 | MitoPBN | 95.00% | Unkown | |
| HY-139703 | Se-DMC | 98.88% | Unkown | |
| HY-139901 | Chk1-IN-6 | Inhibitor | 98.39% | Unkown |
| HY-148669B | (S)-Bleximenib oxalate | Control | 98.37% | Unkown |
| HY-148790 | Pralurbactam | Inhibitor | 98.69% | Unkown |
| HY-15193B | EMD638683 (S-Form) | Inhibitor | 99.95% | Unkown |
| HY-153120A | PI3K/mTOR Inhibitor-13 sodium | Inhibitor | 98.11% | Unkown |
| HY-153377 | Lipid 14 | 95.0% | Unkown | |
| HY-155156 | PF-07238025 | Inhibitor | 99.46% | Unkown |
| HY-155539 | Cisd2 agonist 2 | Agonist | 99.17% | Unkown |
| HY-156277 | SP4f | Activator | 99.77% | Unkown |
| HY-156842 | MCAAD-3 | 98.19% | Unkown | |
| HY-157014 | TPT-004 | Inhibitor | 99.90% | Unkown |
| HY-158694A | TLR7 agonist 20 hydrochloride | Agonist | 99.86% | Unkown |
| HY-158990 | GE1111 | 95.73% | Unkown | |
| HY-161627 | Anemoside A3-methyl 6-aminohexanoate | Inhibitor | 98.62% | Unkown |
| HY-161853 | TX-2552 | Inhibitor | 99.69% | Unkown |
| HY-162445 | KRASG12D-IN-3 | Inhibitor | 98.38% | Unkown |
| HY-162562 | E28362 | Inhibitor | 94.51% | Unkown |
| HY-162629 | LDHA-IN-7 | Inhibitor | 99.59% | Unkown |
| HY-162702 | AZ'3137 | Degrader | 99.90% | Unkown |
| HY-163039 | DOTA-biotin | / | Unkown | |
| HY-163532 | FLS-359 | Modulator | 95.41% | Unkown |
| HY-164478 | G-631 | Inhibitor | 99.88% | Unkown |
| HY-164826 | Acetyl zingerone | 99.34% | Unkown | |
| HY-165677 | C22 Galactosylceramide | 99.9% | Unkown | |
| HY-167983 | Cx43 HC-IN-1 | Inhibitor | / | Unkown |
| HY-169240 | MX69-102 | Activator | 99.44% | Unkown |
| HY-169703 | SPA0355 | Inhibitor | 99.54% | Unkown |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-171272 | PRDX1-IN-3 | 99.52% | Unkown | |
| HY-171804 | Linvemastat | Inhibitor | 98.30% | Unkown |
| HY-172946 | SD-2301 | Degrader | / | Unkown |
| HY-173033 | MI-883 | 99.57% | Unkown | |
| HY-173267 | CES2A-IN-2 | Inhibitor | 99.16% | Unkown |
| HY-173482 | TFAP4/Wnt/β-catenin-IN-1 | Inhibitor | 95.39% | Unkown |
| HY-174452 | BER-5 | 99.83% | Unkown | |
| HY-174981 | LC-MF-4 | 98.05% | Unkown | |
| HY-175278 | BAL-1516 | Inhibitor | / | Unkown |
| HY-175615A | RSL3-NH2 hydrochloride | / | Unkown | |
| HY-176761 | NSC647889 | 99.28% | Unkown | |
| HY-176806 | Legubicin | 98.01% | Unkown | |
| HY-176847 | DHQZ-17 | 99.58% | Unkown | |
| HY-177760 | PrCP-7414 | / | Unkown | |
| HY-182014 | TLC-2716 | Inhibitor | / | Unkown |
| HY-182774 | YU241279 | Inhibitor | 99.58% | Unkown |
| HY-185323 | Gem-C12 | 99.48% | Unkown | |
| HY-186112 | PSFL2915 | Inhibitor | 98.72% | Unkown |
| HY-186178 | CD38-IN-6 | Inhibitor | 99.96% | Unkown |
| HY-19015 | Probimane | Inhibitor | 99.91% | Unkown |
| HY-75625 | 2-Hydroxy-4-methoxybenzoic acid | 99.64% | Unkown | |
| HY-B0950A | Mefexamide hydrochloride | Activator | 99.45% | Unkown |
| HY-B2232A | Benzalkonium chloride (solid) | Inhibitor | 99.00% | Unkown |
| HY-D3004 | GSH Tracker Probe | 98.43% | Unkown | |
| HY-N0278 | Anemonin | Inhibitor | 99.41% | Unkown |
| HY-N11630 | Pinellic acid | Inhibitor | 99.0% | Unkown |
| HY-N12124 | Monascuspiloin | 95% | Unkown | |
| HY-N15574 | Saringosterol | ≥90.0% | Unkown | |
| HY-N3558 | Ceanothic acid | Inhibitor | 98.0% | Unkown |
| HY-N9794 | Isoboldine | 95.0% | Unkown | |
| HY-NP143 | Nerve Growth Factor 2.5S,murine submaxillary gland | Activator | 98% | Unkown |
| HY-P10027A | Clovibactin TFA | Inhibitor | 98.50% | Unkown |
| HY-P10502 | L57 | 99.44% | Unkown | |
| HY-P10927A | BRP TFA | / | Unkown | |
| HY-P11112 | PTD-DBM | 96.12% | Unkown | |
| HY-P11208C | mNLS-CPP-WSTF TFA | Inhibitor | 96.20% | Unkown |
| HY-P1949A | Cyclic MKEY TFA | 98.47% | Unkown | |
| HY-P3343 | hFSH-β-(33-53) | Antagonist | / | Unkown |
| HY-P5003 | Collagen Type II Fragment | 99.39% | Unkown | |
| HY-P5396A | GAD65 (524-543) acetate | 98.08% | Unkown | |
| HY-P6292 | KS-133 | 98.75% | Unkown | |
| HY-W006566 | 5-AIQ | Inhibitor | 99.75% | Unkown |
| HY-W009688 | Dibutyl maleate | 99.19% | Unkown | |
| HY-W012837 | Benzylmethyl ether | Inhibitor | 98.70% | Unkown |
| HY-W017500 | N-Methyl-DL-aspartic acid | Agonist | 99.02% | Unkown |
| HY-W019704 | N-Acetyl-DL-methionine | 98.73% | Unkown | |
| HY-W072962 | WX2-43 | 98.74% | Unkown | |
| HY-W145481A | D-Galacto-D-mannan | / | Unkown | |
| HY-W201317 | E17241 | Agonist | 95.04% | Unkown |
| HY-W653921 | Tenuazonic acid-d13 | Inhibitor | 99.20% | Unkown |
| HY-W781133 | cDPCP | 99.9% | Unkown | |
| HY-101064S2 | Fmoc-leucine-d3 | Modulator | 99.25% | Unkown |
| HY-101064S3 | Fmoc-leucine-d10 | Modulator | 99.40% | Unkown |
| HY-107336 | Cyclovalone | Inhibitor | 99.9% | Unkown |
| HY-120565 | WB403 | Activator | 99.16% | Unkown |
| HY-125135 | (-)-β-Peltatin | 99.45% | Unkown | |
| HY-134454 | Z-Pro-Pro-CHO | Inhibitor | 98.03% | Unkown |
| HY-161940 | PCSK9-IN-30 | Inhibitor | / | Unkown |
| HY-167692 | JI069 | Inhibitor | 98.03% | Unkown |
| HY-168352 | Orphine | Ligand | 98.2% | Unkown |
| HY-16900R | Rolipram (Standard) | Inhibitor | 99.24% | Unkown |
| HY-185218 | WR 146459 | Inhibitor | / | Unkown |
| HY-185260 | AA76-lipid | / | Unkown | |
| HY-20874 | Deschlorodemethyldiazepam | 99.80% | Unkown | |
| HY-N0278A | (Rac)-Anemonin | Inhibitor | 98.48% | Unkown |
| HY-N0394S5 | L-Cystine-13C6,15N2 | 98.4% | Unkown | |
| HY-N11286 | Tridocosahexaenoylglycerol | 98.7% | Unkown | |
| HY-N13250 | Hawthorn Extract | / | Unkown | |
| HY-N7741 | Isozaluzanin C | Inhibitor | 96.18% | Unkown |
| HY-N8693 | Withanoside IV | 98.47% | Unkown | |
| HY-N9517 | QS 7 | 90% | Unkown | |
| HY-W009512 | CVT-2738 | 99.81% | Unkown | |
| HY-W012974R | 3-Aminoisobutyric acid (Standard) | 98.49% | Unkown | |
| HY-W013755 | Dioctyl phthalate | 99.40% | Unkown | |
| HY-W024365 | 3-tert-Butyl-4-methoxyphenol | 99.69% | Unkown | |
| HY-W153897 | N-Methyltyramine | Agonist | 99.83% | Unkown |
| HY-W196368 | Thymohydroquinone | Inhibitor | 99.91% | Unkown |
| HY-W587414 | Neospiramycin I | Inhibitor | 96.27% | Unkown |
| HY-W587957 | Gypsogenic acid | Inhibitor | 99.9% | Unkown |
| HY-Y1826 | IITR01324 | 99.12% | Unkown | |
| HY-123671 | CYM2503 | Modulator | 96.01% | Unkown |
| HY-159500 | Zopocianine | 98.12% | Unkown | |
| HY-164485 | INI-4001 | / | Unkown | |
| HY-101030A | MBM-17S | / | Unkown | |
| HY-103089 | LY393558 | Antagonist | 99.0% | Unkown |
| HY-120872 | AJS1669 free acid | Activator | 99.15% | Unkown |
| HY-150636 | Autophagy-IN-1 | Inducer | 99.18% | Unkown |
| HY-157763 | Mal-PEG1-Val-Cit-PABC-diphosphate-BTK degrader-1 | Degrader | / | Unkown |
| HY-173189A | 2-5A pentasodium solution (100 mM) | Inhibitor | 90.0% | Unkown |
| HY-175342 | FCN-338 | Inhibitor | 99.33% | Unkown |
| HY-175547 | PROTAC HPK1 Degrader-5 | / | Unkown | |
| HY-175750 | MOMA-341 | Inhibitor | / | Unkown |
| HY-178061 | APS03118 | Inhibitor | / | Unkown |
| HY-178500 | WCY-8-67 | / | Unkown | |
| HY-B1120 | Temephos | Inhibitor | 99.35% | Unkown |
| HY-125858A | MI-1061 TFA | 97.47% | Unkown | |
| HY-133127 | AR453588 | Activator | 99.84% | Unkown |
| HY-136523 | S2157 | 98.44% | Unkown | |
| HY-137439 | Fanotaprim | 98.89% | Unkown | |
| HY-150254 | SLB1122168 | Inhibitor | / | Unkown |
| HY-153114 | HEC96719 | Agonist | 98.01% | Unkown |
| HY-153262 | (7R)-Elisrasib | Inhibitor | 99.52% | Unkown |
| HY-153369 | BAY-747 | Activator | 98.01% | Unkown |
| HY-N6608S | Physostigmine-d3 | Inhibitor | 99.51% | Unkown |
| HY-100617A | (RS)-4CPG | Antagonist | 99.04% | Unkown |
| HY-100751 | N-563 | 98.0% | Unkown | |
| HY-100839 | (RS)-(Tetrazol-5-yl)glycine | Agonist | 96.53% | Unkown |
| HY-101726 | DuP 105 | Inhibitor | 99.38% | Unkown |
| HY-102086 | MSX3 | / | Unkown | |
| HY-103177 | PSB-10 hydrochloride | Inhibitor | / | Unkown |
| HY-103327 | MJ15 | Antagonist | / | Unkown |
| HY-106382 | PMEDAP | Inhibitor | 98.0% | Unkown |
| HY-106817 | Amitivir | Inhibitor | / | Unkown |
| HY-107504 | VU0360172 hydrochloride | Agonist | 98.94% | Unkown |
| HY-107659 | YM-244769 hydrochloride | Inhibitor | 98.09% | Unkown |
| HY-109506S1 | DPPC-d9 | 98.0% | Unkown | |
| HY-109506S3 | DPPC-d9-1 | ≥99.0% | Unkown | |
| HY-109506S9 | DPPC-13C2 | 95.0% | Unkown | |
| HY-111782 | 8-Mercaptoguanosine | Activator | 98.0% | Unkown |
| HY-112636 | Astrophloxine | Inhibitor | 98.34% | Unkown |
| HY-113308S1 | Taurolithocholic acid-d4 | 98.36% | Unkown | |
| HY-113486R | Lathosterol (Standard) | 96.91% | Unkown | |
| HY-113878 | 12-OAHSA | 99.0% | Unkown | |
| HY-115762 | 4-Hydroxytryptamine creatinine sulfate | Agonist | 97.94% | Unkown |
| HY-117764 | LSP4-2022 | Agonist | 98.06% | Unkown |
| HY-117771A | DO34 analog | Inhibitor | 98.42% | Unkown |
| HY-118748 | Suprafenacine | Inhibitor | 98.0% | Unkown |
| HY-119980S | Fluphenazine-d8 | 99.12% | Unkown | |
| HY-120148A | SM19712 | Inhibitor | 99.0% | Unkown |
| HY-120514 | JNc-440 | 98.04% | Unkown | |
| HY-121271 | Kadsurin | 99.38% | Unkown | |
| HY-121469 | Dioxone | Inducer | 98.0% | Unkown |
| HY-121845 | 4-Br-Bnlm | Inhibitor | 99.46% | Unkown |
| HY-121870 | Dimethocaine | Substrate | 99.90% | Unkown |
| HY-122672 | Adhesamine | Activator | 99.46% | Unkown |
| HY-122817 | FR900098 sodium | Inhibitor | 99.77% | Unkown |
| HY-123801 | MIDD0301 | Modulator | 98.14% | Unkown |
| HY-123929 | PAWI-2 | 99.29% | Unkown | |
| HY-123983 | HS56 | Inhibitor | 99.6% | Unkown |
| HY-124084A | SW203668 TFA | Inhibitor | 99.79% | Unkown |
| HY-12442 | LY5 | 97.02% | Unkown | |
| HY-124693 | DB1055 | Inducer | / | Unkown |
| HY-124713 | ML372 | Modulator | 99.17% | Unkown |
| HY-12611 | Sergliflozin etabonate | Inhibitor | 99.64% | Unkown |
| HY-126152 | Chlorthiamid | 95.69% | Unkown | |
| HY-12678S | Entrectinib-d4 | Inhibitor | / | Unkown |
| HY-126850 | 4-Epidoxycycline | / | Unkown | |
| HY-12701A | U-99194 maleate | Antagonist | 99.23% | Unkown |
| HY-129246 | Cytembena | Inhibitor | 99.53% | Unkown |
| HY-130136 | TMPRSS6-IN-1 | Inhibitor | / | Unkown |
| HY-131102 | Mequindox | Inhibitor | 99.62% | Unkown |
| HY-131605 | Ganciclovir triphosphate | Inhibitor | / | Unkown |
| HY-132246 | WWL123 analogue-1 | Inhibitor | 98.04% | Unkown |
| HY-133180 | YW1128 | Inhibitor | 99.38% | Unkown |
| HY-136404 | Melanin probe-1 | 98.06% | Unkown | |
| HY-14316C | Tebanicline tosylate | Modulator | 98.65% | Unkown |
| HY-143237 | ATX inhibitor 11 | Inhibitor | 99.44% | Unkown |
| HY-143792 | HTT-D3 | / | Unkown | |
| HY-144287 | Glucokinase activator 3 | 98.36% | Unkown | |
| HY-145153 | S-777469 | Agonist | 98.19% | Unkown |
| HY-14533 | K 01-162 | Inhibitor | 98.0% | Unkown |
| HY-145454 | (R)-Preclamol | 99.56% | Unkown | |
| HY-145491 | Resolvin D5 | Inhibitor | 98.3% | Unkown |
| HY-146036 | NADH-IN-1 | Inhibitor | 99.38% | Unkown |
| HY-146054 | CXCR4 modulator-2 | Modulator | / | Unkown |
| HY-146231 | SS47 | / | Unkown | |
| HY-146672 | ITK inhibitor 6 | Inhibitor | / | Unkown |
| HY-147049 | PAL-4 | Activator | 99.10% | Unkown |
| HY-148135 | hCAI/II-IN-6 | Inhibitor | 98.0% | Unkown |
| HY-149208 | HDAC-IN-53 | 95.73% | Unkown | |
| HY-149708 | UCM-13207 | Inhibitor | 99.61% | Unkown |
| HY-150186 | RXFP2 agonist 2 | / | Unkown | |
| HY-150236 | FITC-labeled Tominersen sodium | Inhibitor | 97.65% | Unkown |
| HY-150286 | SM875 | Degrader | 98.89% | Unkown |
| HY-150501 | Diprovocim-X | Agonist | 98.64% | Unkown |
| HY-151704 | ICG-alkyne | 99.17% | Unkown | |
| HY-151876 | Glucocorticoid receptor modulator 1 | 99.79% | Unkown | |
| HY-151959 | FXR agonist 4 | Inhibitor | 99.37% | Unkown |
| HY-153793 | Alcudacigib | Inhibitor | / | Unkown |
| HY-153972 | URAT1&XO inhibitor 2 | Inhibitor | 98.69% | Unkown |
| HY-15427A | GDC-0834 Racemate | 98.04% | Unkown | |
| HY-155525 | Anti-NASH agent 1 | Inhibitor | 98.49% | Unkown |
| HY-156276 | SP4e | Activator | 99.72% | Unkown |
| HY-156936 | RCB-02-4-8 | 99.3% | Unkown | |
| HY-15698B | CRT0066101 trihydrochloride | / | Unkown | |
| HY-157388 | CARM1/HDAC2-IN-1 | Inhibitor | 95.17% | Unkown |
| HY-15791 | FR173657 | Antagonist | / | Unkown |
| HY-158310 | SOS1/EGFR-IN-1 | Inhibitor | 99.54% | Unkown |
| HY-159798 | NR-11c | Inhibitor | 99.75% | Unkown |
| HY-159972 | PKR1 antagonist 1 | Antagonist | / | Unkown |
| HY-160550 | DPM-1003 | Inhibitor | / | Unkown |
| HY-160887 | FPT | Agonist | 98.06% | Unkown |
| HY-161297 | NT-0249 | Inhibitor | / | Unkown |
| HY-161618 | MJ04 | Inhibitor | 98.08% | Unkown |
| HY-161901 | BC-1293 | Inhibitor | 98.40% | Unkown |
| HY-162006 | Pim-1 kinase inhibitor 8 | 99.90% | Unkown | |
| HY-162477 | TS-24 | 98.96% | Unkown | |
| HY-162588 | MC-ND-18 | Degrader | / | Unkown |
| HY-162765 | TRPV4-IN-5 | Inhibitor | 98.77% | Unkown |
| HY-162831 | MPC-IN-1 | Inhibitor | 98.55% | Unkown |
| HY-162863 | ERK-MYD88 interaction inhibitor 1 | Inducer | 99.02% | Unkown |
| HY-163121 | PST3.1a | Inhibitor | / | Unkown |
| HY-163561 | CARM1-IN-6 | 99.59% | Unkown | |
| HY-163683 | EB-PSMA-617 | Inhibitor | 96.38% | Unkown |
| HY-16676 | 7-Epi-docetaxel | Activator | 98.76% | Unkown |
| HY-167856 | RTI-122 | Agonist | / | Unkown |
| HY-167862A | UCM-05194 ammonium | Agonist | / | Unkown |
| HY-170524 | TDI-015051 | Inhibitor | / | Unkown |
| HY-170935 | SRSF1-IN-1 | / | Unkown | |
| HY-171572 | Atezolizumab-MMAE | 98.04% | Unkown | |
| HY-172687 | DSPE-PEG2000-CSTSMLKAC | / | Unkown | |
| HY-172903 | Nav1.8-IN-16 | Inhibitor | / | Unkown |
| HY-173191 | SK-124 | Inhibitor | / | Unkown |
| HY-173234 | GI-Y2 | Inhibitor | / | Unkown |
| HY-173266 | TO-1187 | Degrader | / | Unkown |
| HY-173517 | NHE-1-IN-2 | Inhibitor | 99.57% | Unkown |
| HY-174819 | VNRX-9945 | Modulator | 99.46% | Unkown |
| HY-175202 | CIDD-8633 | / | Unkown | |
| HY-175208 | MST3-IN-1 | / | Unkown | |
| HY-175381 | DeFer-2 | 98.25% | Unkown | |
| HY-175615 | RSL3-NH2 | / | Unkown | |
| HY-175980 | TRPA1 agonist-3 | Agonist | 99.78% | Unkown |
| HY-176224 | Anti-virulence factor-IN-2 | Inhibitor | 98.41% | Unkown |
| HY-176798 | NCI-006 | 98.73% | Unkown | |
| HY-177119 | ZBP1 Covalent PROTAC-1 | Inhibitor | 96.87% | Unkown |
| HY-177204 | DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW | 95.0% | Unkown | |
| HY-177963 | NV914 | Inhibitor | 98.98% | Unkown |
| HY-178037 | TLR9 antagonist 1 | / | Unkown | |
| HY-179474 | TSI-13-57 | Inhibitor | 98.73% | Unkown |
| HY-180107 | H36-E4 | Inhibitor | 98.57% | Unkown |
| HY-180108 | H111-H7 | Inhibitor | 98.14% | Unkown |
| HY-180554 | UCB1244283 | Modulator | / | Unkown |
| HY-181127 | GluN2B-NMDAR Allosteric modulator 1 | Modulator | / | Unkown |
| HY-18164 | TASP0277308 | Antagonist | 99.00% | Unkown |
| HY-181789 | DOT1L808 | Degrader | / | Unkown |
| HY-181955 | MS1129 | / | Unkown | |
| HY-181976 | dHTC3 | Degrader | / | Unkown |
| HY-182305 | VKT-17-P4-23 | Inhibitor | / | Unkown |
| HY-182644 | SMU-Z1 | / | Unkown | |
| HY-182820 | YZ-836P | Inhibitor | / | Unkown |
| HY-183513 | L-Ala-BPA | Substrate | / | Unkown |
| HY-184178A | HF-125 | Inducer | / | Unkown |
| HY-186072 | NT-0527 | 99.80% | Unkown | |
| HY-186212 | PROTAC survivin degrader-1 | / | Unkown | |
| HY-B0561S4 | Spironolactone-d6-1 | 99.26% | Unkown | |
| HY-B1002R | Oxolinic acid (Standard) | Inhibitor | 97.60% | Unkown |
| HY-D1056A5 | Lipopolysaccharides, from E. coli K-235 | Activator | / | Unkown |
| HY-D1065 | NIR-H2O2 | / | Unkown | |
| HY-N0430 | Coptisine | / | Unkown | |
| HY-N0592 | Demethyleneberberine | ≥98.0% | Unkown | |
| HY-N0620 | Mulberroside C | 99.77% | Unkown | |
| HY-N0927 | (-)-Isocorypalmine | 99.67% | Unkown | |
| HY-N10196 | Cerebroside D | 95% | Unkown | |
| HY-N10390 | 3β-Hydroxylanosta-8,24-dien-21-al | 98.46% | Unkown | |
| HY-N12127 | Gymnoside I | 99.24% | Unkown | |
| HY-N19420 | Theasinensin C | / | Unkown | |
| HY-N2620 | Rutaevin | Inhibitor | 99.77% | Unkown |
| HY-N3204 | Neoechinulin A | Inhibitor | 98.0% | Unkown |
| HY-N3506 | Wilfortrine | Inhibitor | 98.83% | Unkown |
| HY-N3960 | Glycyrin | Inhibitor | 98.0% | Unkown |
| HY-N5097 | 13-Oxo-9E,11E-octadecadienoic acid | Activator | / | Unkown |
| HY-N6651 | Isocryptotanshinone | ≥98.0% | Unkown | |
| HY-N7514 | Strictosidinic acid | Inhibitor | 95% | Unkown |
| HY-N9502 | Linalool oxide | 98.0% | Unkown | |
| HY-N9685 | Digitoxose | 98.86% | Unkown | |
| HY-NP134 | Flagellin from S. typhimurium | 95% | Unkown | |
| HY-P10233 | SAAP 148 | Inhibitor | / | Unkown |
| HY-P10641 | Heart-homing peptide | / | Unkown | |
| HY-P10775A | BT1769 acetate | Inhibitor | / | Unkown |
| HY-P10897 | SjDX5-271 | Inhibitor | 98.90% | Unkown |
| HY-P10966A | Tat-IKIP (46-60) TFA | Inhibitor | 99.76% | Unkown |
| HY-P11060 | MC38 SLP Adpgk | 97.52% | Unkown | |
| HY-P11603 | SK56 | Inhibitor | / | Unkown |
| HY-P11655 | NOTA-TATE | Ligand | / | Unkown |
| HY-P1624S1 | Teduglutide-Leu(13C6,15N) sodium | 96.60% | Unkown | |
| HY-P1837 | Influenza HA (518-526) | Inhibitor | 98.28% | Unkown |
| HY-P2260C | Tat-beclin 1 scrambled TFA | 96.26% | Unkown | |
| HY-P4111 | Peptide R | Antagonist | / | Unkown |
| HY-P5117 | TAT-CIRP | Inhibitor | 98.32% | Unkown |
| HY-P5352 | Hyaluronan-IN-1 | Inhibitor | 99.84% | Unkown |
| HY-P5437 | PKCε (85-92) | Activator | 98.50% | Unkown |
| HY-P5890A | YVAD-CHO TFA | Inhibitor | 98.48% | Unkown |
| HY-P6084 | RP-220 | / | Unkown | |
| HY-W008610 | GBR 12783 | Inhibitor | / | Unkown |
| HY-W010243 | Methylisothiazolinone hydrochloride | 99.93% | Unkown | |
| HY-W011592 | N-Phthaloyl-L-glutamic acid | / | Unkown | |
| HY-W013411 | (E/Z)-Locostatin | Control | 99.52% | Unkown |
| HY-W049875 | Nitroxynil | 98.92% | Unkown | |
| HY-W1123936B | DBCO-PEG1000-FA | Ligand | / | Unkown |
| HY-W674241A | 4-Ethylphenyl sulfate sodium | Inducer | / | Unkown |
| HY-W854385 | Sialyl Lewis A | / | Unkown | |
| HY-WAA0304 | Agmatine | / | Unkown | |
| HY-Y0070 | Cyanamide | Inhibitor | 97.0% | Unkown |
| HY-12242A | GBR 12935 | Inhibitor | / | Unkown |
| HY-123115 | Leucrose | 98.53% | Unkown | |
| HY-126813 | Concanamycin C | Inhibitor | 99.9% | Unkown |
| HY-12688 | Succinyl phosphonate | Inhibitor | / | Unkown |
| HY-127023 | Eicosapentaenoyl serotonin | Inhibitor | 99.0% | Unkown |
| HY-134261A | 8-Br-ADPR disodium | Inhibitor | / | Unkown |
| HY-138289 | 4-acetoxy MPT | 98.8% | Unkown | |
| HY-141582S | Ceramide 3-d3 | Inhibitor | 98.0% | Unkown |
| HY-152169 | BIHC | ≥98.0% | Unkown | |
| HY-158812 | Eicosapentaenoyl-L-carnitine chloride | 93.4% | Unkown | |
| HY-160066 | SYL3C aptamer sodium | Ligand | 95.31% | Unkown |
| HY-160926 | 16-Oxocafestol | Inducer | 98.0% | Unkown |
| HY-165014 | 2C-I-FLY hydrochloride | 99.3% | Unkown | |
| HY-165421 | Mps1-IN-10 | Inhibitor | 98.20% | Unkown |
| HY-169858 | Prostaglandin E2 Inhibitor 3 | Inhibitor | 99.2% | Unkown |
| HY-172705 | DSPE-PEG2000-RVG29 | Ligand | / | Unkown |
| HY-177493 | SSTR3 Agonist-1 | Agonist | / | Unkown |
| HY-181604 | MDH2-IN-2 | Inhibitor | / | Unkown |
| HY-70062R | Pevonedistat (Standard) | 99.51% | Unkown | |
| HY-N11546 | Sapindoside B | Inhibitor | 96.68% | Unkown |
| HY-N12087 | 8-Deoxylactucin | Inhibitor | 95.0% | Unkown |
| HY-N16039 | TAN-1030A | Activator | / | Unkown |
| HY-N2720 | 6-O-Caffeoylarbutin | 99.47% | Unkown | |
| HY-N2867 | Andrographiside | Inhibitor | 96% | Unkown |
| HY-W012481 | Nirvanol | 95.34% | Unkown | |
| HY-W015338 | 1-(4-Methoxyphenyl)-1-propanol | / | Unkown | |
| HY-W115558 | L-Serine-O-sulfate potassium | Inhibitor | / | Unkown |
| HY-W142457 | Dihydromyrcenol | Inhibitor | / | Unkown |
| HY-W265314 | Arvelexin | Inhibitor | / | Unkown |
| HY-W338446 | BF-170 | Ligand | 99.74% | Unkown |
| HY-W585843 | 1,1′-Ethylidenebis[L-tryptophan] | Activator | 96.04% | Unkown |
| HY-W770410 | 9-PAHSA-13C4 | 99.9% | Unkown | |
| HY-N12740 | Napyradiomycin B4 | Inhibitor | / | Unkown |
| HY-185561 | Misitatug blivedotin | / | Unkown | |
| HY-101029A | MBM-55S | / | Unkown | |
| HY-101030 | MBM-17 | / | Unkown | |
| HY-112467 | Tivozanib hydrate | Inhibitor | 99.0% | Unkown |
| HY-113308AS | Taurolithocholic acid-d4 sodium | 99.4% | Unkown | |
| HY-115507 | NMac1 | / | Unkown | |
| HY-116514R | (S)-(-)-Perillyl alcohol (Standard) | / | Unkown | |
| HY-120667 | DS-5272 | / | Unkown | |
| HY-12459 | Pyrindamycin B | Inhibitor | / | Unkown |
| HY-130609A | Aβ42-IN-1 free base | Modulator | / | Unkown |
| HY-132302A | Hu7691 free base | Inhibitor | / | Unkown |
| HY-139798 | Iboxamycin | Inhibitor | / | Unkown |
| HY-143443 | DS17701585 | Inhibitor | / | Unkown |
| HY-143497 | HDAC1/2 and CDK2-IN-1 | / | Unkown | |
| HY-144026S | 9-PAHSA-d9 | / | Unkown | |
| HY-146615 | Axl-IN-6 | Inhibitor | / | Unkown |
| HY-149917 | PROTAC ITK degrader 1 | Degrader | / | Unkown |
| HY-172883 | ABP/PPAR modulator 1 | Modulator | / | Unkown |
| HY-174129 | TM471-1 | / | Unkown | |
| HY-174458 | MD-4251 | Degrader | / | Unkown |
| HY-174850 | CFON-026 | Inhibitor | / | Unkown |
| HY-176266 | KIT-13 | Activator | / | Unkown |
| HY-178749 | MS6076 | / | Unkown | |
| HY-181703 | 4-PSQ | Modulator | / | Unkown |
| HY-181954 | ZW-49 | / | Unkown | |
| HY-182082 | XYD270 | / | Unkown | |
| HY-182242 | AGB-374 | Inhibitor | / | Unkown |
| HY-184142 | EYE1118 | Inhibitor | / | Unkown |
| HY-N1393R | 2-Methoxybenzoic acid (Standard) | / | Unkown | |
| HY-122068 | ITX5061 free base | Inhibitor | / | Unkown |
| HY-123922 | NOSO-502 | Inhibitor | / | Unkown |
| HY-124244 | DB-959 | Inhibitor | / | Unkown |
| HY-125790 | Cyclazocine | Modulator | / | Unkown |
| HY-133127A | AR453588 hydrochloride | Activator | / | Unkown |
| HY-136220A | AHR antagonist 5 hemimaleate | Antagonist | / | Unkown |
| HY-14932A | Pafuramidine maleate | Inhibitor | / | Unkown |
| HY-150080 | GSK3739936 | Inhibitor | / | Unkown |
| HY-152096 | (R)-ZG197 | Inhibitor | / | Unkown |
| HY-152097 | (S)-ZG197 | Inhibitor | / | Unkown |
| HY-165504 | Nagstatin | Inhibitor | / | Unkown |
| HY-184107 | Bcl-2-IN-25 | Inhibitor | / | Unkown |
| HY-184265 | Mito-Esculetin | / | Unkown | |
| HY-186117 | KG-FP-003 | Degrader | / | Unkown |
| HY-49538C | ASP7967 hemifumarate | Inducer | / | Unkown |
| HY-B0396B | Tebipenem pivoxil hydrobromide | / | Unkown | |
| HY-14393S | Emodin-d4 | Inhibitor | / | Unkown |
| HY-P1089 | Cytochrome c-pigeon (88-104) | / | Unkown | |
| HY-W052508S | Norquetiapine-d8 | / | Unkown | |
| HY-100113A | Buloxibutid hydrochloride | / | Unkown | |
| HY-100469 | LXRβ agonist-2 | Agonist | / | Unkown |
| HY-100679B | (R)-Pirlindole mesylate | Inhibitor | / | Unkown |
| HY-100782 | DL-AP7 | Antagonist | / | Unkown |
| HY-10084 | CK0106023 | Inhibitor | / | Unkown |
| HY-100922 | N-Acetylglycyl-D-glutamic acid | Agonist | / | Unkown |
| HY-101021 | Ascochlorin | / | Unkown | |
| HY-10104 | GRL-8234 | Inhibitor | / | Unkown |
| HY-10109A | AS-605240 potassium | Inhibitor | / | Unkown |
| HY-101139 | Xanthine amine congener | Antagonist | / | Unkown |
| HY-101220 | RMI-61140 | Inhibitor | / | Unkown |
| HY-101317A | TAN-67 | Agonist | / | Unkown |
| HY-101349A | L 741742 hydrochloride | / | Unkown | |
| HY-101384 | Ro 10-5824 | Agonist | / | Unkown |
| HY-101393 | CGP 12177 | Modulator | / | Unkown |
| HY-101699 | AMG-076 free base | Antagonist | / | Unkown |
| HY-101780A | Tinostamustine hydrochloride | Inhibitor | / | Unkown |
| HY-101824 | NC-2100 | Activator | / | Unkown |
| HY-102009 | BB-83698 | Inhibitor | / | Unkown |
| HY-103052 | CGS-9896 | Agonist | / | Unkown |
| HY-103117 | S 32212 hydrochloride | Inhibitor | / | Unkown |
| HY-103151A | CP94253 | Agonist | / | Unkown |
| HY-103216A | RWJ52353 hydrochloride | Agonist | / | Unkown |
| HY-103303 | CRSP-1 | Activator | / | Unkown |
| HY-103357 | LY288513 | Antagonist | / | Unkown |
| HY-103496 | U-90042 | Agonist | / | Unkown |
| HY-103537A | BIIB042 | Modulator | / | Unkown |
| HY-103567 | Desmethyl-YM-298198 hydrochloride | Antagonist | / | Unkown |
| HY-103639 | M62812 free base | Inhibitor | / | Unkown |
| HY-105052 | SC 34301 | / | Unkown | |
| HY-105059 | Denzimol | / | Unkown | |
| HY-105059A | Denzimol hydrochloride | / | Unkown | |
| HY-105098B | (±)-Lobucavir | / | Unkown | |
| HY-105211 | KU-2285 | / | Unkown | |
| HY-105236 | (Rac)-Enadoline | Agonist | / | Unkown |
| HY-105365 | PD 175069 | Antagonist | / | Unkown |
| HY-105433 | Perrimustine | / | Unkown | |
| HY-105498 | ADD-196022 | / | Unkown | |
| HY-105578A | Letimide hydrochloride | / | Unkown | |
| HY-105579 | Isonixin | Inhibitor | / | Unkown |
| HY-105592 | Phenopyrazone | / | Unkown | |
| HY-105628 | Prodilidine | / | Unkown | |
| HY-105762A | Etamiphyllin camsylate | / | Unkown | |
| HY-105790 | Piperilate | / | Unkown | |
| HY-105879 | Tepirindole | / | Unkown | |
| HY-105885 | Sumacetamol | / | Unkown | |
| HY-105969 | Dichloromethotrexate | / | Unkown | |
| HY-106055 | Murabutide | / | Unkown | |
| HY-106110 | OP-2507 | / | Unkown | |
| HY-106115 | Vintoperol | / | Unkown | |
| HY-106159 | SB-T-101141 | Inducer | / | Unkown |
| HY-106193 | RC-552 | / | Unkown | |
| HY-106203B | (R)-Crinecerfont | Antagonist | / | Unkown |
| HY-106224AS | Orexin A-13C6,15N (human, rat, mouse) TFA | / | Unkown | |
| HY-106300 | AA 193 | Inhibitor | / | Unkown |
| HY-106435 | Cystemustine | Inhibitor | / | Unkown |
| HY-106471 | Pildralazine | / | Unkown | |
| HY-106556 | Zorubicin | Inhibitor | / | Unkown |
| HY-106752 | CI-936 | Agonist | / | Unkown |
| HY-106761 | Oxodipine | Antagonist | / | Unkown |
| HY-106837 | Israpafant | Antagonist | / | Unkown |
| HY-106866 | Bulaquine | Inhibitor | / | Unkown |
| HY-106893 | Pimilprost | Agonist | / | Unkown |
| HY-106901B | Asoxime dimesylate | / | Unkown | |
| HY-106902 | F-1394 | Inhibitor | / | Unkown |
| HY-106929B | Moxilubant hydrochloride | Antagonist | / | Unkown |
| HY-106946 | E 5065 | Inhibitor | / | Unkown |
| HY-106979 | Olcorolimus | Inhibitor | / | Unkown |
| HY-106997 | Icofungipen | Inhibitor | / | Unkown |
| HY-107064 | Cefroxadine | Inhibitor | / | Unkown |
| HY-107401 | Ancriviroc | / | Unkown | |
| HY-107513 | BAY 36-7620 | Antagonist | / | Unkown |
| HY-107761 | JMV 390-1 | / | Unkown | |
| HY-108035 | (-)-JM-1232 | / | Unkown | |
| HY-108041 | MGS 0210 | Agonist | / | Unkown |
| HY-108281 | Enfenamic acid | / | Unkown | |
| HY-108352 | HU 331 | Inhibitor | / | Unkown |
| HY-10845 | CGI-17341 | Inhibitor | / | Unkown |
| HY-108459 | 6-Iodonordihydrocapsaicin | Antagonist | / | Unkown |
| HY-108497A | L-803087 TFA | Agonist | / | Unkown |
| HY-108538 | Ethacrynic acid D5 | Inhibitor | / | Unkown |
| HY-108942 | ASP5854 | Antagonist | / | Unkown |
| HY-108960 | PPADS | / | Unkown | |
| HY-109120S | Odevixibat-d5 | Inhibitor | / | Unkown |
| HY-109120S1 | Odevixibat-13C6 | Inhibitor | / | Unkown |
| HY-109968A | Irdabisant hydrochloride | Antagonist | / | Unkown |
| HY-110020 | rel-O-2050 | Antagonist | / | Unkown |
| HY-110197A | 6bK formate | Inhibitor | 97.02% | Unkown |
| HY-110198 | ONO-8130 | / | Unkown | |
| HY-110262 | MSC 2032964A | Inhibitor | / | Unkown |
| HY-110268 | NVP CXCR2 20 | Antagonist | / | Unkown |
| HY-110303 | Xanthine amine congener dihydrochloride | Antagonist | / | Unkown |
| HY-110350 | CHR-6494 TFA | Inhibitor | / | Unkown |
| HY-111077 | INCB16562 | Inhibitor | / | Unkown |
| HY-111315 | XEN103 | Inhibitor | / | Unkown |
| HY-111320 | Chrysomycin B | Inhibitor | / | Unkown |
| HY-111906 | SCYX-6759 | Inhibitor | / | Unkown |
| HY-112417 | Ki11502 | 99.30% | Unkown | |
| HY-113161S | L-Octanoylcarnitine-d3 | / | Unkown | |
| HY-113308AS2 | Taurolithocholic acid-d4-1 sodium | / | Unkown | |
| HY-113308S | Taurolithocholic acid-d5 | / | Unkown | |
| HY-113326 | Phytoene | Inhibitor | / | Unkown |
| HY-113354S1 | Anserine-d4 hydrochloride | / | Unkown | |
| HY-113484 | Leukotriene B5 | Activator | / | Unkown |
| HY-113486S1 | lathosterol-d7 | / | Unkown | |
| HY-113619A | ABT-255 hydrochloride | Inhibitor | / | Unkown |
| HY-113798 | ICI 198583 | / | Unkown | |
| HY-113829 | Valnemulin | Inhibitor | 99.0% | Unkown |
| HY-113866 | E-55888 | Agonist | / | Unkown |
| HY-113889 | ZK112993 | Antagonist | / | Unkown |
| HY-113898 | Ganoderic acid K | Inhibitor | / | Unkown |
| HY-113902 | (2-(β-Piperidinoethyl)-9-hydroxyellipticinium chloride | Inhibitor | / | Unkown |
| HY-113958 | Difethialone | Inhibitor | 99.84% | Unkown |
| HY-113958S | Difethialone-d4 | / | Unkown | |
| HY-113958S1 | Difethialone-d4-1 | Inhibitor | / | Unkown |
| HY-114162B | VTP50469 mesylate | / | Unkown | |
| HY-114298 | 7-Dehydro desmosterol | / | Unkown | |
| HY-114542 | LY 201409 | / | Unkown | |
| HY-114598 | WAY-123783 | Inhibitor | / | Unkown |
| HY-114611 | BDM44768 | / | Unkown | |
| HY-114651 | Phenazoviridin | / | Unkown | |
| HY-114900 | BB-3497 | / | Unkown | |
| HY-114969 | Clioxanide | / | Unkown | |
| HY-115581 | Thymidine 3',5'-disphosphate | Inducer | / | Unkown |
| HY-115826 | AB-163 | / | Unkown | |
| HY-115996 | Antitumor agent-51 | Control | / | Unkown |
| HY-116046 | GR 196429 | Agonist | / | Unkown |
| HY-116145 | MHY884 | Inhibitor | / | Unkown |
| HY-116182 | RO5487624 | Inhibitor | / | Unkown |
| HY-116282P | Dextran sulfate, high sulfate (MW 5000) | Inhibitor | / | Unkown |
| HY-116330 | Hyperforin | / | Unkown | |
| HY-116488 | IND8 | Activator | / | Unkown |
| HY-116586 | AF710B | / | Unkown | |
| HY-116595 | J-104118 | Inhibitor | / | Unkown |
| HY-116597 | L-783483 | Agonist | / | Unkown |
| HY-116636 | KRCA-0377 | Inhibitor | / | Unkown |
| HY-116881 | SCH 57790 | Antagonist | / | Unkown |
| HY-117039 | YM-359445 dihydroxybutanedioate | Inhibitor | / | Unkown |
| HY-117051 | STA-2842 | Inhibitor | / | Unkown |
| HY-117087 | K103 | Inducer | / | Unkown |
| HY-117172 | CP320626 | Inhibitor | / | Unkown |
| HY-117231 | RM 06 | / | Unkown | |
| HY-117461 | Y 25510 | Activator | / | Unkown |
| HY-117482A | BPN-15606 besylate | Modulator | / | Unkown |
| HY-117513 | CEP1612 | / | Unkown | |
| HY-117521 | EVP-0015962 | Inhibitor | / | Unkown |
| HY-117555 | 4010B-30 | Activator | / | Unkown |
| HY-117569 | KF24345 free base | Inhibitor | / | Unkown |
| HY-117593 | NSC 23925B | Inhibitor | / | Unkown |
| HY-117599 | JPC-3210 | Inhibitor | / | Unkown |
| HY-117603 | CM-10-18 | Inhibitor | / | Unkown |
| HY-117638 | CB 966 | / | Unkown | |
| HY-117660S | Lincomycin-d3 | Inhibitor | 99.90% | Unkown |
| HY-117660S1 | Lincomycin-13C,d3 | Inhibitor | / | Unkown |
| HY-117707 | EBI-907 | Inhibitor | / | Unkown |
| HY-117774 | AHR-2244 hydrochloride | / | Unkown | |
| HY-117811 | (R,R)-MK 287 | Inhibitor | / | Unkown |
| HY-117836 | FAK-IN-16 | Inhibitor | / | Unkown |
| HY-117881 | CJ-15208 | / | Unkown | |
| HY-118018 | CHF-2993 | Inhibitor | / | Unkown |
| HY-118030 | RQ-00311651 | Antagonist | / | Unkown |
| HY-118032 | Bozepinib | / | Unkown | |
| HY-118113 | BVT-116429 | Inhibitor | / | Unkown |
| HY-118243 | KMS88009 | Inhibitor | / | Unkown |
| HY-118363 | Lu AE51090 | Agonist | 99.51% | Unkown |
| HY-118382 | SCH-451659 | Inhibitor | / | Unkown |
| HY-118426 | (Rac)-Tipifarnib | Inhibitor | / | Unkown |
| HY-118523 | AL-321 | Inhibitor | / | Unkown |
| HY-118574 | UBP141 | Antagonist | / | Unkown |
| HY-118626 | PD-254552 | Inhibitor | / | Unkown |
| HY-118668 | ABD-350 | / | Unkown | |
| HY-118775 | LEK 8804 | Agonist | / | Unkown |
| HY-118807A | Mepyramine hydrochloride | / | Unkown | |
| HY-118900 | CP-654577 | / | Unkown | |
| HY-118950 | J 628 | / | Unkown | |
| HY-118970 | LG190155 | / | Unkown | |
| HY-118992 | Aurodox | Inhibitor | / | Unkown |
| HY-119105 | LY81067 | / | Unkown | |
| HY-119206 | Sulbenicillin | / | Unkown | |
| HY-119261 | Ruboxyl | / | Unkown | |
| HY-119316 | CM-414 | Inhibitor | / | Unkown |
| HY-119386 | SAS-0132 | / | Unkown | |
| HY-119519 | OB-2 | Inhibitor | / | Unkown |
| HY-119578 | Imiprothrin | Activator | / | Unkown |
| HY-119601 | GRI918013 | Inhibitor | / | Unkown |
| HY-119716 | Cyheptamide | / | Unkown | |
| HY-119789 | Albofungin | Inhibitor | / | Unkown |
| HY-119805 | YM 13650 | / | Unkown | |
| HY-119899 | BO-0742 | / | Unkown | |
| HY-119925 | Amaralin | / | Unkown | |
| HY-120015 | BE-16627B | Inhibitor | / | Unkown |
| HY-120105 | NSC666715 | / | Unkown | |
| HY-120116 | AM-8508 | Inhibitor | / | Unkown |
| HY-120148 | SM19712 free acid | Inhibitor | / | Unkown |
| HY-120171 | DH-376 | Inhibitor | / | Unkown |
| HY-120225 | NJK14047 | Inhibitor | / | Unkown |
| HY-120257 | IDN-1965 | Inhibitor | / | Unkown |
| HY-120291 | ASP9436 | Inhibitor | / | Unkown |
| HY-120382 | LY 215890 | Inhibitor | / | Unkown |
| HY-120561 | PC-046 | / | Unkown | |
| HY-120600 | Sibiriline | Inhibitor | / | Unkown |
| HY-120643 | BMS-823778 hydrochloride | Inhibitor | / | Unkown |
| HY-120769 | Pimprinine | Inhibitor | ≥90.0% | Unkown |
| HY-120782A | Yhhu-3792 hydrochloride | Activator | / | Unkown |
| HY-120783 | Lu AF58801 | / | Unkown | |
| HY-120804 | PH-46A | Inhibitor | / | Unkown |
| HY-120925 | TRV0109101 | / | Unkown | |
| HY-121007 | Bepafant | Antagonist | / | Unkown |
| HY-121182 | Chalcomycin | Inhibitor | / | Unkown |
| HY-121328 | Empenthrin | Inhibitor | / | Unkown |
| HY-121365 | Forphenicinol | Inhibitor | / | Unkown |
| HY-12142S | rac-Vofopitant-d3 | Antagonist | / | Unkown |
| HY-121431 | FR-901235 | / | Unkown | |
| HY-121473 | Aklavin | Inhibitor | / | Unkown |
| HY-12153 | JNJ-1930942 | Modulator | / | Unkown |
| HY-121554 | Kojic amine | / | Unkown | |
| HY-121565 | SaRI 59-801 | Activator | / | Unkown |
| HY-121582 | (E)-SI-2 | / | Unkown | |
| HY-121621 | RO5101576 | / | Unkown | |
| HY-121670 | Ambenoxan | / | Unkown | |
| HY-121670A | Ambenoxan hydrochloride | / | Unkown | |
| HY-121671 | TBTC | Activator | 97.22% | Unkown |
| HY-12191 | A-331440 | Antagonist | / | Unkown |
| HY-12192 | A-423579 | Antagonist | / | Unkown |
| HY-122133 | CI 750 | / | Unkown | |
| HY-122176 | NU-7107 | Inhibitor | / | Unkown |
| HY-122179 | NUCC-555 | Antagonist | / | Unkown |
| HY-122189 | Akuammine | / | Unkown | |
| HY-122275 | A-371191 | Antagonist | / | Unkown |
| HY-122278 | Melevodopa | / | Unkown | |
| HY-122282 | AZ11657312 | Activator | / | Unkown |
| HY-122303 | 4-hydroxy DiPT hydrochloride | Agonist | / | Unkown |
| HY-122309 | A-71497 | / | Unkown | |
| HY-122323 | L-Leucyl-L-arginine | / | Unkown | |
| HY-122518 | 8-Deazafolic acid | Inhibitor | / | Unkown |
| HY-122529 | Almurtide | Inhibitor | / | Unkown |
| HY-122542 | PPACK | Inhibitor | / | Unkown |
| HY-122549 | Lophenol | Activator | / | Unkown |
| HY-122557 | AZD3676 | Ligand | / | Unkown |
| HY-122613 | YM543 free base | Inhibitor | / | Unkown |
| HY-122655 | HMCEF | Inhibitor | / | Unkown |
| HY-122849 | CHMFL-KIT-031 | Inhibitor | / | Unkown |
| HY-122916 | 7-Acetyllycopsamine | / | Unkown | |
| HY-123013 | Y 9000 | / | Unkown | |
| HY-123020 | CYD-2-88 | Antagonist | / | Unkown |
| HY-123165 | NU7200 | Inhibitor | / | Unkown |
| HY-123171 | ASP8497 | Inhibitor | / | Unkown |
| HY-123189 | LY 171859 | / | Unkown | |
| HY-123207 | BP 554 | Agonist | / | Unkown |
| HY-123221 | RS-0481 | Activator | / | Unkown |
| HY-123237 | KRC-108 | / | Unkown | |
| HY-123255 | BSc2118 | / | Unkown | |
| HY-123280 | SCH 54388 | / | Unkown | |
| HY-123357 | IMM-H004 | Inhibitor | / | Unkown |
| HY-123371 | Ro 07-1902 | / | Unkown | |
| HY-123525 | COR628 | / | Unkown | |
| HY-123664 | Trioxifene mesylate | Modulator | / | Unkown |
| HY-123795 | NY0123 | Inhibitor | / | Unkown |
| HY-123882 | IRAK4-IN-29 | / | Unkown | |
| HY-12392A | Iprindole hydrochloride | Agonist | / | Unkown |
| HY-124084 | SW203668 | Inhibitor | / | Unkown |
| HY-124110 | TC299423 | Agonist | / | Unkown |
| HY-124112 | PAM 1392 | Inhibitor | / | Unkown |
| HY-124412S | Paynantheine-d3 | / | Unkown | |
| HY-124557 | Mahanimbine | Inhibitor | / | Unkown |
| HY-124623 | DNDI-8219 | Inhibitor | / | Unkown |
| HY-124627 | THIQ 40 | Degrader | / | Unkown |
| HY-124792 | MRLB-223 | / | Unkown | |
| HY-124941 | 7-Deacetylgedunin | Activator | / | Unkown |
| HY-124954 | MN-25 | Agonist | / | Unkown |
| HY-125209A | TH5427 hydrochloride | / | Unkown | |
| HY-125230 | CN427 | Inhibitor | / | Unkown |
| HY-125405 | AZ3971 | Inhibitor | / | Unkown |
| HY-125426 | ToP-DNJ | Inhibitor | / | Unkown |
| HY-125447 | Artemisinin B | Inhibitor | / | Unkown |
| HY-125527AS | 17(R)-Resolvin D1-d5 | Inhibitor | / | Unkown |
| HY-125646 | YH18968 | Activator | / | Unkown |
| HY-125675 | VPC-16606 | Inhibitor | / | Unkown |
| HY-125721 | Tetranactin | Inhibitor | / | Unkown |
| HY-125858B | (S,R,S)-MI-1061 | Control | / | Unkown |
| HY-12602 | TNKS-IN-4 | Inhibitor | / | Unkown |
| HY-12608 | TA-1887 | Inhibitor | / | Unkown |
| HY-126185 | Nibroxane | Inhibitor | / | Unkown |
| HY-126731 | Rudolfomycin | Inhibitor | / | Unkown |
| HY-126740 | Anguinomycin A | Inhibitor | / | Unkown |
| HY-126835 | A924 | / | Unkown | |
| HY-126898 | 5-LO/mPGES1-IN-1 | Inhibitor | 99.00% | Unkown |
| HY-126910 | Mesyl Salvinorin B | Agonist | / | Unkown |
| HY-126969 | C333H | Modulator | / | Unkown |
| HY-12701 | U-99194 | Antagonist | / | Unkown |
| HY-127039 | Antipain | Inhibitor | / | Unkown |
| HY-12736 | GSK143 | Inhibitor | / | Unkown |
| HY-128387S | 2,3-Butanediol-d6 | / | Unkown | |
| HY-128435 | 2,4'-Dihydroxybenzophenone-1 | 99.63% | Unkown | |
| HY-128753A | Lyxose | / | Unkown | |
| HY-12896 | SLR080811 | Inhibitor | / | Unkown |
| HY-129250 | AZD5213 | Antagonist | / | Unkown |
| HY-129335 | Chlorozotocin | Inhibitor | / | Unkown |
| HY-129406 | AF 698 | / | Unkown | |
| HY-129442 | MNA 279 | / | Unkown | |
| HY-129577 | Aplysin | Inhibitor | / | Unkown |
| HY-129615 | MIP-1072 | Inhibitor | / | Unkown |
| HY-129661 | AH 7959 | / | Unkown | |
| HY-129684 | IAXO-101 iodide | Inhibitor | / | Unkown |
| HY-129762 | Yoshi-864 | Inhibitor | / | Unkown |
| HY-12995 | BI 665915 | Inhibitor | / | Unkown |
| HY-129980A | NPC-15437 | / | Unkown | |
| HY-130235 | Naprodoxime hydrochloride | / | Unkown | |
| HY-131453 | Mitochondrial respiration-IN-1 | Inhibitor | / | Unkown |
| HY-131501S | Menaquinone-9-d7 | / | Unkown | |
| HY-131501S1 | Menaquinone-9-13C6 | / | Unkown | |
| HY-131508 | M&B 5124 | Inhibitor | / | Unkown |
| HY-131651 | Leukotriene B4 ethanolamide | Antagonist | / | Unkown |
| HY-131954 | 5-HT3 antagonist 4 | Antagonist | / | Unkown |
| HY-13225D | Rivanicline fumarate | Agonist | / | Unkown |
| HY-13225H | Rivanicline hydrochloride | Agonist | / | Unkown |
| HY-132972 | TrxR-IN-2 | / | Unkown | |
| HY-13312A | GTx-134 | / | Unkown | |
| HY-133151 | CXCR6 antagonist 1 | Antagonist | / | Unkown |
| HY-133533 | O-2050 | Antagonist | / | Unkown |
| HY-133800 | Volvaltrate B | / | Unkown | |
| HY-134191 | Cryptochrome modulator 1 | Modulator | / | Unkown |
| HY-134261 | 8-Br-ADPR | Inhibitor | / | Unkown |
| HY-134483 | 5-HT7/5-HT2A receptor antagonist 1 | Antagonist | / | Unkown |
| HY-134998 | Oltipraz metabolite M2 | / | Unkown | |
| HY-135167 | HOCPCA | / | Unkown | |
| HY-135529 | Trioxifene | Modulator | / | Unkown |
| HY-135629 | PF-5236216 | Inhibitor | / | Unkown |
| HY-13589A | Cemadotin hydrochloride | Inhibitor | / | Unkown |
| HY-136450S | Triclabendazole sulfoxide-d3 | Inhibitor | / | Unkown |
| HY-136450S1 | Triclabendazole sulfoxide-13C,d3 | Inhibitor | / | Unkown |
| HY-137502A | ML267 free base | Inhibitor | 98.45% | Unkown |
| HY-13774 | WK-X-34 | Inhibitor | / | Unkown |
| HY-138008 | WX-132-18B | / | Unkown | |
| HY-138135 | OP-1118 | Inhibitor | / | Unkown |
| HY-138443A | BF-175 | / | Unkown | |
| HY-13846 | BM-1074 | / | Unkown | |
| HY-138842 | DDN | Activator | / | Unkown |
| HY-139247 | pNPS-DHA | / | Unkown | |
| HY-139499 | Sudemycin D6 | Modulator | / | Unkown |
| HY-13976A | PRL-8-53 | / | Unkown | |
| HY-139844 | Anti-inflammatory agent 7 | Inhibitor | / | Unkown |
| HY-13991A | (S)-CCG-1423 | / | Unkown | |
| HY-139987 | LeuRS-IN-1 | Inhibitor | / | Unkown |
| HY-139994 | XN methyl pyrazole | / | Unkown | |
| HY-141439 | TBE 31 | / | Unkown | |
| HY-141878 | di-Ellipticine-RIBOTAC | / | Unkown | |
| HY-141878A | di-Ellipticine-RIBOTAC TFA | / | Unkown | |
| HY-141896 | RET-IN-7 | Inhibitor | 98.00% | Unkown |
| HY-14222 | UMB24 | Antagonist | / | Unkown |
| HY-142946 | KRAS G12C inhibitor 44 | Inhibitor | / | Unkown |
| HY-143312C | (S)-V-0219 | Modulator | / | Unkown |
| HY-143322 | CRK12-IN-2 | Inhibitor | / | Unkown |
| HY-143330 | MAO-B-IN-4 | Inhibitor | / | Unkown |
| HY-143402 | Topoisomerase I/II inhibitor 2 | Inhibitor | / | Unkown |
| HY-143414 | Metallo-β-lactamase-IN-6 | Inhibitor | / | Unkown |
| HY-143420 | ATX inhibitor 15 | Inhibitor | / | Unkown |
| HY-143434 | FLT3/D835Y-IN-1 | Inhibitor | / | Unkown |
| HY-143464 | BChE-IN-4 | Inhibitor | / | Unkown |
| HY-143586 | CDK7-IN-8 | Inhibitor | / | Unkown |
| HY-14364 | A-987306 | Antagonist | / | Unkown |
| HY-143879 | MRGPRX1 agonist 3 | Agonist | / | Unkown |
| HY-143880 | MRGPRX1 agonist 4 | Agonist | / | Unkown |
| HY-144232 | Anticancer agent 28 | / | Unkown | |
| HY-144297 | HDAC1-IN-3 | Inhibitor | / | Unkown |
| HY-144361 | Antitumor agent-44 | Inducer | / | Unkown |
| HY-144497 | HE-S2 | / | Unkown | |
| HY-144655 | IP2 | Activator | / | Unkown |
| HY-144658 | FXIa-IN-8 | Inhibitor | / | Unkown |
| HY-144668 | RdRP-IN-4 | Inhibitor | / | Unkown |
| HY-144743 | ATX inhibitor 12 | Inhibitor | / | Unkown |
| HY-144777 | FLT3-IN-14 | / | Unkown | |
| HY-144786 | Tubulin polymerization-IN-4 | / | Unkown | |
| HY-145147A | AAA-10 formic | Inhibitor | / | Unkown |
| HY-145265 | Antimicrobial photosensitizer-1 | / | Unkown | |
| HY-145454A | Preclamol | Agonist | / | Unkown |
| HY-145525 | Linoleoyl-L-carnitine chloride | / | Unkown | |
| HY-145690 | HP1328 | Inhibitor | / | Unkown |
| HY-145812 | CRK12-IN-1 | Inhibitor | / | Unkown |
| HY-145829 | Tofacitinib Prodrug-1 | Inhibitor | / | Unkown |
| HY-145836 | FGFR4-IN-8 | Inhibitor | / | Unkown |
| HY-145844 | EGFR-IN-44 | / | Unkown | |
| HY-145845 | HDAC1/MAO-B-IN-1 | Inhibitor | / | Unkown |
| HY-146001 | Influenza virus-IN-4 | Inhibitor | / | Unkown |
| HY-146019 | HIV-1 inhibitor-24 | Inhibitor | / | Unkown |
| HY-146058 | NF-κB/PON1-IN-1 | Inhibitor | / | Unkown |
| HY-146151 | γ-Secretase modulator 12 | / | Unkown | |
| HY-146190 | Callophycin A | Inhibitor | / | Unkown |
| HY-146261 | HI5 | / | Unkown | |
| HY-146272 | Vasopressin V2 receptor antagonist 1 | Antagonist | / | Unkown |
| HY-146280 | mGAT3/4-IN-1 | Inhibitor | / | Unkown |
| HY-146281 | mGAT3/4-IN-2 | Inhibitor | / | Unkown |
| HY-146293 | HDAC6/HSP90-IN-1 | Inhibitor | / | Unkown |
| HY-146297 | Xanthine oxidoreductase-IN-2 | Inhibitor | / | Unkown |
| HY-146354 | Antiproliferative agent-4 | Inducer | / | Unkown |
| HY-146366 | Tubulin inhibitor 26 | Inhibitor | / | Unkown |
| HY-146401 | CXCR4 antagonist 6 | Antagonist | / | Unkown |
| HY-146435 | Anti-inflammatory agent 22 | Inhibitor | / | Unkown |
| HY-146452 | Anticancer agent 57 | Inducer | / | Unkown |
| HY-146458 | Antibacterial agent 102 | Inhibitor | / | Unkown |
| HY-146468 | DPP-4/GPR119 modulator 1 | / | Unkown | |
| HY-146494 | Androgen receptor antagonist 5 | Antagonist | / | Unkown |
| HY-146495 | Antitubercular agent-19 | Inhibitor | / | Unkown |
| HY-146496 | Antitubercular agent-20 | Inhibitor | / | Unkown |
| HY-146497 | Topoisomerase I inhibitor 7 | Inhibitor | / | Unkown |
| HY-146505 | Tubulin polymerization-IN-6 | / | Unkown | |
| HY-146540 | GEM-5 | / | Unkown | |
| HY-146617 | GLS1 Inhibitor-4 | / | Unkown | |
| HY-146619 | RAGE/SERT-IN-1 | Inhibitor | / | Unkown |
| HY-146704 | COX-2/sEH-IN-1 | Inhibitor | / | Unkown |
| HY-146715 | IDO/Tubulin-IN-2 | / | Unkown | |
| HY-146723 | IKKβ-IN-1 | Inhibitor | / | Unkown |
| HY-146740 | PD-1/PD-L1-IN-27 | Inhibitor | / | Unkown |
| HY-146780 | TGFβRI-IN-4 | Inhibitor | / | Unkown |
| HY-146883A | As-358 hydrochloride | Inhibitor | / | Unkown |
| HY-147013 | Caprochlorone | Inhibitor | / | Unkown |
| HY-147014 | Cyclic HPMPC | Inhibitor | / | Unkown |
| HY-147016 | NIOCH 14 | / | Unkown | |
| HY-147278 | Manusiran | Inhibitor | / | Unkown |
| HY-147335 | 6,9,12,15-Hexadecatetraenoic acid-ethyl ester | / | Unkown | |
| HY-147529 | mGluR2 modulator 3 | Modulator | / | Unkown |
| HY-147678 | GPR40 agonist 5 | Agonist | / | Unkown |
| HY-147692 | COX-2-IN-14 | Inhibitor | / | Unkown |
| HY-147712 | PKC-IN-4 | Inhibitor | / | Unkown |
| HY-147720 | γ-Secretase modulator 11 | / | Unkown | |
| HY-147720A | γ-Secretase modulator 11 hydrochloride | Modulator | / | Unkown |
| HY-147772 | ZC0101 | / | Unkown | |
| HY-147975 | JAK3-IN-12 | Inhibitor | / | Unkown |
| HY-148038 | 5-HT3 antagonist 5 | Antagonist | 99.75% | Unkown |
| HY-14811A | Beloranib hemioxalate | / | Unkown | |
| HY-148232 | BAY-3153 | Antagonist | / | Unkown |
| HY-148291 | BrP-LPA sodium | / | Unkown | |
| HY-14840A | (R)-Phenylpiracetam | Inhibitor | / | Unkown |
| HY-148456 | Anti-inflammatory agent 34 | 98.13% | Unkown | |
| HY-148548 | p-HTAA | / | Unkown | |
| HY-148572 | NAMPT/IDO1-IN-1 | Inhibitor | / | Unkown |
| HY-148617 | ALDH2 modulator 1 | Modulator | / | Unkown |
| HY-148640 | WK500B | / | Unkown | |
| HY-148708A | Oleoyl-D-lysine sodium | Inhibitor | / | Unkown |
| HY-148839 | c-Myc inhibitor 9 | Inhibitor | / | Unkown |
| HY-149031 | DHODH-IN-22 | Inhibitor | / | Unkown |
| HY-149218 | THR-β agonist 6 | Agonist | / | Unkown |
| HY-149227 | IDO1-IN-21 | Inhibitor | / | Unkown |
| HY-149240 | Anticancer agent 108 | Inhibitor | / | Unkown |
| HY-149296 | JAK1-IN-12 | Inhibitor | / | Unkown |
| HY-149298 | PSMA-IN-2 | Inhibitor | / | Unkown |
| HY-14931 | Naproxcinod | Inhibitor | / | Unkown |
| HY-149333 | BO-1 | Inhibitor | / | Unkown |
| HY-149357 | Yhhu6669 | Inhibitor | / | Unkown |
| HY-149401 | EGFR-IN-82 | Inhibitor | / | Unkown |
| HY-149403 | J-1048 | Inhibitor | / | Unkown |
| HY-149429 | PPARδ agonist 9 | Agonist | / | Unkown |
| HY-149521 | PI3K-IN-47 | Inhibitor | / | Unkown |
| HY-149696 | IR-Crizotinib | Inhibitor | / | Unkown |
| HY-149719 | Ferroptosis-IN-4 | Inhibitor | / | Unkown |
| HY-149776 | RGH-560 | / | Unkown | |
| HY-149838 | NF-κB-IN-9 | Inhibitor | / | Unkown |
| HY-149844 | S-F24 | Inhibitor | / | Unkown |
| HY-149940 | SIMR3030 | Inhibitor | / | Unkown |
| HY-149955 | SARS-CoV-2-IN-38 | Inhibitor | / | Unkown |
| HY-149975 | AMPA receptor modulator-4 | Activator | / | Unkown |
| HY-149984 | MAO-B-IN-21 | Inhibitor | / | Unkown |
| HY-150036 | Anthramycin | Antagonist | / | Unkown |
| HY-15041 | NVP-SAA164 | Antagonist | / | Unkown |
| HY-150503 | KH-259 | Inhibitor | / | Unkown |
| HY-150545 | AChE-IN-21 | Inhibitor | / | Unkown |
| HY-150562 | CDK9-IN-19 | Inhibitor | / | Unkown |
| HY-150596 | CT1-3 | / | Unkown | |
| HY-150613 | PARP1/BRD4-IN-2 | / | Unkown | |
| HY-150723 | PBI-6DNJ | Inhibitor | / | Unkown |
| HY-150755 | Topo I/COX-2-IN-2 | / | Unkown | |
| HY-15080 | GYKI 53405 | Antagonist | / | Unkown |
| HY-150963 | Renin inhibitor-1 | Inhibitor | / | Unkown |
| HY-151138 | α-Glucosidase-IN-16 | Inhibitor | / | Unkown |
| HY-151153 | HDAC1-IN-5 | / | Unkown | |
| HY-151155 | ALK-IN-23 | Inhibitor | / | Unkown |
| HY-151263 | G4/HDAC-IN-1 | / | Unkown | |
| HY-151342 | Ser@TPP@CUR | / | Unkown | |
| HY-151389 | BChE-IN-14 | / | Unkown | |
| HY-151451 | Cav 3.2 inhibitor 2 | Inhibitor | / | Unkown |
| HY-151484 | Anti-infective agent 4 | Inhibitor | / | Unkown |
| HY-151485 | Anti-infective agent 5 | Inhibitor | / | Unkown |
| HY-151900 | SARS-CoV-2 Mpro-IN-4 | Inhibitor | / | Unkown |
| HY-151901 | SARS-CoV-2 Mpro-IN-5 | Inhibitor | / | Unkown |
| HY-151967 | Anti-IAV agent 1 | Inhibitor | / | Unkown |
| HY-151968 | KRAS G12C inhibitor 57 | Inhibitor | / | Unkown |
| HY-152031 | Glutaminyl Cyclase Inhibitor 5 | Inhibitor | / | Unkown |
| HY-152080A | (R)-Blovacitinib | Inhibitor | / | Unkown |
| HY-152104 | FGFR-IN-9 | Inhibitor | / | Unkown |
| HY-152199 | AMPD2 inhibitor 2 | Inhibitor | / | Unkown |
| HY-152471 | Eleven-Nineteen-Leukemia Protein IN-3 | Inhibitor | / | Unkown |
| HY-152506 | Antioxidant agent-8 | Inhibitor | / | Unkown |
| HY-152535 | ATV041 | / | Unkown | |
| HY-152552 | α-Synuclein inhibitor 8 | Inhibitor | / | Unkown |
| HY-153067 | Mal-cyclohexane-Gly-Gly-Phe-Gly-Exatecan | Inhibitor | / | Unkown |
| HY-153120 | PI3K/mTOR Inhibitor-13 | Inhibitor | / | Unkown |
| HY-153127 | Florbenazine | / | Unkown | |
| HY-153149 | LJ-2698 | / | Unkown | |
| HY-153184 | GalNAc-L96 free base | / | Unkown | |
| HY-153238 | AN15368 | Inhibitor | / | Unkown |
| HY-153350 | ERK-IN-7 | Inhibitor | / | Unkown |
| HY-153513 | PHD-1-IN-4 | Inhibitor | 99.94% | Unkown |
| HY-153699 | SHP2-IN-14 | Inhibitor | / | Unkown |
| HY-153834 | GTI 2040 | Inhibitor | / | Unkown |
| HY-153834A | GTI 2040 sodium | / | Unkown | |
| HY-153903 | RASP-IN-1 | / | Unkown | |
| HY-153920A | Pimicotinib hydrochloride | Inhibitor | / | Unkown |
| HY-154868 | MMP-13-IN-1 | Inhibitor | / | Unkown |
| HY-154973 | AMPK activator 11 | Activator | / | Unkown |
| HY-154979 | Anti-hepatic fibrosis agent 2 | / | Unkown | |
| HY-154985 | DSO-5a | / | Unkown | |
| HY-15498S | Rimegepant-d4 | Antagonist | / | Unkown |
| HY-155028 | FGFR-IN-11 | Inhibitor | / | Unkown |
| HY-155029 | sEH inhibitor-16 | Inhibitor | / | Unkown |
| HY-155032 | P-gp inhibitor 15 | Inhibitor | / | Unkown |
| HY-155199 | PDE1-IN-5 | Inhibitor | / | Unkown |
| HY-155226 | FLT3-IN-21 | / | Unkown | |
| HY-155229 | CBP/p300-IN-21 | Inhibitor | / | Unkown |
| HY-155236 | Ancistrotecine B | Inhibitor | / | Unkown |
| HY-155249 | KGP591 | Inhibitor | / | Unkown |
| HY-155328 | GK444 | Inhibitor | / | Unkown |
| HY-155329 | GK718 | Inhibitor | / | Unkown |
| HY-155529 | FD1024 | Inhibitor | / | Unkown |
| HY-155548 | RORγt inverse agonist 31 | Inhibitor | / | Unkown |
| HY-155551 | Anti-inflammatory agent 46 | / | Unkown | |
| HY-155553 | GPR119 agonist 2 | Agonist | / | Unkown |
| HY-155652 | ABCG2-IN-1 | Inhibitor | / | Unkown |
| HY-155653 | ABCG2-IN-2 | Inhibitor | / | Unkown |
| HY-155682 | Antibacterial agent 150 | Inhibitor | / | Unkown |
| HY-15570 | NU6301 | Inhibitor | / | Unkown |
| HY-155801 | CRX 527 | / | Unkown | |
| HY-155887 | DSPE-PEG-Amine, MW 3400 ammonium | / | Unkown | |
| HY-155966 | CDK2-IN-19 | Inhibitor | / | Unkown |
| HY-155991 | RUNX-IN-2 | Inducer | / | Unkown |
| HY-155995 | PRO-905 | / | Unkown | |
| HY-155997 | Anti-inflammatory agent 56 | Inhibitor | / | Unkown |
| HY-156083 | CDK9-IN-28 | Inhibitor | / | Unkown |
| HY-156109 | PDK-IN-2 | / | Unkown | |
| HY-156124 | Sigma-2 Radioligand 1 | / | Unkown | |
| HY-156126 | Lentztrehalose C | / | Unkown | |
| HY-15616 | BMS-470539 | Agonist | / | Unkown |
| HY-156240 | DI-1548 | / | Unkown | |
| HY-156505A | R-(+)-EU-1180-453 | Inhibitor | / | Unkown |
| HY-156593 | ROCK-IN-9 | Inhibitor | / | Unkown |
| HY-156600A | Bevemipretide trihydrochloride | / | Unkown | |
| HY-156792 | RIOK2-IN-1 | Inhibitor | / | Unkown |
| HY-156959 | Ovalicin | Inhibitor | / | Unkown |
| HY-156991 | NODAGA-NHS | / | Unkown | |
| HY-157085 | BX-2819 | Inhibitor | / | Unkown |
| HY-157172 | MorHap | Inhibitor | / | Unkown |
| HY-157211 | Anti-inflammatory agent 66 | Inhibitor | / | Unkown |
| HY-157326 | hMAO-B-IN-6 | Inhibitor | / | Unkown |
| HY-157387 | c-Met-IN-22 | / | Unkown | |
| HY-157429 | 25N-N1-Nap | Agonist | / | Unkown |
| HY-157430 | BET-IN-21 | Inhibitor | / | Unkown |
| HY-157457 | Z21090 | Inhibitor | / | Unkown |
| HY-157492 | RO7075573 | Inhibitor | / | Unkown |
| HY-157534 | Pancreatic lipase-IN-2 | / | Unkown | |
| HY-157548 | Antitumor agent-133 | Inducer | / | Unkown |
| HY-158003 | COE-PNH2 | / | Unkown | |
| HY-158005 | Anticancer agent 195 | Inducer | / | Unkown |
| HY-158006 | SDX-7539 | Inhibitor | / | Unkown |
| HY-158051 | CIDD-0072424 | Inhibitor | / | Unkown |
| HY-158058 | WYJ-2 | / | Unkown | |
| HY-158093 | NIC-12 | Inhibitor | / | Unkown |
| HY-158111 | NLRP3-IN-34 | Inhibitor | / | Unkown |
| HY-158119A | PSMA-trillium | Ligand | / | Unkown |
| HY-158138 | TOPOI/PARP-1-IN-1 | / | Unkown | |
| HY-158148 | CSF1R-IN-23 | Inhibitor | / | Unkown |
| HY-158160 | LBA-3 | Inhibitor | / | Unkown |
| HY-158198 | PRXS571 | Modulator | / | Unkown |
| HY-158261 | AChE-IN-63 | Inhibitor | / | Unkown |
| HY-158272 | Penicillin/OVA | Inhibitor | / | Unkown |
| HY-158311 | Anti-osteoporosis agent-8 | Inhibitor | / | Unkown |
| HY-158316 | BTL-MK | Inhibitor | / | Unkown |
| HY-158319 | Mutant IDH1/NAMPT-IN-1 | / | Unkown | |
| HY-158365 | LRRK2-IN-14 | Inhibitor | / | Unkown |
| HY-158368 | PRDX1-IN-2 | / | Unkown | |
| HY-158374 | BIO-8169 | Inhibitor | / | Unkown |
| HY-158434 | IRAK1-IN-1 | Inhibitor | / | Unkown |
| HY-158435 | P-gp inhibitor 23 | Inhibitor | / | Unkown |
| HY-158649 | Fasnall benzenesulfonate | / | Unkown | |
| HY-158694 | TLR7 agonist 20 | Agonist | / | Unkown |
| HY-158701 | KRAS G12D inhibitor 23 | Inhibitor | / | Unkown |
| HY-158703 | KRAS G12D inhibitor 24 | Inhibitor | / | Unkown |
| HY-158706 | SAE-IN-2 | Inhibitor | / | Unkown |
| HY-158725 | N-Octadecenoyl-(cis-9)-sulfatide | / | Unkown | |
| HY-158776 | SLU-10482 | Inhibitor | / | Unkown |
| HY-159088 | KOR agonist 2 | Agonist | / | Unkown |
| HY-159106 | MeSeI | / | Unkown | |
| HY-159144 | Anti-inflammatory agent 91 | Inhibitor | / | Unkown |
| HY-159159 | MS-II-124 | Inhibitor | 99.66% | Unkown |
| HY-159194 | DSPE-PEG2000-Cy5.5 | / | Unkown | |
| HY-15947G | Ravoxertinib (GMP) | Inhibitor | / | Unkown |
| HY-159602 | BET BD2-IN-3 | Inhibitor | / | Unkown |
| HY-159756B | KI-MS2-008 | Inhibitor | / | Unkown |
| HY-159768A | DOTAGA.Glu.(FAPi)2 | Ligand | / | Unkown |
| HY-159796A | Cefetecol | Inhibitor | / | Unkown |
| HY-159891 | Microtubule destabilizing agent-2 | / | Unkown | |
| HY-159895 | PAR4 antagonist 7 | Antagonist | / | Unkown |
| HY-159897 | PAK4-IN-5 | / | Unkown | |
| HY-159898 | AChE/BChE-IN-23 | / | Unkown | |
| HY-159910 | LH1513 | / | Unkown | |
| HY-159925 | QKY-613 | Activator | 98.24% | Unkown |
| HY-159941 | tau-0N4R-IN-1 | Inhibitor | / | Unkown |
| HY-159942 | 5-HT7R antagonist 3 | / | Unkown | |
| HY-159964 | USP7-IN-16 | Inhibitor | / | Unkown |
| HY-160025 | IDO antagonist-1 | Antagonist | / | Unkown |
| HY-160156 | SSTR5 antagonist 4 | Antagonist | / | Unkown |
| HY-160236B | 3-(3-Sulfooxyphenyl)propanoic acid disodium | 98.47% | Unkown | |
| HY-160849 | N-Desmethyl Rilmazolam | / | Unkown | |
| HY-161243 | AChE-IN-56 | Inhibitor | / | Unkown |
| HY-161281 | α-Glucosidase-IN-49 | Inhibitor | / | Unkown |
| HY-161340 | Anti-melanoma agent 2 | Inducer | / | Unkown |
| HY-161349 | LTA4H-IN-4 | Inhibitor | / | Unkown |
| HY-161372 | PARP1/c-Met-IN-1 | / | Unkown | |
| HY-161373 | PI3Kα-IN-22 | Inhibitor | / | Unkown |
| HY-161425 | Antitumor agent-149 | Inducer | / | Unkown |
| HY-161458 | GSK-3β inhibitor 16 | / | Unkown | |
| HY-161471 | DCLK1-IN-5 | Inhibitor | / | Unkown |
| HY-161494 | XYD190 | / | Unkown | |
| HY-161495 | CBP/p300 ligand 4 | / | Unkown | |
| HY-161496 | Boc-NHCH2-Ph-Py-NH2 | / | Unkown | |
| HY-161497 | Thalidomide-benzylamine-Py-NH2 | / | Unkown | |
| HY-161498 | XYD198 | / | Unkown | |
| HY-161499 | Boc-NHCH2-Ph-pyrimidine-NH2 | / | Unkown | |
| HY-161500 | Thalidomide-NHCH2-Ph-pyrimidine-NH2 | / | Unkown | |
| HY-161501 | 3-Fluoro-evodiamine glucose | / | Unkown | |
| HY-161751 | MJ34 | Inhibitor | / | Unkown |
| HY-161815 | Anti-inflammatory agent 89 | Inhibitor | / | Unkown |
| HY-161833 | HSP90-IN-31 | Inhibitor | / | Unkown |
| HY-161840 | Antitumor agent-176 | Inhibitor | / | Unkown |
| HY-161860 | Antibacterial agent 233 | Inhibitor | / | Unkown |
| HY-161863 | Tubulin polymerization-IN-67 | / | Unkown | |
| HY-161887 | SMARCA2-IN-8 | Inhibitor | / | Unkown |
| HY-161890 | Antimycobacterial agent-8 | Inhibitor | / | Unkown |
| HY-161893 | Anti-MRSA agent 15 | Inhibitor | / | Unkown |
| HY-161926 | YGT-31 | Modulator | / | Unkown |
| HY-161953 | O-GlcNAcase-IN-2 | Inhibitor | / | Unkown |
| HY-162033 | PAT1inh-A0030 | Inhibitor | / | Unkown |
| HY-162115 | TLR7 agonist 17 | Agonist | / | Unkown |
| HY-162227 | Antitumor agent-138 | / | Unkown | |
| HY-162269 | Nampt activator-5 | Activator | / | Unkown |
| HY-162329 | Antibacterial agent 195 | Inhibitor | / | Unkown |
| HY-162357 | PD-L1-IN-5 | Inhibitor | / | Unkown |
| HY-162372 | Hedgehog IN-6 | Inhibitor | / | Unkown |
| HY-162396 | P-gp inhibitor 21 | Inhibitor | / | Unkown |
| HY-162399 | PD-L1-IN-6 | Inhibitor | / | Unkown |
| HY-162406 | UNC8969 | / | Unkown | |
| HY-162407 | I-As-1 | Inhibitor | / | Unkown |
| HY-162498 | Antileishmanial agent-29 | Inhibitor | / | Unkown |
| HY-162585 | 5-HT1AR agonist 1 | Agonist | / | Unkown |
| HY-162589 | Lw13 | / | Unkown | |
| HY-162600 | CDK8-IN-15 | Inhibitor | / | Unkown |
| HY-162606 | MAO-A/B-IN-3 | Inhibitor | / | Unkown |
| HY-162633 | USP1-IN-9 | / | Unkown | |
| HY-162646 | FXIIa-IN-5 | Inhibitor | / | Unkown |
| HY-162655A | SLF80821178 hydrochloride | Inhibitor | / | Unkown |
| HY-162681 | eeAChE-IN-3 | Inhibitor | / | Unkown |
| HY-162703 | Lipid-lowering agent-2 | Activator | / | Unkown |
| HY-162710 | LTA4H-IN-5 | Inhibitor | / | Unkown |
| HY-162712 | OX-201 | / | Unkown | |
| HY-162720 | NNRT-IN-4 | Inhibitor | / | Unkown |
| HY-162727 | GCS-12 | / | Unkown | |
| HY-162729 | LSD1-IN-34 | Inhibitor | / | Unkown |
| HY-162751 | Anticancer agent 249 | / | Unkown | |
| HY-162754 | LMP7/LMP2-IN-1 | Inhibitor | / | Unkown |
| HY-162757 | Anticonvulsant agent 5 | Modulator | / | Unkown |
| HY-162760 | COMT-IN-1 | Inhibitor | / | Unkown |
| HY-162764 | Androgen receptor degrader-5 | Degrader | / | Unkown |
| HY-162860 | FO-4-15 | 99.45% | Unkown | |
| HY-162867 | Photosensitizer-5 | Inducer | / | Unkown |
| HY-162879 | FAK inhibitor 7 | / | Unkown | |
| HY-162893 | SX29 | Inhibitor | / | Unkown |
| HY-162895 | NL13 | / | Unkown | |
| HY-162928 | RIPK1-IN-26 | Inhibitor | / | Unkown |
| HY-163003 | Antitrypanosomal agent 19 | Inhibitor | / | Unkown |
| HY-163027 | R079 | / | Unkown | |
| HY-163034 | Antitumor photosensitizer-5 | Inducer | / | Unkown |
| HY-163066 | α-Glucosidase-IN-44 | Inhibitor | / | Unkown |
| HY-163195 | Tubulin inhibitor 40 | Inhibitor | / | Unkown |
| HY-163207 | sEH/HDAC6-IN-1 | Inhibitor | / | Unkown |
| HY-163300 | NLRP3-IN-30 | Inhibitor | / | Unkown |
| HY-163315 | YPLP | / | Unkown | |
| HY-163320 | AChE/Aβ-IN-5 | Inhibitor | / | Unkown |
| HY-163345 | 5-HT7R antagonist 2 | Antagonist | / | Unkown |
| HY-163346 | TPEG-P | / | Unkown | |
| HY-163363 | β-AR antagonist 2 | Antagonist | / | Unkown |
| HY-163382 | Cbz-Gly-Pro-Ala-O-cinnamyl | Inhibitor | / | Unkown |
| HY-163403 | VEGFR-2-IN-43 | Inhibitor | / | Unkown |
| HY-163431 | URAT1 inhibitor 10 | Inhibitor | / | Unkown |
| HY-163433 | α-Glucosidase-IN-57 | Inhibitor | / | Unkown |
| HY-163482 | ELQ-596 | Inhibitor | / | Unkown |
| HY-163483 | ELQ-598 | Inhibitor | / | Unkown |
| HY-163484 | ELQ-650 | Inhibitor | / | Unkown |
| HY-163505 | Anti-MRSA agent 11 | Inhibitor | / | Unkown |
| HY-163506 | Ebselen derivative 1 | Inhibitor | / | Unkown |
| HY-163611 | XY039 | Agonist | / | Unkown |
| HY-163612 | XY077 | / | Unkown | |
| HY-163618 | DHMQ | / | Unkown | |
| HY-163651 | (R)-Vorbipiprant | Antagonist | / | Unkown |
| HY-163709 | PROTAC FAK degrader 2 | / | Unkown | |
| HY-163749 | STING-IN-8 | Inhibitor | / | Unkown |
| HY-163797 | WRN inhibitor 10 | Inhibitor | / | Unkown |
| HY-163799 | PRMT5-MTA-IN-1 | Inhibitor | / | Unkown |
| HY-163816 | Antiproliferative agent-53-d3 | Inhibitor | / | Unkown |
| HY-163817 | PARP1/2-IN-3 | Inhibitor | / | Unkown |
| HY-163879 | hMAO-B-IN-9 | Inhibitor | / | Unkown |
| HY-163906 | Anti-MRSA agent 16 | Inhibitor | / | Unkown |
| HY-163923 | Apoptosis inducer 24 | Inducer | / | Unkown |
| HY-163965 | Antitumor agent-185 | / | Unkown | |
| HY-163978 | YGZ-331 | Activator | / | Unkown |
| HY-163983 | Tubulin polymerization-IN-68 | / | Unkown | |
| HY-164311 | GPR17 modulator-1 | Modulator | / | Unkown |
| HY-164320 | Anticancer agent 245 | Inducer | / | Unkown |
| HY-164909 | PZ-3022 | / | Unkown | |
| HY-165061 | 5(Z),11(Z),14(Z)-Eicosatrienoic acid | Inhibitor | / | Unkown |
| HY-165360 | JJ1 | Inhibitor | / | Unkown |
| HY-165369 | IBPR002 | Inhibitor | / | Unkown |
| HY-165375 | Plenolin | / | Unkown | |
| HY-165425 | KR31173 | Antagonist | / | Unkown |
| HY-165484 | AVP-13358 | Inhibitor | / | Unkown |
| HY-165503 | AZ1366 | Inhibitor | / | Unkown |
| HY-165557 | GSK1370319A | Inhibitor | / | Unkown |
| HY-165571 | E2072 | Inhibitor | / | Unkown |
| HY-165600A | Trimedoxime | Activator | / | Unkown |
| HY-165606 | SB-T-1214 | Inducer | / | Unkown |
| HY-16561G | Resveratrol (GMP) | / | Unkown | |
| HY-16561S1 | Resveratrol-13C6 | / | Unkown | |
| HY-165677S | C22 Galactosylceramide-d4 | / | Unkown | |
| HY-167153 | PNA5 | / | Unkown | |
| HY-167655 | KF-19418 | Inhibitor | / | Unkown |
| HY-167741 | Chlorisondamine | Antagonist | / | Unkown |
| HY-167939 | (R)-Bambuterol | / | Unkown | |
| HY-168002 | MPO-IN-8 | Inhibitor | / | Unkown |
| HY-168021 | MAO-A/SERT-IN-1 | Inhibitor | / | Unkown |
| HY-168031 | AChE/BChE-IN-21 | / | Unkown | |
| HY-168214 | Kv7.2/Kv7.3 agonist 1 | Inhibitor | / | Unkown |
| HY-168270 | PROTAC ER Degrader-11 | Degrader | / | Unkown |
| HY-168301 | CL-13 | Inhibitor | / | Unkown |
| HY-168444 | CDK4/6-IN-23 | Inhibitor | / | Unkown |
| HY-168481 | GLP-1R agonist 27 | Agonist | / | Unkown |
| HY-168566 | EV206 | Inhibitor | 99.62% | Unkown |
| HY-168567 | RIPK2-IN-6 | Inhibitor | / | Unkown |
| HY-168651 | FBPase-IN-4 | Inhibitor | / | Unkown |
| HY-168705 | Anti-MRSA agent 20 | Inhibitor | / | Unkown |
| HY-168713 | LZ-007 | Agonist | / | Unkown |
| HY-168728 | MAO-B-IN-37 | Inhibitor | / | Unkown |
| HY-168742 | V1a/V2 antagonist 1 | Antagonist | / | Unkown |
| HY-168875 | TrxR1 prodrug-1 | Inhibitor | / | Unkown |
| HY-168913 | CTT2274 | / | Unkown | |
| HY-168919 | KRASG12C IN-16 | / | Unkown | |
| HY-168997 | CB1R agonist 1 | Agonist | / | Unkown |
| HY-169007 | STAT3-IN-34 | Inhibitor | / | Unkown |
| HY-16900G | Rolipram (GMP) | Inhibitor | / | Unkown |
| HY-169019 | XJTU-L453 | / | Unkown | |
| HY-169026 | DCN1-IN-2 | Inhibitor | / | Unkown |
| HY-169037 | Δ8-Tetrahydrocannabinoquinone | Inducer | / | Unkown |
| HY-169054 | NCATS-SM4420 | / | Unkown | |
| HY-169059 | Ferroptosis-IN-12 | Inhibitor | / | Unkown |
| HY-169080 | ABCA1 inducer 1 | Inducer | / | Unkown |
| HY-169104 | InhA-IN-8 | Inhibitor | / | Unkown |
| HY-169135 | PROTAC 20S proteasome subunit β5 degrader 2 | Degrader | / | Unkown |
| HY-169177 | JNK-1-IN-4 | Inhibitor | / | Unkown |
| HY-169215 | Anti-inflammatory agent 93 | / | Unkown | |
| HY-169224 | SARS-CoV-2-IN-100 | Inhibitor | / | Unkown |
| HY-169327 | MD-265 | Degrader | 99.31% | Unkown |
| HY-169394 | 5-HT1AR agonist 2 | / | Unkown | |
| HY-169421 | Nav1.7-IN-18 | Inhibitor | / | Unkown |
| HY-169432 | TET-13 | Modulator | / | Unkown |
| HY-169446 | ALEPH hydrochloride | Agonist | / | Unkown |
| HY-169478 | Lipid N2-3L | / | Unkown | |
| HY-169480 | Lipid C2 | / | Unkown | |
| HY-169784 | PPI-1040 | / | Unkown | |
| HY-169867 | BNTX | Antagonist | / | Unkown |
| HY-169928 | WRN inhibitor 14 | Inhibitor | / | Unkown |
| HY-170232 | RIPK1-IN-29 | Inhibitor | / | Unkown |
| HY-170237 | SIK2/3-IN-1 | Inhibitor | / | Unkown |
| HY-170321 | Apoptosis inducer 31 | Inducer | / | Unkown |
| HY-170377 | ER degrader 10 | / | Unkown | |
| HY-170444 | ADS1017 | Antagonist | / | Unkown |
| HY-170475 | 5-MeO-MET | Agonist | / | Unkown |
| HY-170572 | PB01 | Inhibitor | / | Unkown |
| HY-170576 | FLT3-IN-28 | / | Unkown | |
| HY-170654 | Opioid receptor antagonist 1 | Antagonist | / | Unkown |
| HY-170659 | NF-κB-IN-18 | Inhibitor | / | Unkown |
| HY-170765 | ATX-IN-1 | Inhibitor | / | Unkown |
| HY-170773 | Mtb-IN-9 | Inhibitor | / | Unkown |
| HY-170801 | Anticonvulsant agent 7 | Control | / | Unkown |
| HY-170839 | TRPV1-IN-3 | Inhibitor | / | Unkown |
| HY-170887 | MAO-B-IN-39 | / | Unkown | |
| HY-170900 | SJ44236 | / | Unkown | |
| HY-170934 | BW710 | Inhibitor | / | Unkown |
| HY-170976 | BuChE-IN-16 | / | Unkown | |
| HY-170977 | JAK1/STAT3-IN-1 | Inhibitor | / | Unkown |
| HY-170994 | I2-IRs ligand-1 | Ligand | / | Unkown |
| HY-171035 | PRL-295 | Inhibitor | / | Unkown |
| HY-171592 | RIPK2-IN-7 | Inhibitor | / | Unkown |
| HY-171722 | Ascr#10 | Activator | / | Unkown |
| HY-171732 | FANFT | / | Unkown | |
| HY-171745 | ATR-IN-32 | Inhibitor | / | Unkown |
| HY-171758 | BU72 | Agonist | / | Unkown |
| HY-171778 | QLS-81 | Inhibitor | / | Unkown |
| HY-171807 | TC-2559 free base | / | Unkown | |
| HY-171824 | PROTAC c-Met Degrader-4 | / | Unkown | |
| HY-171837A | t9,t11,c15-CLNA | / | Unkown | |
| HY-171888 | BI-9740 | Inhibitor | / | Unkown |
| HY-171927 | Lipid 12T-O14 | / | Unkown | |
| HY-172099 | EP4 receptor agonist 3 | Agonist | / | Unkown |
| HY-172105 | Anti-NASH agent 2 | Agonist | / | Unkown |
| HY-172120 | GPR119 agonist 3 | Agonist | / | Unkown |
| HY-172127 | NUAK1-IN-1 | Inhibitor | / | Unkown |
| HY-172128 | NUAK1-IN-2 | Inhibitor | / | Unkown |
| HY-172133 | HDAC3-IN-6 | / | Unkown | |
| HY-172135 | PDE4-IN-26 | Inhibitor | / | Unkown |
| HY-172152 | MP-010 | / | Unkown | |
| HY-172226 | P2Y14R antagonist 3 | Antagonist | / | Unkown |
| HY-172257 | HIF-PHD-IN-4 | Inhibitor | / | Unkown |
| HY-172350 | WEHI-P8 | Inhibitor | / | Unkown |
| HY-172351B | PEG10000-bis-amine | / | Unkown | |
| HY-172400 | FXIa-IN-16 | Inhibitor | / | Unkown |
| HY-172455 | TREK inhibitor-3 | Inhibitor | / | Unkown |
| HY-172456 | JSF-4898 | Inhibitor | / | Unkown |
| HY-172502 | DSPE-PEG1000-Mal-Cys-KAAKNK | / | Unkown | |
| HY-172503 | DSPE-PEG2000-Mal-Cys-KAAKNK | / | Unkown | |
| HY-172503A | DSPE-PEG3400-Mal-Cys-KAAKNK | / | Unkown | |
| HY-172504 | DSPE-PEG5000-Mal-Cys-KAAKNK | / | Unkown | |
| HY-172598 | SG16 | Inhibitor | / | Unkown |
| HY-172604 | Neuroprotective agent 10 | Inhibitor | / | Unkown |
| HY-172614 | RK-0080552 | / | Unkown | |
| HY-172617 | APD-94 | / | Unkown | |
| HY-172674 | HPK1-IN-59 | Inhibitor | / | Unkown |
| HY-172699 | DSPE-PEG2000-ANG | / | Unkown | |
| HY-172732 | PRMT5-IN-50 | Inhibitor | / | Unkown |
| HY-172768 | SCUT1-2 | Inhibitor | / | Unkown |
| HY-172781 | HDAC6-IN-55 | Inhibitor | / | Unkown |
| HY-172795 | EGFR-IN-158 | / | Unkown | |
| HY-172806 | PARP14 inhibitor 1 | Inhibitor | / | Unkown |
| HY-172813 | Vancomycin prodrug | Inhibitor | / | Unkown |
| HY-172826 | Anti-MRSA agent 26 | Antagonist | / | Unkown |
| HY-172871 | Anti-inflammatory agent 102 | Inhibitor | / | Unkown |
| HY-172883A | (E/Z)-ABP/PPAR modulator 1 | Modulator | 97.22% | Unkown |
| HY-172885 | TRBP-IN-1 | / | Unkown | |
| HY-172887 | Kv7.2/Kv7.3 activator-2 | Activator | / | Unkown |
| HY-172910 | MTHFD2-IN-6 | / | Unkown | |
| HY-172954 | Androgen receptor ligand 1 | / | Unkown | |
| HY-173116 | DOTA-XYIMSR-01 | Inhibitor | / | Unkown |
| HY-173129 | Anti-inflammatory agent 97 | / | Unkown | |
| HY-173130 | α-Glucosidase-IN-86 | Inhibitor | / | Unkown |
| HY-173160 | HDAC1-IN-10 | Inhibitor | / | Unkown |
| HY-173216 | Pseudorabies virus-IN-1 | Inhibitor | / | Unkown |
| HY-173217 | PPARα agonist 5 | / | Unkown | |
| HY-173290 | PDE4D inhibitor 1 | Inhibitor | / | Unkown |
| HY-173309 | P53/TLR2 modulator-1 | / | Unkown | |
| HY-173316 | STING-IN-12 | Inhibitor | / | Unkown |
| HY-173347 | BLINK11 | Inhibitor | / | Unkown |
| HY-173348 | BLINK15 | Inhibitor | / | Unkown |
| HY-173398 | NMDAR antagonist 5 | Antagonist | / | Unkown |
| HY-173399 | hSTING activator-1 | / | Unkown | |
| HY-173403 | TrxR-IN-8 | / | Unkown | |
| HY-173437 | CW-2 | Degrader | / | Unkown |
| HY-173471 | TRPA1 agonist-1 | Agonist | / | Unkown |
| HY-173473 | Anticancer agent 272 | Inducer | / | Unkown |
| HY-173479 | GLP-1R agonist 30 | Agonist | / | Unkown |
| HY-173493 | ALK-IN-31 | / | Unkown | |
| HY-173515 | FAK-IN-26 | Inhibitor | / | Unkown |
| HY-173518 | SIN 14 | / | Unkown | |
| HY-173545 | 1-Palmitoyl-2-10-oahsa-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-173547 | 1-Palmitoyl-2-9-pahsa-3-oleoyl-sn-glycerol | / | Unkown | |
| HY-173558 | PD-L1/HDAC3-IN-1 | / | Unkown | |
| HY-174128 | Multi-target kinase-IN-5 | / | Unkown | |
| HY-174142 | IHMT-15130 | Inhibitor | / | Unkown |
| HY-174212 | MXC-017 | Inducer | / | Unkown |
| HY-174215 | TAU-IN-3 | Inhibitor | / | Unkown |
| HY-174247 | CPS-021 | Degrader | / | Unkown |
| HY-174260 | Neuroprotective agent 11 | / | Unkown | |
| HY-174282 | RDS-04-010 | Inhibitor | 98.84% | Unkown |
| HY-174285 | NAPAP | Inhibitor | / | Unkown |
| HY-174301 | USP7-IN-18 | / | Unkown | |
| HY-174308 | ZSA-215 | Agonist | / | Unkown |
| HY-174315 | WZH-17-002 | / | Unkown | |
| HY-174318 | NARS-3′ | Inhibitor | / | Unkown |
| HY-174324 | VEGFR-2/P-gp-IN-1 | / | Unkown | |
| HY-174330 | TRK-IN-31 | Inhibitor | / | Unkown |
| HY-174330A | TRK-IN-31 hydrochloride | Inhibitor | / | Unkown |
| HY-174332 | Cholesterol 24-hydroxylase-IN-3 | Inhibitor | 98.74% | Unkown |
| HY-174339 | Neuroprotective agent 12 | / | Unkown | |
| HY-174343 | ELQ-121 | Inhibitor | / | Unkown |
| HY-174380 | DPP-1-IN-1 | Inhibitor | / | Unkown |
| HY-174381 | BChE-IN-41 | Inhibitor | / | Unkown |
| HY-174383 | PDE3/4-IN-2 | Inhibitor | 99.75% | Unkown |
| HY-174387 | KIN-8741 | Inhibitor | / | Unkown |
| HY-174399 | AChE/BChE-IN-27 | Inhibitor | / | Unkown |
| HY-174405 | PROTAC PDE4 degrader-1 | / | Unkown | |
| HY-174415 | ZSH-2117 | / | Unkown | |
| HY-174421 | FAPI-JNU | Ligand | / | Unkown |
| HY-174422 | Opioid receptor antagonist 2 | Antagonist | / | Unkown |
| HY-174428 | PROTAC JAK2 degrader-1 | / | Unkown | |
| HY-174437 | FLT3-IN-32 | / | Unkown | |
| HY-174445 | C199 | / | Unkown | |
| HY-174468 | dPDL1-4 | / | Unkown | |
| HY-174811 | PROTAC BRD4 Degrader-33 | Degrader | / | Unkown |
| HY-174820 | AZ'320 | Inhibitor | / | Unkown |
| HY-174828 | ATR/PARP1-IN-1 | / | Unkown | |
| HY-174846 | TRPM8 antagonist 4 prodrug | / | Unkown | |
| HY-174847 | VCP/p97 IN-2 | Inhibitor | / | Unkown |
| HY-174870 | PROTAC ERα Degrader-11 | / | Unkown | |
| HY-174913 | Factor B-IN-5 | Inhibitor | / | Unkown |
| HY-174988 | JAK2-IN-13 | Inhibitor | / | Unkown |
| HY-174989 | ATM-IN-2 | / | Unkown | |
| HY-175014 | LGT-1 | Ligand | / | Unkown |
| HY-175018 | VEGFR-2-IN-71 | / | Unkown | |
| HY-175026 | RIPK2-IN-8 | / | Unkown | |
| HY-175030 | TNI-97 | / | Unkown | |
| HY-175039 | FAK-IN-28 | / | Unkown | |
| HY-175042 | D-myo-Inositol-1,3,4,5,6-pentaphosphate ammonium salt | Inhibitor | 98% | Unkown |
| HY-175164 | SVC112 | / | Unkown | |
| HY-175201 | pro-FTY | Inhibitor | / | Unkown |
| HY-175206 | P-gp-IN-30 | Inhibitor | / | Unkown |
| HY-175210 | STING-IN-16 | Inhibitor | / | Unkown |
| HY-175214 | Antitumor photosensitizer-9 | Agonist | / | Unkown |
| HY-175217 | Nrf2 activator-20 | Activator | / | Unkown |
| HY-175229 | PSMA ligand 1 | Ligand | / | Unkown |
| HY-175230 | ZG-2492 | / | Unkown | |
| HY-175244 | SOS1-IN-20 | Inhibitor | / | Unkown |
| HY-175248 | PSMA-DIM | Ligand | / | Unkown |
| HY-175265 | PQ32 | / | Unkown | |
| HY-175277 | PIM1-IN-8 | Inhibitor | / | Unkown |
| HY-175281 | SJ11646 | / | Unkown | |
| HY-175294 | PD-L1/Nampt-IN-1 | Inhibitor | / | Unkown |
| HY-175305 | DMU759 | Inhibitor | / | Unkown |
| HY-175317 | Nogo-B-IN-1 | / | Unkown | |
| HY-175318S | p53 Activator 15 | Activator | / | Unkown |
| HY-175320 | PROTAC c-Met degrader-5 | / | Unkown | |
| HY-175321 | PROTAC c-Met degrader-6 | / | Unkown | |
| HY-175326 | SOS1-IN-21 | Inhibitor | / | Unkown |
| HY-175340 | Kv7.2/Kv7.3 activator-3 | Activator | / | Unkown |
| HY-175344 | TMP1 | Inhibitor | / | Unkown |
| HY-175361 | RORγ agonist 2 | Agonist | / | Unkown |
| HY-17538A | ZLN005 hydrochloride | Activator | / | Unkown |
| HY-175422 | K-833 | Agonist | / | Unkown |
| HY-175430 | TNF-α-IN-26 | Inhibitor | / | Unkown |
| HY-175455 | LYA914 | / | Unkown | |
| HY-175478 | Enpp-1-IN-27 | / | Unkown | |
| HY-175486 | KOR agonist 6 | Agonist | / | Unkown |
| HY-175497 | ROR1-IN-4 | / | Unkown | |
| HY-175502 | MGD-22 | / | Unkown | |
| HY-175508 | NMDA receptor modulator 9 | Agonist | / | Unkown |
| HY-175521 | HIF-1α-IN-8 | Inhibitor | / | Unkown |
| HY-175527 | ALK degrader 2 | / | Unkown | |
| HY-175532 | M4 mAChR Modulator-2 | Activator | / | Unkown |
| HY-175537 | ATX-IN-3 | Inhibitor | / | Unkown |
| HY-175541 | TQ-3959 | Degrader | / | Unkown |
| HY-175544 | anti-TNBC agent-10 | / | Unkown | |
| HY-175555 | Tubulin-IN-54 | / | Unkown | |
| HY-175562 | LDH-IN-4 | Inhibitor | / | Unkown |
| HY-175589 | XSJ81 | / | Unkown | |
| HY-175591 | Photosensitizer-7 | / | Unkown | |
| HY-175610 | PROTAC FLT3/JAK2/BRD4 Degrader-1 | Degrader | / | Unkown |
| HY-175643 | COX-2-IN-58 | Inhibitor | / | Unkown |
| HY-175645 | NLRP3/URAT1-IN-1 | Inhibitor | / | Unkown |
| HY-175655 | BChE/p38-α MAPK-IN-1 | Inhibitor | / | Unkown |
| HY-175660 | KCL-HO-1i | Inhibitor | / | Unkown |
| HY-175662 | TGF-β/Smad-IN-2 | Inhibitor | / | Unkown |
| HY-175663 | EYE-002 | Inhibitor | / | Unkown |
| HY-175664 | EYE-003 | Inhibitor | / | Unkown |
| HY-175670 | GABAA receptor modulator-10 | Agonist | / | Unkown |
| HY-175785 | X15695 | 98.45% | Unkown | |
| HY-175826 | USP30-IN-20 | / | Unkown | |
| HY-175841 | Tau Protein Phosphorylation-IN-1 | Inhibitor | / | Unkown |
| HY-175863 | 2-PMPA prodrug 1 | / | Unkown | |
| HY-175874 | Tubulin-IN-55 | / | Unkown | |
| HY-175876 | ADAM17-IN-1 | Inhibitor | / | Unkown |
| HY-175970 | MLS000099089 | Inhibitor | / | Unkown |
| HY-175981 | Paclitaxel-bromothiophene | / | Unkown | |
| HY-175991S | Sodium octadecyl sulfate-d37 | / | Unkown | |
| HY-176028 | N-Stearoyl-DPPE ammonium | / | Unkown | |
| HY-176052 | PPO-allene | Inhibitor | / | Unkown |
| HY-176063 | TRPV1 antagonist 11 | / | Unkown | |
| HY-176127 | JX10 | Inhibitor | / | Unkown |
| HY-176128 | BWA-6047 | / | Unkown | |
| HY-176194 | Antifibrotic agent 1 | / | Unkown | |
| HY-176220 | GPX4-AUTAC | / | Unkown | |
| HY-176223 | Antimalarial agent 51 | / | Unkown | |
| HY-176225 | BY13 | / | Unkown | |
| HY-176239 | PROTAC PI3Kδ degrader-1 | / | Unkown | |
| HY-17623S | Tegoprazan-d6 | Inhibitor | / | Unkown |
| HY-176241 | DC-174 | / | Unkown | |
| HY-176249 | Tetrazanbigen | Inducer | / | Unkown |
| HY-176256 | endo-S-cGAFMP | Agonist | / | Unkown |
| HY-176264 | DNDI-6510 | Inhibitor | / | Unkown |
| HY-176288 | eIF4E/eIF4G PPI-IN-1 | / | Unkown | |
| HY-176482 | MerTK-IN-3 | Inhibitor | / | Unkown |
| HY-176497 | GW273297X | Inhibitor | / | Unkown |
| HY-176519 | ANT2681 | Inhibitor | / | Unkown |
| HY-176561 | IOR-160 | Inhibitor | / | Unkown |
| HY-176706 | AAK1-IN-10 | Inhibitor | / | Unkown |
| HY-176731 | MSK-9 | Modulator | / | Unkown |
| HY-176732 | MJ-26 | Inhibitor | / | Unkown |
| HY-176755 | CCL-34 | Activator | / | Unkown |
| HY-176775 | TPP-IOA | Inhibitor | / | Unkown |
| HY-176781 | 1-Deoxyceramide (m18:1/20:0) | / | Unkown | |
| HY-176908 | SIOC-XJC-SF02 | Inducer | / | Unkown |
| HY-176916 | Mutant p53 modulator-2 | Modulator | / | Unkown |
| HY-176937 | HSN608 | / | Unkown | |
| HY-176957 | PKMYT1-IN-11 | Inhibitor | / | Unkown |
| HY-176995 | AZ-GHS-38 | Agonist | / | Unkown |
| HY-177011 | ERRγ-IN-1 | Inhibitor | / | Unkown |
| HY-177021 | Tubulin-IN-51 | / | Unkown | |
| HY-177091 | AS2795440 | Inhibitor | / | Unkown |
| HY-177096 | Ledasorexton | Agonist | / | Unkown |
| HY-177218 | M119 | Inhibitor | / | Unkown |
| HY-177268 | CHNQD-01426 | / | Unkown | |
| HY-177270 | CHNQD-01281 | Modulator | / | Unkown |
| HY-177297 | LCZ960 | Activator | / | Unkown |
| HY-177497 | SKLB-03220 | / | Unkown | |
| HY-177573 | Cholesteryl γ-aminobutyrate | / | Unkown | |
| HY-178008 | Mcl-1-IN-16 | / | Unkown | |
| HY-178015 | THR-β agonist 11 | Agonist | / | Unkown |
| HY-178016 | H3R antagonist 8 | Antagonist | / | Unkown |
| HY-178028 | PRMT5-IN-53 | Inhibitor | / | Unkown |
| HY-178045 | MYC-IN-4 | Inhibitor | / | Unkown |
| HY-178098 | TEAD-IN-21 | Inhibitor | / | Unkown |
| HY-178135 | SCR005 | Inhibitor | / | Unkown |
| HY-178137 | SCR007 | Inhibitor | / | Unkown |
| HY-178149 | MAO-A/B-IN-5 | Inhibitor | / | Unkown |
| HY-178153 | BPAM363 | Modulator | / | Unkown |
| HY-178163 | Zharp1-163 | Inhibitor | / | Unkown |
| HY-178214 | CSBP ligand 1 | / | Unkown | |
| HY-178230 | EVT-401 | Agonist | / | Unkown |
| HY-178236 | TRPM5 agonist-1 | Inhibitor | / | Unkown |
| HY-178238 | LD2-3 | Inhibitor | / | Unkown |
| HY-178248 | PSMA-R2 | Ligand | / | Unkown |
| HY-178302 | TNF-α agonistic 2 | / | Unkown | |
| HY-178323 | MW073 | / | Unkown | |
| HY-178328 | VDR agonist 4 | / | Unkown | |
| HY-178370 | Ferroptosis inducer-12 | Inducer | 96.32% | Unkown |
| HY-178372 | GSTO1-IN-4 | Inhibitor | / | Unkown |
| HY-178383 | α-Glucosidase-IN-98 | Inhibitor | / | Unkown |
| HY-178465 | EP4 receptor antagonist 8 | / | Unkown | |
| HY-178489 | BGC1614 | / | Unkown | |
| HY-178738 | GC-072 | Inhibitor | / | Unkown |
| HY-178748 | PKM2-IN-12 | / | Unkown | |
| HY-178760 | TGF-8027 | Agonist | / | Unkown |
| HY-178785 | Anti-infective agent 11 | Inhibitor | / | Unkown |
| HY-178786 | RET-IN-31 | Inhibitor | / | Unkown |
| HY-178804 | BCL6 ligand-5 | Ligand | / | Unkown |
| HY-178850 | TJN-331 | Inhibitor | / | Unkown |
| HY-178857 | CB1 antagonist 6 | Antagonist | / | Unkown |
| HY-178858 | PROTAC FLT3/CHK1 Degrader-1 | / | Unkown | |
| HY-178899 | C14-Tri-LAN-Gly | / | Unkown | |
| HY-178926 | RAGE406R | Inhibitor | / | Unkown |
| HY-178966 | STING agonist-48 | Agonist | / | Unkown |
| HY-178967 | DRAK1/2-IN-2 | Inhibitor | / | Unkown |
| HY-178999 | Carnosol analog 1 | / | Unkown | |
| HY-179008 | 5-HT2CR agonist 2 | Agonist | / | Unkown |
| HY-179008A | (S)-5-HT2CR agonist 1 | Agonist | / | Unkown |
| HY-179016 | Ferroptosis/apoptosis inducer-3 | / | Unkown | |
| HY-179105 | Axl-IN-20 | Inhibitor | / | Unkown |
| HY-179113 | IL-17A-IN-5 | Inhibitor | / | Unkown |
| HY-179246 | CXT29 | / | Unkown | |
| HY-179282 | Mu opioid receptor antagonist 9 | Antagonist | / | Unkown |
| HY-179313 | PEG-DPCA conjugate 1 | / | Unkown | |
| HY-179320 | mPEG-Amide-tri(DPCA) | / | Unkown | |
| HY-179379 | EP4 receptor agonist 3 prodrug | / | Unkown | |
| HY-179429 | NLRP3-IN-85 | Inhibitor | / | Unkown |
| HY-179436 | 9β,10β-epoxy Hexahydrocannabinol | Ligand | / | Unkown |
| HY-179463 | BKI 1708 | Inhibitor | / | Unkown |
| HY-179512 | BSJ-04-146 | Degrader | / | Unkown |
| HY-179701 | NIK-IN-3 | Inhibitor | / | Unkown |
| HY-179724A | PZ-1657 hydrochloride | Inhibitor | / | Unkown |
| HY-179729 | α-Glucosidase-IN-106 | Inhibitor | / | Unkown |
| HY-180087 | GABA-AT-IN-2 | Inhibitor | / | Unkown |
| HY-180112 | SH543 | / | Unkown | |
| HY-180165 | Antiallergic agent-5 | Inhibitor | / | Unkown |
| HY-180189 | Carbonic anhydrase-IN-37 | Inhibitor | / | Unkown |
| HY-180193 | Tubulin polymerization-IN-86 | / | Unkown | |
| HY-180221 | FXR agonist 14 | Agonist | / | Unkown |
| HY-180268 | TGR5 agonist 8 | Inhibitor | / | Unkown |
| HY-180291 | Anti-inflammatory agent 109 | Inhibitor | / | Unkown |
| HY-180323 | ER-38925 | Agonist | / | Unkown |
| HY-180336 | LM9 | Inhibitor | / | Unkown |
| HY-180372 | CSP-2503 | Agonist | / | Unkown |
| HY-180384 | 1,10-Bis(methylsulfinyl)decane | / | Unkown | |
| HY-180400 | PAM-2 | / | Unkown | |
| HY-180402 | 1,10-Bis(ethylsulfinyl)decane | / | Unkown | |
| HY-180411 | SM-15178 | Antagonist | / | Unkown |
| HY-180415 | UE2316 | Inhibitor | / | Unkown |
| HY-180418 | Homidium chloride | Inhibitor | / | Unkown |
| HY-180419 | SF-3-030 | / | Unkown | |
| HY-180423 | IRFI-165 | Antagonist | 98.0% | Unkown |
| HY-180582 | QND8 | Agonist | / | Unkown |
| HY-180642 | THR-β modulator-3 | Modulator | / | Unkown |
| HY-180749 | L-4-Hydroxyglutamate semialdehyde | / | Unkown | |
| HY-180785 | G243-1720 | Inhibitor | / | Unkown |
| HY-180802 | BCFTP | Modulator | / | Unkown |
| HY-180829 | HDAC6-IN-71 | Inhibitor | / | Unkown |
| HY-18088 | PIM-IN-4 | Inhibitor | / | Unkown |
| HY-180889 | PROTAC BRD3 degrader-1 | Degrader | / | Unkown |
| HY-180997 | Aβ aggregation-IN-5 | Inhibitor | / | Unkown |
| HY-18100 | PRE-084 | / | Unkown | |
| HY-181004 | PKMYT1-IN-13 | Inhibitor | / | Unkown |
| HY-181021 | Kir4.1-IN-1 | Inhibitor | 99.07% | Unkown |
| HY-181060 | Apoptosis inducer 56 | / | Unkown | |
| HY-181069 | Neuroprotective agent 16 | Inhibitor | / | Unkown |
| HY-181077 | AMPKα1 activator 1 | Activator | / | Unkown |
| HY-181080 | TOP1/TDP1-IN-1 | / | Unkown | |
| HY-181084 | PROTAC BCL6/GSPT1 Degrader-1 | / | Unkown | |
| HY-181088 | PDE3/4-IN-4 | Inhibitor | / | Unkown |
| HY-181091 | α-Glucosidase-IN-109 | Inhibitor | / | Unkown |
| HY-181110 | MAO-A-IN-4 | Inhibitor | / | Unkown |
| HY-181123 | AS1-6 | Inhibitor | / | Unkown |
| HY-181136 | Antiestrogenic agent-1 | / | Unkown | |
| HY-181146 | MK-7762 | Inhibitor | / | Unkown |
| HY-181286 | ETX1975-3 | Inhibitor | / | Unkown |
| HY-181306 | PROTAC EZH2 Degrader-11 | Degrader | / | Unkown |
| HY-181335 | SKL1223 | Inhibitor | / | Unkown |
| HY-181352 | SB-140 | Inhibitor | / | Unkown |
| HY-181427 | UT-143 | Antagonist | / | Unkown |
| HY-181431 | PXS 64 | Inducer | / | Unkown |
| HY-181472 | 10(11)-Cl-BBQ | / | Unkown | |
| HY-181474 | CF-Vanillin | / | Unkown | |
| HY-181486 | VDR agonist 5 | Agonist | / | Unkown |
| HY-181505 | BRD4-IN-12 | / | Unkown | |
| HY-181513 | DPP-1-IN-2 | Inhibitor | / | Unkown |
| HY-181517 | Antitumor agent-212 | Inhibitor | / | Unkown |
| HY-181543 | CVN14 | Inhibitor | / | Unkown |
| HY-181551 | RGH-706 | Antagonist | / | Unkown |
| HY-181558 | Anticancer agent 303 | / | Unkown | |
| HY-181560 | SLD1121 | Agonist | / | Unkown |
| HY-181573 | TC8026 | / | Unkown | |
| HY-181596 | WJH-C19 | Inhibitor | 98.65% | Unkown |
| HY-181605 | MOR antagonist 2 hydrochloride | Antagonist | / | Unkown |
| HY-181611 | Polθ-IN-10 | / | Unkown | |
| HY-181613 | 5-HT2A&5-HT2C agonist-3 | Agonist | / | Unkown |
| HY-181649 | S1R agonist 3 | Agonist | / | Unkown |
| HY-181655 | Cathepsin D degrader 1 | Degrader | / | Unkown |
| HY-181663 | PJ27 | Inhibitor | / | Unkown |
| HY-181668 | ULK1-IN-4 | Inhibitor | / | Unkown |
| HY-181679 | TML-2Cl | / | Unkown | |
| HY-181684 | PDE5/CA-IN-1 | Inhibitor | / | Unkown |
| HY-181687 | Hsp90-IN-46 | Inhibitor | / | Unkown |
| HY-181691 | JAK2-IN-20 | Inhibitor | / | Unkown |
| HY-181695 | PROTAC KAT2A/B degrader-1 | Degrader | / | Unkown |
| HY-181700 | PTP1B-IN-34 | / | Unkown | |
| HY-181709 | TPM003 | Agonist | / | Unkown |
| HY-181711 | nNOS-IN-6 | Inhibitor | / | Unkown |
| HY-181712 | IRAK1-IN-2 | Inhibitor | / | Unkown |
| HY-181723 | Anticancer agent 304 | / | Unkown | |
| HY-181727 | AR/AR-V7 degrader-1 | / | Unkown | |
| HY-181739 | GCB-27a | Activator | / | Unkown |
| HY-181740 | GCB-27b | Activator | / | Unkown |
| HY-181743 | Piezo1 agonist 2 | Agonist | / | Unkown |
| HY-181752 | FGFR3-IN-12 | / | Unkown | |
| HY-181753 | INSP-0154 | / | Unkown | |
| HY-181762 | Multitarget AD-IN-6 | Inhibitor | / | Unkown |
| HY-181768 | HDAC3-IN-8 | Inhibitor | / | Unkown |
| HY-181770 | PDE4B-IN-7 | Inhibitor | / | Unkown |
| HY-181785 | Influenza A virus-IN-18 | Inhibitor | / | Unkown |
| HY-181790 | DOT1L ligand-2 | Ligand | / | Unkown |
| HY-181808 | HSF1/AMPK activator 1 | / | Unkown | |
| HY-181815 | SBP-5147 | / | Unkown | |
| HY-181828 | SePP | Antagonist | / | Unkown |
| HY-181839 | DDR1/2 IN-4 | Inhibitor | / | Unkown |
| HY-181849 | MS2928 | Inhibitor | / | Unkown |
| HY-181853 | NOTA-SP2A-PSMAL | Ligand | / | Unkown |
| HY-181861 | AChE/MAO-B-IN-9 | Inhibitor | / | Unkown |
| HY-181862 | SHK1112218 | / | Unkown | |
| HY-181872 | JAK1-IN-20 | Inhibitor | / | Unkown |
| HY-181874 | E0714 | Activator | / | Unkown |
| HY-181876 | F44-S101 | Antagonist | / | Unkown |
| HY-181881 | MV78-OH | Ligand | / | Unkown |
| HY-181889 | KRAS G12C-IN-75 | Inhibitor | / | Unkown |
| HY-181897 | mHTT ligand-1 | Ligand | / | Unkown |
| HY-181906 | ZnPc-PEG2-VH032 | / | Unkown | |
| HY-181907 | NBE5 | / | Unkown | |
| HY-181909 | PROTAC SMARCA2 degrader-36 | Degrader | / | Unkown |
| HY-181917 | Pantothenate kinase-IN-3 | Activator | / | Unkown |
| HY-181930 | TNIK-IN-10 | / | Unkown | |
| HY-181934 | ClpP activator-2 | / | Unkown | |
| HY-181936 | Atg4B activator-1 | / | Unkown | |
| HY-181960 | BP1.3656B | Antagonist | / | Unkown |
| HY-181969 | BFB78 | Inhibitor | / | Unkown |
| HY-181970 | XY25026 | Inhibitor | / | Unkown |
| HY-181971 | XY25028 | Inhibitor | / | Unkown |
| HY-181983 | VPC285785 | Inhibitor | / | Unkown |
| HY-181996 | BTK-IN-47 | / | Unkown | |
| HY-181998 | CN016 | Inhibitor | / | Unkown |
| HY-182000 | Xanthine oxidase-IN-23 | / | Unkown | |
| HY-182008 | NEURL1B-IN-1 | / | Unkown | |
| HY-182023 | Anticonvulsant agent 11 | / | Unkown | |
| HY-182026 | FXR agonist 17 | / | Unkown | |
| HY-18203 | HBF-0079 | Inducer | / | Unkown |
| HY-182033 | ClpP agonist 1 | Inhibitor | / | Unkown |
| HY-182034 | GAP214 | / | Unkown | |
| HY-182040 | Nrf2 activator-24 | / | Unkown | |
| HY-182048 | PD-1/PD-L1-IN-62 | / | Unkown | |
| HY-182050 | YL0441 | Inhibitor | / | Unkown |
| HY-182051 | HDAC3 degrader-2 | / | Unkown | |
| HY-182060 | PDE4B/D-IN-5 | / | Unkown | |
| HY-182064 | EGFR-IN-206 | / | Unkown | |
| HY-182065 | SARS-CoV-2 Mpro-IN-56 | Inhibitor | / | Unkown |
| HY-182066 | Photosensitizer-9 | Activator | / | Unkown |
| HY-182067 | anti-TNBC agent-15 | / | Unkown | |
| HY-182083 | PROTAC PI3Kα/δ degrader-1 | Degrader | / | Unkown |
| HY-182237 | Palmitoyl glutathione | / | Unkown | |
| HY-182240 | Cy5-ZW2-617 | Ligand | / | Unkown |
| HY-182241 | JR4-187 | / | Unkown | |
| HY-182248 | Teglicar chloride | Inhibitor | / | Unkown |
| HY-182264 | Masoprocol tetrapivalate | Inhibitor | / | Unkown |
| HY-182270 | GPR61 Inverse agonist 2 | Antagonist | / | Unkown |
| HY-182271 | GPR61 Inverse agonist 3 | Inhibitor | / | Unkown |
| HY-182272 | FAP-IN-9 | Inhibitor | / | Unkown |
| HY-182282 | PI3K/AKT-IN-6 | Inhibitor | / | Unkown |
| HY-182287 | PRDX1-IN-4 | / | Unkown | |
| HY-182288 | YN11 | / | Unkown | |
| HY-182289 | LY-23 | Inhibitor | / | Unkown |
| HY-182295 | Negundoside | Inhibitor | / | Unkown |
| HY-182304 | CLR01 sodium | Inhibitor | / | Unkown |
| HY-182309 | SC83288 | Inhibitor | / | Unkown |
| HY-182317 | (+)-Mosnodenvir | / | Unkown | |
| HY-182321 | HDAC2-IN-3 | Inhibitor | / | Unkown |
| HY-182323 | SGK1-IN-7 | Inhibitor | / | Unkown |
| HY-182326 | WF-3161 | Inhibitor | / | Unkown |
| HY-182335 | PF-07245303 | Inhibitor | / | Unkown |
| HY-182336 | DeDPP4 | / | Unkown | |
| HY-182342 | SGK1-IN-8 | Inhibitor | / | Unkown |
| HY-182343 | PROTAC MLKL Degrader-3 | / | Unkown | |
| HY-182346 | FBPase-IN-7 | Inhibitor | / | Unkown |
| HY-182349 | Bax activator-2 | / | Unkown | |
| HY-182350 | FXR DUBTAC modulator-1 | Modulator | / | Unkown |
| HY-182355 | MTHFD2-IN-7 | Inhibitor | / | Unkown |
| HY-182361 | NUAK1-IN-3 | Inhibitor | / | Unkown |
| HY-182367 | TMN-OMe | Agonist | / | Unkown |
| HY-182370 | TKP-5 | Degrader | / | Unkown |
| HY-182375A | SLB1122168 free base | Inhibitor | / | Unkown |
| HY-182377 | DT-5461 | Antagonist | / | Unkown |
| HY-182378 | Vps34-IN-5 | / | Unkown | |
| HY-182379 | SBI-0802767 | Inhibitor | / | Unkown |
| HY-182388 | Cinflumide | / | Unkown | |
| HY-182400 | AGI-25696 | Inhibitor | / | Unkown |
| HY-182403 | GR-891 | Inducer | / | Unkown |
| HY-182418 | UR-11353 | / | Unkown | |
| HY-182429 | NB-533 | Inhibitor | / | Unkown |
| HY-182454 | GPR119 agonist 4 | Agonist | / | Unkown |
| HY-182456 | CHDI-340246 | Inhibitor | / | Unkown |
| HY-182459 | Org 34167 (freebase) | Modulator | / | Unkown |
| HY-182469 | FuBIG | / | Unkown | |
| HY-182501 | HSC mobilizer-1 | / | Unkown | |
| HY-182506 | Azimexon | / | Unkown | |
| HY-182558 | Nandinine | / | Unkown | |
| HY-182579 | CBS-3408 | Inhibitor | / | Unkown |
| HY-182582 | ZY12201 | / | Unkown | |
| HY-182584 | S 15931 | Inhibitor | / | Unkown |
| HY-182589 | SRP-001 | Inhibitor | / | Unkown |
| HY-182601 | MC-100093 | / | Unkown | |
| HY-182610 | ISP-VT | Inhibitor | / | Unkown |
| HY-182631 | CX1763 | Modulator | / | Unkown |
| HY-182642 | MRS2339 | Activator | / | Unkown |
| HY-182648 | K811 | Inhibitor | / | Unkown |
| HY-182649 | NN-429 | / | Unkown | |
| HY-182687 | MRS7469 | Agonist | / | Unkown |
| HY-182688 | ITYR-DBRMD | / | Unkown | |
| HY-182695 | AS2030680 | Antagonist | / | Unkown |
| HY-182707 | JWX-A0108 | / | Unkown | |
| HY-182710 | DA-0218 | Inhibitor | / | Unkown |
| HY-182712 | HPSE-IN-2 | Inhibitor | / | Unkown |
| HY-182724 | PSB-18422 | Agonist | / | Unkown |
| HY-182734 | BMS-357075 | Inhibitor | / | Unkown |
| HY-182746 | RG7388-PEG3-Click-F | / | Unkown | |
| HY-182748 | NL-26 | / | Unkown | |
| HY-182777 | HDAC6-IN-80 | Inhibitor | / | Unkown |
| HY-182782 | Analgesic agent-4 | Ligand | / | Unkown |
| HY-182783 | JNJ-10450232 | Agonist | / | Unkown |
| HY-182788 | Multitarget AD-IN-7 | / | Unkown | |
| HY-182790 | BAA-065 | Inhibitor | / | Unkown |
| HY-182791 | BAA-009 | Inhibitor | / | Unkown |
| HY-182793 | MLL1-IN-1 | Inhibitor | / | Unkown |
| HY-182795 | Colchicine derivative-1 | / | Unkown | |
| HY-182802 | Ferroptosis inducer-15 | / | Unkown | |
| HY-182809 | Androgen receptor degrader-6 | / | Unkown | |
| HY-182818 | SH494 | / | Unkown | |
| HY-182850 | UCUF-965 | Modulator | / | Unkown |
| HY-182894 | MR1-114 | Inhibitor | / | Unkown |
| HY-182895 | Influenza A virus-IN-19 | Inhibitor | / | Unkown |
| HY-182896 | HKC54 | Antagonist | / | Unkown |
| HY-182905 | SSTR5/TGR5-modulator-1 | Modulator | / | Unkown |
| HY-182939 | MNK1/2-IN-10 | Inhibitor | / | Unkown |
| HY-182941 | Parawixin10 | / | Unkown | |
| HY-182943 | BTK-IN-49 | Inhibitor | / | Unkown |
| HY-182945 | IKZF2-degrader 5 | / | Unkown | |
| HY-182971 | PROTAC EV-A71 Degrader-1 | Inhibitor | / | Unkown |
| HY-183031 | BrAA-glycine-BG-PAB-Exatecan | / | Unkown | |
| HY-183120 | EGFR T790M/FAK-IN-2 | / | Unkown | |
| HY-183147A | LAT1-IN-2 hydrochloride | Substrate | / | Unkown |
| HY-183149 | BPN-37440 | Inhibitor | / | Unkown |
| HY-183166 | Z-Arg-Lys-AOMK | Inhibitor | / | Unkown |
| HY-183205 | SSTR5 antagonist 7 | Antagonist | / | Unkown |
| HY-18326 | BMS-869780 | Modulator | / | Unkown |
| HY-183262 | Antileishmanial agent-40 | / | Unkown | |
| HY-183265 | GO847 | / | Unkown | |
| HY-183269 | SERT-IN-5 | Inhibitor | / | Unkown |
| HY-183279 | FXR antagonist 4 | / | Unkown | |
| HY-183280 | 17β-HSD10/CDK5-IN-1 | Inhibitor | / | Unkown |
| HY-183284 | GZD-552 | / | Unkown | |
| HY-183285 | PI3Kα-IN-32 | Inhibitor | / | Unkown |
| HY-183286 | DHFR-IN-27 | Inhibitor | / | Unkown |
| HY-183289 | Ferroptosis-IN-25 | Inhibitor | / | Unkown |
| HY-183290 | Antileishmanial agent-41 | / | Unkown | |
| HY-183296 | NLRP3-IN-91 | Inhibitor | / | Unkown |
| HY-183301 | TLR2/1 agonist-1 | Agonist | / | Unkown |
| HY-183308 | Antifungal agent-161 | Inhibitor | / | Unkown |
| HY-183313 | IAV-IN-5 | / | Unkown | |
| HY-183325 | FTO-IN-17 | Inhibitor | / | Unkown |
| HY-183327 | PI3K/mTOR-IN-22 | Inhibitor | / | Unkown |
| HY-183331 | YXX0237 | Activator | / | Unkown |
| HY-183332 | YXX0248 | Activator | / | Unkown |
| HY-183333 | CHNQD-02204 | Inhibitor | / | Unkown |
| HY-183340 | Antibacterial agent 341 | / | Unkown | |
| HY-183341 | sEH/AChE-IN-5 | / | Unkown | |
| HY-183355 | KRAS G12D-IN-37 | / | Unkown | |
| HY-183357 | GABAAR/5-HT2AR modulator-1 | / | Unkown | |
| HY-183358 | ALK-IN-37 | / | Unkown | |
| HY-183365 | SL43 | Inhibitor | / | Unkown |
| HY-183367 | Anti-inflammatory agent 115 | Inhibitor | / | Unkown |
| HY-183370 | JAK2/STAT3-IN-2 | Inhibitor | / | Unkown |
| HY-183374 | NYM074 | Ligand | / | Unkown |
| HY-183488 | R9-caPep | / | Unkown | |
| HY-183538 | Necroptosis inducer 2 | / | Unkown | |
| HY-183539 | INCB191358 | Inhibitor | / | Unkown |
| HY-183542 | DprE1-IN-15 | Inhibitor | / | Unkown |
| HY-183557 | O-GlcNAcase-IN-6 | Inhibitor | / | Unkown |
| HY-183578 | TYY-31 | Agonist | / | Unkown |
| HY-183584 | ARN25699 | / | Unkown | |
| HY-183593 | SHIP1-IN-1 | / | Unkown | |
| HY-183596 | L-His-BPA | / | Unkown | |
| HY-183597 | L-BPA-BPA | / | Unkown | |
| HY-183599 | MK-1088 | Antagonist | / | Unkown |
| HY-183627 | 066ATZ | Inhibitor | / | Unkown |
| HY-183637 | E822-1968 | Inhibitor | / | Unkown |
| HY-183638 | T7117 | Inhibitor | / | Unkown |
| HY-183639 | SUCNR1 antagonist-1 | / | Unkown | |
| HY-183658 | URAT1/GLUT9-IN-3 | Inhibitor | / | Unkown |
| HY-183689 | OAT-4828 | Inhibitor | / | Unkown |
| HY-183692 | FXR agonist 18 | / | Unkown | |
| HY-183693 | GLP-1 receptor agonist 21 | Agonist | / | Unkown |
| HY-183694 | GLP-1 receptor agonist 22 | Agonist | / | Unkown |
| HY-183710 | CDK9-IN-50 | / | Unkown | |
| HY-183747 | Antitrypanosomal agent 32 | Inhibitor | / | Unkown |
| HY-183749 | c-Met-IN-29 | / | Unkown | |
| HY-183760 | AChE/BChE-IN-37 | Inhibitor | / | Unkown |
| HY-183763 | RORγt inverse agonist 37 | / | Unkown | |
| HY-183773 | KOR agonist-9 | Agonist | / | Unkown |
| HY-183781 | RIPK1-IN-41 | Inhibitor | / | Unkown |
| HY-183784 | P2X7R antagonist-1 | / | Unkown | |
| HY-183786 | Anticancer agent 327 | / | Unkown | |
| HY-183804 | PROTAC ER Degrader-16 | Degrader | / | Unkown |
| HY-183809 | ZSW | Inhibitor | / | Unkown |
| HY-183819 | CRBN ligand-903-trans-1,4-cyclohexanediamine-Boc | / | Unkown | |
| HY-183836 | FABP4/5-IN-7 | Inhibitor | / | Unkown |
| HY-183908 | GSK-3β-IN-29 | Inhibitor | / | Unkown |
| HY-183937A | PD-305 | / | Unkown | |
| HY-183986 | SR210831C | Inhibitor | / | Unkown |
| HY-184000 | SIRT5-IN-10 | Inhibitor | / | Unkown |
| HY-184001 | LT-1339-553 | Inhibitor | / | Unkown |
| HY-184011 | SERT-IN-4 | / | Unkown | |
| HY-184078 | 8-F-2-(Me-Pip-Me)-Tryptanthrin | Inhibitor | / | Unkown |
| HY-184118 | ADGRL1-IN-1 | Activator | / | Unkown |
| HY-184125 | PI3Kδ-IN-28 | Inhibitor | / | Unkown |
| HY-184141 | EYE1090 | Inhibitor | / | Unkown |
| HY-184158 | HATC | Degrader | / | Unkown |
| HY-184182 | Antimalarial agent 64 | Inhibitor | / | Unkown |
| HY-184203 | SM-06-09 | Inhibitor | / | Unkown |
| HY-184206 | A-3190 | Inhibitor | / | Unkown |
| HY-184226A | ASAP-0036543 | Inhibitor | / | Unkown |
| HY-184236 | Cbl-b-IN-34 | Inhibitor | / | Unkown |
| HY-184277 | Tubulin/PARP1-IN-1 | / | Unkown | |
| HY-184278 | ATX-IN-28 | Inhibitor | / | Unkown |
| HY-184279 | JDS364 | Activator | / | Unkown |
| HY-184324 | Anti-inflammatory agent 116 | Inhibitor | / | Unkown |
| HY-184362 | P-SETDB1-4 | / | Unkown | |
| HY-184448 | CIB-Q22 | / | Unkown | |
| HY-185167 | PSMA-1-DOTA | / | Unkown | |
| HY-185306 | Morfamquat dichloride | Activator | / | Unkown |
| HY-185311 | NEK7 degrader-3 | / | Unkown | |
| HY-185341 | PTERi | Inhibitor | 98.04% | Unkown |
| HY-185355 | μ Opioid receptor agonist 4 | Agonist | / | Unkown |
| HY-185356 | SR-14968 | Agonist | / | Unkown |
| HY-185492 | MC-cBu-Cit-seco-CBI dimer | / | Unkown | |
| HY-185585 | JNJ-27548547 | / | Unkown | |
| HY-185701 | W-GTF01 | Inhibitor | / | Unkown |
| HY-185709 | 2-ARA-LysoPtdEtn | / | Unkown | |
| HY-185718 | Trastuzumab-DM4 | Inhibitor | / | Unkown |
| HY-185775 | ADC Control Human IgG1 (C214S light chain, C226V and C229V heavy chain)-Tesirine | / | Unkown | |
| HY-185778 | PBA-Q76-O16B | / | Unkown | |
| HY-186046 | MPO-IN-10 | Inhibitor | / | Unkown |
| HY-186073 | HDAC1 activator-1 | Activator | / | Unkown |
| HY-186103 | Glycolipid C34 | Inhibitor | / | Unkown |
| HY-186105 | P7C3-S243 | / | Unkown | |
| HY-186105A | (-)-P7C3-S243 | Inhibitor | / | Unkown |
| HY-186122 | CCK2R agonist-1 | Agonist | / | Unkown |
| HY-186148 | YL-602 | / | Unkown | |
| HY-186170B | (R,S)-MDMA | Agonist | / | Unkown |
| HY-186186 | FD236 | Inhibitor | / | Unkown |
| HY-186214 | PDE4-IN-36 | Inhibitor | / | Unkown |
| HY-19009B | Propagermanium | Inhibitor | / | Unkown |
| HY-19018 | CGP-6809 | Inhibitor | / | Unkown |
| HY-19019 | Y-20024 hydrochloride | Antagonist | / | Unkown |
| HY-19272 | OGT-719 | / | Unkown | |
| HY-19337S | Ketodarolutamide-d3 | Antagonist | / | Unkown |
| HY-19337S1 | Ketodarolutamide-d6 | Antagonist | / | Unkown |
| HY-19377 | SS-750 | / | Unkown | |
| HY-19380 | Ro-65-2299 | Agonist | / | Unkown |
| HY-19392 | LA-419 | / | Unkown | |
| HY-19510 | RORγt inhibitor 4 | Inhibitor | / | Unkown |
| HY-19606 | Cytogenin | Inhibitor | / | Unkown |
| HY-19612 | DDP-38003 | Inhibitor | / | Unkown |
| HY-19648 | Ebiratide | / | Unkown | |
| HY-19682A | Enciprazine dihydrochloride | / | Unkown | |
| HY-19848 | Cevoglitazar | Agonist | 97.00% | Unkown |
| HY-19938 | MTL-005 | / | Unkown | |
| HY-201256 | UCI-14 | / | Unkown | |
| HY-204056 | Telomerase-IN-8 | Inhibitor | / | Unkown |
| HY-40156A | Mycobacterium Tuberculosis-IN-5 | Inhibitor | / | Unkown |
| HY-404647 | FK3453 | Inhibitor | / | Unkown |
| HY-44602 | Thioaspirine | Inhibitor | / | Unkown |
| HY-69019A | 7-Nitroindazole sodium | Inhibitor | / | Unkown |
| HY-76737 | 4-Chlorodiphenyl ether | / | Unkown | |
| HY-A0188 | Norzine dimalate | / | Unkown | |
| HY-B0131A | Alprostadil sodium | Control | / | Unkown |
| HY-B0149S3 | Tranexamic acid-13C2,15N | / | Unkown | |
| HY-B0168AS | Milnacipran-d5 hydrochloride | Inhibitor | / | Unkown |
| HY-B0448S1 | Phenytoin-15N2,13C | 99.84% | Unkown | |
| HY-B0534S | Moclobemide-d8 | Inhibitor | / | Unkown |
| HY-B0534S1 | Moclobemide-d4 | Inhibitor | 99.0% | Unkown |
| HY-B0612B | (S)-Lercanidipine | Inhibitor | / | Unkown |
| HY-B0693S | Ranitidine-d6 | / | Unkown | |
| HY-B0950 | Mefexamide | Activator | / | Unkown |
| HY-B0973S | Dibenzothiophene-d8 | Inhibitor | / | Unkown |
| HY-B1002S | Oxolinic acid-d5 | Inhibitor | 98.0% | Unkown |
| HY-B1199A | Nialamide hydrochloride | / | Unkown | |
| HY-B1509B | Trypaflavin bromide | Inhibitor | 97.27% | Unkown |
| HY-B1681 | Lithium salicylate | Inhibitor | / | Unkown |
| HY-B1803 | Tracazolate | Activator | / | Unkown |
| HY-B2010S | Fomesafen-d3 | / | Unkown | |
| HY-B2046S | Simazine-d10 | / | Unkown | |
| HY-B2176S8 | ATP-13C10,15N5,d14 dilithium | / | Unkown | |
| HY-B2185 | Tipepidine citrate | / | Unkown | |
| HY-CE01152 | 3-Oxotetradecanoyl-CoA | / | Unkown | |
| HY-CE02028 | Glutaconyl-CoA | / | Unkown | |
| HY-D0195R | Acesulfame potassium (Standard) | 99.89% | Unkown | |
| HY-D0195S | Acesulfame-d4 potassium | 99.72% | Unkown | |
| HY-D1066 | NIR-Thiol dinitrobenzenesulfonate | / | Unkown | |
| HY-D1535 | IR 813 perchlorate | / | Unkown | |
| HY-D2095 | Medical fluorophore 33 | / | Unkown | |
| HY-D2279 | NFL-NH2 | / | Unkown | |
| HY-D2970 | Golgi-P | / | Unkown | |
| HY-D2985 | MI-BP-CC | / | Unkown | |
| HY-D2988 | BIN-3 | / | Unkown | |
| HY-D3141 | DR probe | / | Unkown | |
| HY-D3143 | QM-B-CF | / | Unkown | |
| HY-D3152 | NRh-Cu | / | Unkown | |
| HY-D3167 | HDAC-IN-101 | Inhibitor | / | Unkown |
| HY-D3168 | PCL-2 | / | Unkown | |
| HY-D3169 | IETDC | / | Unkown | |
| HY-D3170 | C-HBrO-GGT | Substrate | / | Unkown |
| HY-D3185 | AlDeSense AM | / | Unkown | |
| HY-D3186 | HMRef-βGal | / | Unkown | |
| HY-D3197 | CDg16 | / | Unkown | |
| HY-D3209 | NIR-ASM | / | Unkown | |
| HY-D3210 | DCM-KPV | / | Unkown | |
| HY-D3214 | NIR-Cu(Ⅱ) | / | Unkown | |
| HY-D3220 | PTO-41 | Ligand | / | Unkown |
| HY-D3221 | MAO Probe 1 | / | Unkown | |
| HY-D3224 | HCP | / | Unkown | |
| HY-D3225 | MD-B | / | Unkown | |
| HY-D3226 | Zinc(II) probe-1 | / | Unkown | |
| HY-D3235 | FDOCl-22 | / | Unkown | |
| HY-D3319 | BHQ-3 carboxylic acid chloride | Substrate | 90.0% | Unkown |
| HY-D3353 | PSMA-SulfoCy7 | Ligand | / | Unkown |
| HY-D3411 | Rhobo6 | / | Unkown | |
| HY-D3419 | Neuro-DiO 4-chlorobenzenesulfonate | / | Unkown | |
| HY-D3430 | PTPA-QM | Substrate | / | Unkown |
| HY-D3432 | WazaGaY-1 | Chemical | / | Unkown |
| HY-D3461 | CycLuc1 methyl ester | Substrate | / | Unkown |
| HY-E70182 | Hyaluronidase 2 | Inhibitor | / | Unkown |
| HY-E70599 | Human CES2 Enzyme | 95.00% | Unkown | |
| HY-N0219R | Bicuculline (Standard) | Antagonist | / | Unkown |
| HY-N0307R | Ciwujianoside B (Standard) | Inhibitor | / | Unkown |
| HY-N0660R | Jujuboside B (Standard) | / | Unkown | |
| HY-N10279 | Gymconopin C | / | Unkown | |
| HY-N10312 | Yadanzigan | Inhibitor | / | Unkown |
| HY-N10341 | Centaureidin | Activator | / | Unkown |
| HY-N10508S | Calcitroic acid-13C | / | Unkown | |
| HY-N11020 | Cabenoside D | Inhibitor | / | Unkown |
| HY-N11021 | Feruloyl tyramine | / | Unkown | |
| HY-N1149 | Tilifodiolide | / | Unkown | |
| HY-N11538 | Quercetin-3-O-(2′′-O-galloyl)-β-D-glucopyranoside | / | Unkown | |
| HY-N11723 | Catenarin | Inhibitor | / | Unkown |
| HY-N11728 | 2,7"-Phloroglucinol-6,6'-bieckol | Inhibitor | / | Unkown |
| HY-N11730 | 6',7'-Epoxyrotenone | / | Unkown | |
| HY-N11732 | O-Demethylrotenone | / | Unkown | |
| HY-N11736 | 12-O-Tiglyl-phorbol 13-dodecanoate | Inhibitor | / | Unkown |
| HY-N11997 | Feralolide | Inhibitor | / | Unkown |
| HY-N12016 | Fulvotomentoside B | / | Unkown | |
| HY-N12042 | Taxamairin B | Inhibitor | / | Unkown |
| HY-N12249 | 7-Deoxy-trans-dihydronarciclasine | Inhibitor | / | Unkown |
| HY-N12398 | Psychotridine | / | Unkown | |
| HY-N12461 | Cucurbitacin F | / | Unkown | |
| HY-N12744 | 2-O-trans-p-Coumaroylalphitolic acid | Modulator | / | Unkown |
| HY-N13285 | (-)-Epigallocatechin-4'-O-methylether | / | Unkown | |
| HY-N13352 | Bufothionine | / | Unkown | |
| HY-N13614 | Centaurein | / | Unkown | |
| HY-N13756 | Deoxymikanolide | / | Unkown | |
| HY-N13828 | 1-Prenyl-2-methoxy-6-formyl-8-hydroxy-9H-carbazole | Inhibitor | / | Unkown |
| HY-N1393S1 | 2-Methoxybenzoic acid-d3 | / | Unkown | |
| HY-N14107 | Cinnabarin | Inhibitor | / | Unkown |
| HY-N14116 | Garlic oil | Inducer | / | Unkown |
| HY-N14617 | Rhodirubin A | Inhibitor | / | Unkown |
| HY-N14619 | Rhodirubin B | Inhibitor | / | Unkown |
| HY-N15177 | Δ9-THCB | Agonist | / | Unkown |
| HY-N15263 | Cepafungin III | Inhibitor | / | Unkown |
| HY-N1546 | Protoplumericin A | / | Unkown | |
| HY-N15703 | Norisocorydine | / | Unkown | |
| HY-N15846 | VSA 1 | / | Unkown | |
| HY-N16371 | 6-Methoxy-8-hydroxyisocoumarin-3-carboxylic acid | / | Unkown | |
| HY-N16374 | Mazethramycin B | Inhibitor | / | Unkown |
| HY-N16465 | Cinnamtannin D1 | Inhibitor | / | Unkown |
| HY-N16792 | Sanggenol F | / | Unkown | |
| HY-N16814 | Balsaminone B | / | Unkown | |
| HY-N16926 | Chingchengenamide A | 96% | Unkown | |
| HY-N17375 | Saikosaponin bk1 | / | Unkown | |
| HY-N17462 | Methyl 9-hydroxyoctadeca-10,12,15-trienoate | Inhibitor | / | Unkown |
| HY-N17495 | Luteolin 7-O-(6-O-malonyl-β-D-glucoside) | / | Unkown | |
| HY-N17727 | Divaricatol | / | Unkown | |
| HY-N17761A | Tetrandrine 2'-N-β-oxide | / | Unkown | |
| HY-N17855 | Guavinoside B | Inhibitor | / | Unkown |
| HY-N17876 | Royleanonic acid | Inhibitor | / | Unkown |
| HY-N17882A | Hydroxysaikosaponin D | / | Unkown | |
| HY-N17963 | Cappariloside A | Inhibitor | / | Unkown |
| HY-N18018 | Tetrahydroswertianolin | / | Unkown | |
| HY-N18066 | Esculeogenin A | / | Unkown | |
| HY-N18070 | 12-Deoxyphorbol-13-isobutyrate-20-acetate | / | Unkown | |
| HY-N18080 | Parthenin | Inhibitor | / | Unkown |
| HY-N18091 | Tovophyllin A | / | Unkown | |
| HY-N18124 | 1-O-Tigloyl-1-O-debenzoylohchinal | / | Unkown | |
| HY-N18146 | 14-Acetoxy-12-β-methylbutyl-2E,8E,10E-trien-4,6-diyn-1-ol | / | Unkown | |
| HY-N18182 | Mudanpioside E | Inhibitor | / | Unkown |
| HY-N18254 | Hokbusine A | / | Unkown | |
| HY-N18471 | 5,7-Dihydroxytryptamine | Ligand | / | Unkown |
| HY-N18471A | 5,7-Dihydroxytryptamine hydrobromide | Ligand | / | Unkown |
| HY-N19281 | Puberulin | / | Unkown | |
| HY-N19464 | Dicentrinone | Inhibitor | / | Unkown |
| HY-N19628 | Dianellin | Inhibitor | / | Unkown |
| HY-N19717 | Bartogenic acid | Inhibitor | / | Unkown |
| HY-N19723 | Buddlejasaponin I | Inhibitor | / | Unkown |
| HY-N19772 | Echiguanine B | Inhibitor | / | Unkown |
| HY-N19794 | Derrisaponin A | / | Unkown | |
| HY-N19801 | N-Palmitoyl-D-glucosamine | / | Unkown | |
| HY-N19857 | Millettiasaponin A | / | Unkown | |
| HY-N19876 | WF-5239 | Inhibitor | / | Unkown |
| HY-N20666 | Canola oil | / | Unkown | |
| HY-N2129A | N-Nornuciferine hydrochloride | Inhibitor | / | Unkown |
| HY-N2393S | Kukoamine B-d5 dihydrochloride | Inhibitor | / | Unkown |
| HY-N2573 | Corydalmine | Inhibitor | 99.74% | Unkown |
| HY-N2573A | Corydalmine hydrochloride | Inhibitor | / | Unkown |
| HY-N3018R | Isomaltose (Standard) | Inhibitor | / | Unkown |
| HY-N3098 | Pelirine | / | Unkown | |
| HY-N4024 | Hyptadienic acid | 93.0% | Unkown | |
| HY-N5126 | Juncusol | / | Unkown | |
| HY-N6715S | Tenuazonic acid-13C10 | Inhibitor | / | Unkown |
| HY-N6857C | (±)-Armepavine hydrochloride | / | Unkown | |
| HY-N7047 | 8-Epidiosbulbin E acetate | Inhibitor | 98.42% | Unkown |
| HY-N7106S2 | Dimethyl phthalate-13C6,d4 | / | Unkown | |
| HY-N7106S3 | Dimethyl phthalate-13C6 | / | Unkown | |
| HY-N7271R | Solanidine (Standard) | / | Unkown | |
| HY-N7394 | Galbacin | Activator | / | Unkown |
| HY-N7944 | Eucommiol | / | Unkown | |
| HY-N8250 | cis-THSG | Inhibitor | / | Unkown |
| HY-N8317 | Rubicordifolin | / | Unkown | |
| HY-N8501 | Emestrin | Inhibitor | / | Unkown |
| HY-N9097 | Niazirin | 99.9% | Unkown | |
| HY-N9194 | 5-Methoxycanthin-6-one | / | Unkown | |
| HY-N9475 | Betulonaldehyde | Inhibitor | / | Unkown |
| HY-N9858 | Herpetin | Activator | / | Unkown |
| HY-NP229 | DNP-BSA | / | Unkown | |
| HY-P0036D | NOTA-Octreotide | / | Unkown | |
| HY-P0267A | Melanotan (MT)-II acetate | Agonist | / | Unkown |
| HY-P10029 | Sakura-6 | Inhibitor | / | Unkown |
| HY-P10039 | β Amyloid (1-16) rat | / | Unkown | |
| HY-P10057 | cpm-1285 | Inducer | / | Unkown |
| HY-P10109A | G6PI 325-339 (human) hydrochloride | Activator | / | Unkown |
| HY-P10110 | retro-inverso TAT-Beclin 1 (D-amino acid) | Inducer | / | Unkown |
| HY-P10234 | Poneratoxin | Modulator | / | Unkown |
| HY-P10241 | Ac-LEHD-CHO | Inhibitor | / | Unkown |
| HY-P10301 | CXCL9(74-103) | / | Unkown | |
| HY-P10312 | SPN009 | Agonist | / | Unkown |
| HY-P10382 | M133 peptide | / | Unkown | |
| HY-P10427 | DV1 | / | Unkown | |
| HY-P1058 | Pep2m | Inhibitor | / | Unkown |
| HY-P10612 | Tetanus toxin peptide | / | Unkown | |
| HY-P10707 | Tpp-CAQK | / | Unkown | |
| HY-P10707A | Tpp-CAQK TFA | 99.09% | Unkown | |
| HY-P10721 | Plectasin | Inhibitor | / | Unkown |
| HY-P10765 | DTS-108 | Inhibitor | / | Unkown |
| HY-P10786 | LinTT1 peptide | Inhibitor | / | Unkown |
| HY-P10788 | CK3 peptide | Inhibitor | / | Unkown |
| HY-P10832 | ATWLPPRAANLLMAAS | / | Unkown | |
| HY-P10854 | TAT-N15 | Inhibitor | / | Unkown |
| HY-P10897A | SjDX5-271v | Control | / | Unkown |
| HY-P10939 | Ac-DMLD-CMK | Inhibitor | / | Unkown |
| HY-P10966 | Tat-IKIP (46-60) | Inhibitor | / | Unkown |
| HY-P10972 | GIP (22-51) human | / | Unkown | |
| HY-P10975 | P9R | Inhibitor | / | Unkown |
| HY-P10977 | Tat-ASIC1a (1-20) (mouse, rat) | Inhibitor | / | Unkown |
| HY-P10988 | LVTX-8 | Inducer | / | Unkown |
| HY-P10992 | YVPGP | / | Unkown | |
| HY-P11004 | A3-APO | Inhibitor | / | Unkown |
| HY-P11018 | (123B9)2-L2-PTX | Agonist | / | Unkown |
| HY-P11026 | DOTA-TMVP1446 | / | Unkown | |
| HY-P11028 | M1-20 | Inhibitor | / | Unkown |
| HY-P11031 | CotH3 peptide | Inhibitor | / | Unkown |
| HY-P11042 | TE-8105 | Agonist | / | Unkown |
| HY-P11050A | SP94 | Inducer | / | Unkown |
| HY-P11064 | G(IIKK)3I-NH2 | Inhibitor | / | Unkown |
| HY-P11075 | [Lys5,Tyr6,mLeu9,Nle10]-Neurokinin A (4-10) | Agonist | / | Unkown |
| HY-P11083 | Xentry | / | Unkown | |
| HY-P11091 | PA2-GNU7 | Inhibitor | / | Unkown |
| HY-P11092 | TLQP-62 (mouse,rat) | / | Unkown | |
| HY-P11181 | Chorionic Gonadotropin-beta (109-145) (human) | / | Unkown | |
| HY-P11208 | mNLS-CPP-WSTF | Inhibitor | / | Unkown |
| HY-P11222 | Tat-SERT-15C | Activator | / | Unkown |
| HY-P11226 | TI-16 | / | Unkown | |
| HY-P11232 | NAB815 | Inhibitor | / | Unkown |
| HY-P11250 | HVF18-a3-d | Inhibitor | / | Unkown |
| HY-P11257 | DOTA-BP1 | / | Unkown | |
| HY-P11262 | GUB021794 | Agonist | / | Unkown |
| HY-P11287 | DOTA-Pep-1L | Ligand | / | Unkown |
| HY-P11289 | Intermedin1-53 (Human) | Inhibitor | / | Unkown |
| HY-P11297 | AC-SDKP-NH2 | / | Unkown | |
| HY-P11405 | [D-Arg1,D-Trp5,7,9,Leu11]-Substance P | Antagonist | / | Unkown |
| HY-P11417 | Epidermal mitosis inhibiting pentapeptide | Inhibitor | / | Unkown |
| HY-P11424 | Cyclo(GRGDSPA) | Inhibitor | / | Unkown |
| HY-P11431 | Cyclo(Gly-Pro) | / | Unkown | |
| HY-P11467 | Gy-CATH | / | Unkown | |
| HY-P11486 | NOTA-RHAU18 | Ligand | / | Unkown |
| HY-P11582 | CyLip-20 | Inhibitor | / | Unkown |
| HY-P11589 | PIISVYWK | / | Unkown | |
| HY-P11590 | WGYRGFYC | Ligand | / | Unkown |
| HY-P11592 | KIKIKPWWWPKIKIK-NH2 | Inhibitor | / | Unkown |
| HY-P11594 | JMV 7490 | Modulator | / | Unkown |
| HY-P11604 | C16 acid-I-{Lys(C10 diacid)}-KQELRRIGDEF | Inhibitor | / | Unkown |
| HY-P11608 | FSVVPSPK | / | Unkown | |
| HY-P11614 | LCA-H10 | / | Unkown | |
| HY-P11615 | FuK | Inhibitor | / | Unkown |
| HY-P11616 | WK2 | Inhibitor | / | Unkown |
| HY-P11617 | CLP-d2 | Inhibitor | / | Unkown |
| HY-P11624 | PP-60 | Inducer | / | Unkown |
| HY-P11625 | R9-13 | Activator | / | Unkown |
| HY-P11677 | CPO_Aβ17-21P | / | Unkown | |
| HY-P11699 | AAPDNRETF | / | Unkown | |
| HY-P11701 | SEIDLILGY | / | Unkown | |
| HY-P11702 | f-MFFINTLTL | / | Unkown | |
| HY-P11704 | f-MKKFRW | Activator | / | Unkown |
| HY-P11728 | Peptide E5 | / | Unkown | |
| HY-P11736 | mcIRBP-9 | Inhibitor | / | Unkown |
| HY-P11737 | IPM-N001 | Ligand | / | Unkown |
| HY-P11741 | BV2 | / | Unkown | |
| HY-P11759 | Myr-transportan-Cys | / | Unkown | |
| HY-P11760 | HER2-targeted peptide H10 | Ligand | / | Unkown |
| HY-P11768 | AMBA | Ligand | / | Unkown |
| HY-P11773 | 3P-RGD2 | Ligand | / | Unkown |
| HY-P11781 | HW12 | Control | / | Unkown |
| HY-P11782 | GTGKT | / | Unkown | |
| HY-P11785 | Cpe30 MT2 | Ligand | / | Unkown |
| HY-P11791 | nNIF peptide | / | Unkown | |
| HY-P1181 | Pam2CSK4 | / | Unkown | |
| HY-P11810 | GUB08248 | Agonist | / | Unkown |
| HY-P11811 | GUB10194 | Agonist | / | Unkown |
| HY-P11814 | cTMTP1 | / | Unkown | |
| HY-P11827 | C11 peptide-1 | Inhibitor | / | Unkown |
| HY-P11838 | DOTA-TH10 | / | Unkown | |
| HY-P11843 | TPM004 | Agonist | / | Unkown |
| HY-P11845 | DOTA-NT-20.3-IPBA | Modulator | / | Unkown |
| HY-P11846 | ADA2 | Ligand | / | Unkown |
| HY-P11854 | SWQIGGN | Inducer | / | Unkown |
| HY-P11863 | SMIC-1014 | Ligand | / | Unkown |
| HY-P11871 | NOTA-GZP | Inhibitor | / | Unkown |
| HY-P11880 | LY3324954 | Agonist | / | Unkown |
| HY-P11881 | IUB288 | / | Unkown | |
| HY-P11882 | SYN1436 | Antagonist | / | Unkown |
| HY-P11887 | VHPKQHR | Ligand | / | Unkown |
| HY-P1216 | HS014 | Antagonist | / | Unkown |
| HY-P1241A | BAM(8-22) TFA | / | Unkown | |
| HY-P1259 | PR-39 | Inhibitor | / | Unkown |
| HY-P1302A | Orphanin FQ(1-11) TFA | Agonist | / | Unkown |
| HY-P1333A | Dynorphin A TFA | / | Unkown | |
| HY-P1380 | Difopein | / | Unkown | |
| HY-P1426 | AmmTX3 | Inhibitor | / | Unkown |
| HY-P1426A | AmmTX3 TFA | Inhibitor | / | Unkown |
| HY-P1437A | Neuropeptide S (Mouse) TFA | Agonist | / | Unkown |
| HY-P1438A | Neuropeptide S(Rat) TFA | Agonist | / | Unkown |
| HY-P1617 | LY 190388 | / | Unkown | |
| HY-P1654A | A20FMDV2-Cys | Ligand | / | Unkown |
| HY-P1755 | p53 (17-26) | / | Unkown | |
| HY-P1924A | IRBP(651-670) human, mouse TFA | Activator | / | Unkown |
| HY-P1949 | Cyclic MKEY | / | Unkown | |
| HY-P2210A | BigLEN(mouse) TFA | Activator | / | Unkown |
| HY-P2251 | T-peptide | Inhibitor | / | Unkown |
| HY-P2260A | Tat-beclin 1 TFA | / | Unkown | |
| HY-P2707 | α-Dendrotoxin | Inhibitor | / | Unkown |
| HY-P2712 | Chemerin-9, mouse | / | Unkown | |
| HY-P2818B | Alkaline phosphatase, Chicken Intestine | Inhibitor | / | Unkown |
| HY-P2818F | Alkaline phosphatase, Human (HEK293) | Inhibitor | / | Unkown |
| HY-P2989 | Pyruvate carboxylase | / | Unkown | |
| HY-P3102A | GLP-1(32-36)amide TFA | / | Unkown | |
| HY-P3134 | CPN-267 | Inhibitor | / | Unkown |
| HY-P3248 | J5 peptide | / | Unkown | |
| HY-P3269A | Calciseptine TFA | Inhibitor | 97.55% | Unkown |
| HY-P3483 | Maxadilan | / | Unkown | |
| HY-P3707 | Tumor targeted pro-apoptotic peptide | Inducer | / | Unkown |
| HY-P4610 | H-Trp-Tyr-OH | Activator | 99.43% | Unkown |
| HY-P4650 | Tyrosylhistidine | Inhibitor | / | Unkown |
| HY-P4835 | pTH (2-34) (human) | / | Unkown | |
| HY-P4890 | Relaxin H3 (human) | / | Unkown | |
| HY-P5081 | Endotrophin (Mus musculus) | Activator | / | Unkown |
| HY-P5081A | Endotrophin (Mus musculus) TFA | Activator | / | Unkown |
| HY-P5130 | Big endothelin-1 (rat 1-39) | Ligand | / | Unkown |
| HY-P5183 | Hm1a | Activator | / | Unkown |
| HY-P5396 | GAD65 (524-543) | / | Unkown | |
| HY-P5452 | PKCd (8-17) | Inhibitor | / | Unkown |
| HY-P5502 | Influenza NP (311-325) | / | Unkown | |
| HY-P5522 | TriDAP | / | Unkown | |
| HY-P5523 | iE-DAP | / | Unkown | |
| HY-P5578 | A8SGLP-1 | Agonist | / | Unkown |
| HY-P5578A | A8SGLP-1 TFA | Agonist | / | Unkown |
| HY-P5641 | Pleurocidin | Inhibitor | 98.91% | Unkown |
| HY-P5724 | Nv-CATH | Inhibitor | / | Unkown |
| HY-P5742 | ELAAWCRWGFLLALLPPGIAG | / | Unkown | |
| HY-P5742A | ELAAWCRWGFLLALLPPGIAG TFA | / | Unkown | |
| HY-P5782 | δ-Theraphotoxin-Hm1a toxin | Activator | / | Unkown |
| HY-P5875 | P4pal10 | Antagonist | / | Unkown |
| HY-P5878 | RG33 Peptide | / | Unkown | |
| HY-P5890 | YVAD-CHO | Inhibitor | / | Unkown |
| HY-P5975 | Z-Leu-Leu-Leu-fluoromethyl ketone | Inhibitor | / | Unkown |
| HY-P6053 | KK-103 | Agonist | / | Unkown |
| HY-RS08425 | MICAL1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08426 | MICAL2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08427 | MICAL3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00134A | Benzcyclane fumarate | Antagonist | / | Unkown |
| HY-W001083S1 | 3-Hydroxyphenylacetic acid-d5 | / | Unkown | |
| HY-W001083S2 | 3-Hydroxyphenylacetic acid-d6 | / | Unkown | |
| HY-W004681 | 5-Hydroxy-2-methylpyridine | 99.97% | Unkown | |
| HY-W006566A | 5-AIQ hydrochloride | Inhibitor | / | Unkown |
| HY-W008440S | DL-Cycloserine-15N,d3 | / | Unkown | |
| HY-W010520R | Methylisothiazolinone (Standard) | / | Unkown | |
| HY-W012481S | Nirvanol-d5 | / | Unkown | |
| HY-W012732S2 | Isoquinoline-15N | / | Unkown | |
| HY-W012832 | 2-Ethyl-3-methylpyrazine | / | Unkown | |
| HY-W015464R | N-Isovaleroylglycine (Standard) | / | Unkown | |
| HY-W015464S | N-Isovalerylglycine-d9 | 99.0% | Unkown | |
| HY-W015464S1 | N-Isovaleroylglycine-d2 | / | Unkown | |
| HY-W015635R | Diallyl disulfide (Standard) | Inhibitor | / | Unkown |
| HY-W017540S | Cyclocreatine-13C3 | / | Unkown | |
| HY-W020788 | Benoxacor | 99.39% | Unkown | |
| HY-W040276 | Diafen NN | / | Unkown | |
| HY-W054427 | Ro 13-3978 | Inhibitor | / | Unkown |
| HY-W080687 | 1,3-Diaminotetrafluorobenzene | / | Unkown | |
| HY-W097106 | (S)-3-N-Cbz-Amino-succinimide | 97.0% | Unkown | |
| HY-W1015419 | α-FMH | Inhibitor | / | Unkown |
| HY-W102352 | Triethylene glycol diacetate | 98.50% | Unkown | |
| HY-W102356R | Phenethyl acetate (Standard) | / | Unkown | |
| HY-W102356S | Phenethyl acetate-d3 | / | Unkown | |
| HY-W109107 | GED 0507-34-Levo | / | Unkown | |
| HY-W110242A | (S)-CPP sodium | / | Unkown | |
| HY-W1123936C | DBCO-PEG2000-FA | Ligand | / | Unkown |
| HY-W1123936D | DBCO-PEG3400-FA | Ligand | / | Unkown |
| HY-W1123936E | DBCO-PEG5000-FA | Ligand | / | Unkown |
| HY-W1123936H | DBCO-PEG10000-FA | Ligand | / | Unkown |
| HY-W1130458 | 503O8,12 | / | Unkown | |
| HY-W1130459 | (R)-C12-200 | / | Unkown | |
| HY-W1142093 | ActRIIB-IN-4 | / | Unkown | |
| HY-W127730 | Pyridoxine 3,4-dipalmitate | 99.99% | Unkown | |
| HY-W142432S | Perfluoroundecanoic acid-13C7 | / | Unkown | |
| HY-W150182 | p-Cymen-8-ol | / | Unkown | |
| HY-W153897R | N-Methyltyramine (Standard) | Agonist | / | Unkown |
| HY-W154247 | IP6C | Inhibitor | / | Unkown |
| HY-W169940 | NP-184 | / | Unkown | |
| HY-W197205 | SL010110 | / | Unkown | |
| HY-W207224 | F1386-0303 | Inhibitor | / | Unkown |
| HY-W325509 | AH 8532 | / | Unkown | |
| HY-W331017 | 1-Hexacosanoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W338346 | Salicylate choline | Inhibitor | / | Unkown |
| HY-W344074 | Cytarabine 5’-monophosphate | Inhibitor | 98.04% | Unkown |
| HY-W385577A | (S)-2-Benzylpyrrolidine hydrochloride | / | Unkown | |
| HY-W424839 | Probucol dithiobisphenol | Inducer | / | Unkown |
| HY-W550494 | 1-(Pyridin-4-yl)heptan-1-one | Inhibitor | / | Unkown |
| HY-W615446 | GSTO1-IN-3 | Inhibitor | / | Unkown |
| HY-W663179 | DNDI-VL-2098 | Inhibitor | / | Unkown |
| HY-W665882 | Norketotifen | Inhibitor | / | Unkown |
| HY-W671129 | Frenolicin B | Inhibitor | / | Unkown |
| HY-W674149 | ABI-274 | Inhibitor | / | Unkown |
| HY-W720629 | Cyanamide-15N2 | Inhibitor | / | Unkown |
| HY-W744266 | 9α,10α-Epoxyhexahydrocannabinol | / | Unkown | |
| HY-W744578 | Taurolidine-d6 | / | Unkown | |
| HY-W745872 | Rivanicline-d3 | / | Unkown | |
| HY-W747554 | SM 32 | / | Unkown | |
| HY-W747910A | S584 dihydrochloride | / | Unkown | |
| HY-W748758 | (Z)-Thiothixene-d8 | / | Unkown | |
| HY-W761985 | Furathiocarb | / | Unkown | |
| HY-W767399 | 8-Bromo-2'-deoxyguanosine-13C,15N2 | / | Unkown | |
| HY-W768347 | Xylitol-13C5 | / | Unkown | |
| HY-W772717 | L-Cystine disodium monohydrate | / | Unkown | |
| HY-W778335 | Dimethyl Phthalate-13C2 | / | Unkown | |
| HY-W778375 | Hesperetin triacetate | Inducer | / | Unkown |
| HY-W782935 | MAPKAPK5-IN-1 | / | Unkown | |
| HY-W783351 | CS790AM | / | Unkown | |
| HY-W787758 | 2-Propylpent-4-ynoic acid | Inhibitor | / | Unkown |
| HY-W788542 | Quoromycin | Inhibitor | / | Unkown |
| HY-W795264 | FR900098 | Inhibitor | / | Unkown |
| HY-W795993 | TJU103 | Inhibitor | / | Unkown |
| HY-W879307 | CP-201 | / | Unkown | |
| HY-W893751 | PMO-G | / | Unkown | |
| HY-W975902 | MDL-27531 | Agonist | / | Unkown |
| HY-Z11709 | 13-Hydroxy-alpha-tocopherol | / | Unkown | |
| HY-100442S | Paquinimod-d5 | Inhibitor | / | Unkown |
| HY-100603B | (R)-GSK-F1 | Inhibitor | / | Unkown |
| HY-100840 | (S)-4C3HPG | / | Unkown | |
| HY-101139B | Xanthine amine congener trihydrochloride | Antagonist | / | Unkown |
| HY-101699A | AMG-076 | Antagonist | / | Unkown |
| HY-101775 | 9-Hydroxyellipticin | Inhibitor | / | Unkown |
| HY-101966R | NCT-503 (Standard) | / | Unkown | |
| HY-10231R | PX-478 (Standard) | / | Unkown | |
| HY-103163 | (±)-5'-Chloro-5'-deoxy-ENBA | Agonist | / | Unkown |
| HY-103388 | NCX 466 | Inhibitor | / | Unkown |
| HY-103567A | Desmethyl-YM-298198 | Antagonist | / | Unkown |
| HY-105294 | FR 64822 | Agonist | / | Unkown |
| HY-105589 | Liroldine | Inhibitor | / | Unkown |
| HY-105714 | Etoprine | Inhibitor | / | Unkown |
| HY-105790A | Piperilate hydrochloride | Inhibitor | / | Unkown |
| HY-106929R | Moxilubant (Standard) | Antagonist | / | Unkown |
| HY-107458 | AP23848 | Inhibitor | / | Unkown |
| HY-107632G | GYY4137 (GMP) | / | Unkown | |
| HY-107758 | Y-29794 oxalate | Inhibitor | / | Unkown |
| HY-107855R | DL-Mevalonolactone (Standard) | / | Unkown | |
| HY-108065 | 3'-Sialyllactose | Inhibitor | / | Unkown |
| HY-108238 | BSI-401 | Inhibitor | / | Unkown |
| HY-108874A | Candicidin (≥50%) | Inhibitor | / | Unkown |
| HY-109044S | Tapinarof-d5 | Agonist | / | Unkown |
| HY-109506S2 | (Rac)-DPPC-d6 | 98.0% | Unkown | |
| HY-110133A | JTE-607 free base | Inhibitor | / | Unkown |
| HY-110151 | Bengamide B | Inhibitor | / | Unkown |
| HY-111817A | (Rac)-ACT-451840 | Inhibitor | / | Unkown |
| HY-112726A | PXS-4728A free base | Inhibitor | / | Unkown |
| HY-112817 | 8-Oxo-dGTP | Inducer | / | Unkown |
| HY-112817A | 8-Oxo-dGTP trisodium solution (100 mM) | Inducer | 98.95% | Unkown |
| HY-113308AS1 | Taurolithocholic Acid-d5 sodium salt | / | Unkown | |
| HY-113440R | 5-Methoxytryptophol (Standard) | / | Unkown | |
| HY-113619 | ABT-255 free base | Inhibitor | / | Unkown |
| HY-114527 | TPMP-I-2 | / | Unkown | |
| HY-114730 | CGA-JK3 | Inhibitor | / | Unkown |
| HY-115889 | L-NAPNA | Inhibitor | / | Unkown |
| HY-116143 | MAGL-IN-12 | Inhibitor | / | Unkown |
| HY-116228A | Cadrofloxacin (hydrochloride) | Inhibitor | / | Unkown |
| HY-116799 | NSC 145669 | Inhibitor | / | Unkown |
| HY-117076A | (R)-Moxestrol | Modulator | / | Unkown |
| HY-117446 | AS-1669058 | Agonist | / | Unkown |
| HY-117446A | AS-1669058 free base | Agonist | / | Unkown |
| HY-118184 | AF3485 | Inhibitor | / | Unkown |
| HY-118285 | Ro4491533 | Inhibitor | / | Unkown |
| HY-118537 | ICI 56780 | Inhibitor | / | Unkown |
| HY-118665 | L-736380 | Antagonist | / | Unkown |
| HY-118758 | γ-Kainylglutamic acid | Inhibitor | / | Unkown |
| HY-118802 | 4-Hydroxy DPT | / | Unkown | |
| HY-118803 | AS1468240 | Inhibitor | / | Unkown |
| HY-119110 | LY52 | Inhibitor | / | Unkown |
| HY-119218 | LH 1 | / | Unkown | |
| HY-119955 | Amflutizole | Inhibitor | / | Unkown |
| HY-119980BS | Fluphenazine-d6 hydrochloride | / | Unkown | |
| HY-120016 | RU 43044 | Antagonist | / | Unkown |
| HY-120042 | Heptenophos | Inhibitor | / | Unkown |
| HY-120187 | DDCPPB-Glu | / | Unkown | |
| HY-120450 | CL-55 | Inhibitor | / | Unkown |
| HY-120462 | Genz-669178 | Inhibitor | / | Unkown |
| HY-120550 | RS 49676 | Inhibitor | / | Unkown |
| HY-120657S | 9-PAHSA-d4 | / | Unkown | |
| HY-120657S1 | 9-PAHSA-d31 | 99.00% | Unkown | |
| HY-121229A | (±)-Coniine | Agonist | 97.34% | Unkown |
| HY-121246S | Fluorofenidone-d3 | Inhibitor | / | Unkown |
| HY-121798 | TZD18 | Agonist | / | Unkown |
| HY-122083 | T2384 | Activator | / | Unkown |
| HY-122740 | Retro-1 | / | Unkown | |
| HY-123750 | Zimet 38/74 | Inhibitor | / | Unkown |
| HY-123801A | MIDD0301 sodium | Inhibitor | / | Unkown |
| HY-123826 | CCT68127 | Inhibitor | / | Unkown |
| HY-12392R | Iprindole (Standard) | Agonist | / | Unkown |
| HY-124018 | MMV665852 | Inhibitor | / | Unkown |
| HY-124290A | Carotegrast methyl hydrochloride | Antagonist | / | Unkown |
| HY-124499 | RUC-1 | Inhibitor | / | Unkown |
| HY-12580 | RO5353 | MDM2 Inhibitor | / | Unkown |
| HY-12610 | Carbonic anhydrase inhibitor 27 | Inhibitor | / | Unkown |
| HY-126170 | Valanimycin | Inhibitor | / | Unkown |
| HY-126645 | Atelopidtoxin | Inhibitor | / | Unkown |
| HY-127014 | Julimycin B2 | Inhibitor | / | Unkown |
| HY-12814A | TH588 hydrochloride | Inhibitor | / | Unkown |
| HY-129133 | cis-Miyabenol C | / | Unkown | |
| HY-129318 | MBX-1066 | Inhibitor | / | Unkown |
| HY-129347 | Lankacyclinol A | Inhibitor | / | Unkown |
| HY-130581 | Lipid X | Inhibitor | / | Unkown |
| HY-131527 | Wy-45494 hydrochloride | Inhibitor | 99.65% | Unkown |
| HY-13225 | Rivanicline oxalate | Agonist | / | Unkown |
| HY-134314 | 8-Nitro-cGMP | Inducer | / | Unkown |
| HY-134579 | Chaetomellic acid A | Inhibitor | / | Unkown |
| HY-135000 | Decarbamoylsaxitoxin | / | Unkown | |
| HY-13552 | Asulacrine isethionate | Inhibitor | / | Unkown |
| HY-13589 | Cemadotin | Inhibitor | / | Unkown |
| HY-136450R | Triclabendazole sulfoxide (Standard) | Inhibitor | / | Unkown |
| HY-136700 | SB-699551 free base | / | Unkown | |
| HY-138100 | Hyalodendrin | Inhibitor | / | Unkown |
| HY-138232 | Lys-psi(CH2NH)-Trp(Nps)-OMe | Inhibitor | / | Unkown |
| HY-138291 | Ethoxyquin dimer | 98.70% | Unkown | |
| HY-139226 | GMQ | Antagonist | / | Unkown |
| HY-139240 | Cannabidihexol | / | Unkown | |
| HY-139855 | ZG-2033 | Agonist | / | Unkown |
| HY-139987A | LeuRS-IN-1 hydrochloride | Inhibitor | / | Unkown |
| HY-14162 | AM103 free acid | Inhibitor | / | Unkown |
| HY-14447S1 | Bilastine-d4 | Antagonist | / | Unkown |
| HY-147548 | Keap1-Nrf2-IN-10 | Inhibitor | / | Unkown |
| HY-148708 | Oleoyl-D-lysine | Inhibitor | / | Unkown |
| HY-149779 | RyR2 stabilizer-1 | Modulator | / | Unkown |
| HY-150306A | (Rac)-Adibelivir | Inhibitor | / | Unkown |
| HY-153512 | PHD-1-IN-3 | Inhibitor | / | Unkown |
| HY-156184 | Octanoylcarnitine | / | Unkown | |
| HY-157082 | ZHSI-1 | Inhibitor | / | Unkown |
| HY-15800 | CZC-25146 hydrochloride | Inhibitor | / | Unkown |
| HY-159500A | Zopocianine sodium | / | Unkown | |
| HY-159737 | Rociclovir | Inhibitor | / | Unkown |
| HY-159905 | HPK1-IN-54 | Inhibitor | / | Unkown |
| HY-160475 | AD-9308 | / | Unkown | |
| HY-161065 | HKI12134085 | Inhibitor | / | Unkown |
| HY-161728 | Antibacterial agent 223 | Inhibitor | / | Unkown |
| HY-161935 | 6-(12-Tridecene-1-yl)-2,4-Dihydroxy benzoic acid | Inhibitor | / | Unkown |
| HY-161937 | Antibacterial agent 236 | Inhibitor | / | Unkown |
| HY-162761 | COX-1/2-IN-9 | Inhibitor | / | Unkown |
| HY-163030 | LasB-IN-1 | Inhibitor | / | Unkown |
| HY-164039 | Talorasib | / | Unkown | |
| HY-164384 | DFX117 | / | Unkown | |
| HY-164425 | ENT-03 | / | Unkown | |
| HY-164462 | BHA536 | / | Unkown | |
| HY-164477 | FL442 | Modulator | / | Unkown |
| HY-164547 | WHN-88 | Inhibitor | / | Unkown |
| HY-164551 | YLL545 | / | Unkown | |
| HY-165098 | 3-Aminoisobutyric acid sodium salt | 99.59% | Unkown | |
| HY-165466 | Azidothiorphan | Inhibitor | / | Unkown |
| HY-165600 | Trimedoxime dichloride | Activator | / | Unkown |
| HY-167182 | PUMAi | Inhibitor | / | Unkown |
| HY-167201 | 2ccPA | Inhibitor | / | Unkown |
| HY-167632 | meso-Zeaxanthin | 93.09% | Unkown | |
| HY-167706 | Diethyl-Lodoxamide | / | Unkown | |
| HY-168166 | CHET3 | 99.75% | Unkown | |
| HY-168355 | Δ8-THC methyl ether | Ligand | / | Unkown |
| HY-168365 | (±)-Pellotine hydrochloride | / | Unkown | |
| HY-168368 | exo-Tetrahydrocannabivarin | Ligand | / | Unkown |
| HY-168572 | MZ82 | Inhibitor | / | Unkown |
| HY-168629 | FXR agonist 9 | Inhibitor | / | Unkown |
| HY-168792 | (±)-9-Nor-9α-hydroxy Hexahydrocannabinol | / | Unkown | |
| HY-169222S | RORγ/DHODH-IN-2 | Inhibitor | / | Unkown |
| HY-169429 | CHIKV-IN-5 | Inhibitor | / | Unkown |
| HY-169801 | Rofleponide 21-palmitate | Inhibitor | / | Unkown |
| HY-170717 | 3-Methylnordiazepam | / | Unkown | |
| HY-170970 | Mtb-IN-10 | Inhibitor | / | Unkown |
| HY-171182 | D3017 | / | Unkown | |
| HY-171699 | Antibacterial agent 339 | Inhibitor | / | Unkown |
| HY-171953 | THP1 Lipid | / | Unkown | |
| HY-171956 | Carmaphycin-17 | Inhibitor | / | Unkown |
| HY-172335 | C9-200 | / | Unkown | |
| HY-173302 | sEH inhibitor-20 | Inhibitor | / | Unkown |
| HY-173428 | Antifungal agent 130 | Inhibitor | / | Unkown |
| HY-174325 | Antimalarial agent 50 | Inhibitor | / | Unkown |
| HY-174353 | CYP51-IN-22 | Inhibitor | / | Unkown |
| HY-174353S | CYP51-IN-23-d3 | Inhibitor | / | Unkown |
| HY-174829 | 7,4'-Dimethoxy-3-hydroxyflavone | / | Unkown | |
| HY-175215 | PfPK6-IN-1 | / | Unkown | |
| HY-175491 | HIV-1-IN-85 | Inhibitor | / | Unkown |
| HY-175648 | Antiparasitic agent-28 | Inhibitor | / | Unkown |
| HY-176466 | ST-899 | / | Unkown | |
| HY-176539 | PAK1-IN-2 | Inhibitor | / | Unkown |
| HY-177059 | Nitrobenzylthioinosine 5'-monophosphate | / | Unkown | |
| HY-177140 | CDD-1147 | Inhibitor | / | Unkown |
| HY-177300 | TLR7/8 agonist 13 | / | Unkown | |
| HY-177332 | SLC-391 | Inhibitor | / | Unkown |
| HY-177406 | VR11 aptamer | Inhibitor | / | Unkown |
| HY-177482 | Pro-PTX | / | Unkown | |
| HY-177791 | vRNPs degrader-1 | Inhibitor | / | Unkown |
| HY-177933 | mNOX-E36 | Inhibitor | / | Unkown |
| HY-178147 | Antimalarial agent 52 | Inhibitor | / | Unkown |
| HY-178775 | PI4K-IN-3 | Inhibitor | / | Unkown |
| HY-179369 | 4-Hydroxytryptophol | / | Unkown | |
| HY-180129 | SARS-CoV-2-IN-120 | Inhibitor | / | Unkown |
| HY-180228 | MPXV p37 protein-IN-1 | Inhibitor | / | Unkown |
| HY-180337 | Antiparasitic agent-38 | Inhibitor | / | Unkown |
| HY-180339 | Antiparasitic agent-36 | / | Unkown | |
| HY-180352 | Antiparasitic agent-37 | Inhibitor | / | Unkown |
| HY-180360 | Antiparasitic agent-34 | Inhibitor | / | Unkown |
| HY-180388 | Stibophen | Inhibitor | / | Unkown |
| HY-180936 | FBPase-IN-6 | / | Unkown | |
| HY-180992 | Dual GO/LDHA-IN-1 | Inhibitor | / | Unkown |
| HY-18101 | BD-1063 | / | Unkown | |
| HY-181010 | HDAC1-IN-12 | Inhibitor | / | Unkown |
| HY-181079 | RANKL-IN-2 | Inhibitor | / | Unkown |
| HY-181095 | Xanthine oxidase-IN-22 | Inhibitor | / | Unkown |
| HY-181102 | TGR5 agonist 10 | Agonist | / | Unkown |
| HY-181348 | HBV-IN-56 | Inhibitor | / | Unkown |
| HY-181485 | GPR68 antagonist 1 | / | Unkown | |
| HY-181494 | FAPI-X5 | Inhibitor | / | Unkown |
| HY-181520 | ABCA1 inducer 3 | Inducer | / | Unkown |
| HY-181564 | MGAT2-IN-7 | Inhibitor | / | Unkown |
| HY-181578 | Nampt-IN-17 | / | Unkown | |
| HY-181580 | FAP Ligand 3 | Ligand | / | Unkown |
| HY-181623 | PROTAC BTK degrader-14 | Degrader | / | Unkown |
| HY-181647 | LasB-IN-3 | Inhibitor | / | Unkown |
| HY-181779 | Pyridomycin-4-F | Inhibitor | / | Unkown |
| HY-181991 | IRBM-Z-2 | Inhibitor | / | Unkown |
| HY-182030 | RSV fusion protein IN-1 | Inhibitor | / | Unkown |
| HY-182294 | HYJ-2 | Inhibitor | / | Unkown |
| HY-182485 | U-11634 | Inhibitor | / | Unkown |
| HY-182535 | Tuberactinomycin-O | Inhibitor | / | Unkown |
| HY-182621 | MB4253 | Inhibitor | / | Unkown |
| HY-182679 | L0909 | Inhibitor | / | Unkown |
| HY-182685 | MMV693183 | Inhibitor | / | Unkown |
| HY-182769 | TRβ agonist-4 | Agonist | / | Unkown |
| HY-183001 | ATX-012 | / | Unkown | |
| HY-183142 | CLR/RAMP3-receptor antagonist-1 | Antagonist | / | Unkown |
| HY-183178 | Teroxalene | Inhibitor | / | Unkown |
| HY-183400 | BIM-46174 | / | Unkown | |
| HY-183403 | Ganstigmine | Inhibitor | / | Unkown |
| HY-183482 | GBR 13098 | Inhibitor | / | Unkown |
| HY-183574 | Antimalarial agent 62 | Inhibitor | / | Unkown |
| HY-183576 | HBsAg-IN-1 | Inhibitor | / | Unkown |
| HY-183649 | BCN-PEG6-OH | / | Unkown | |
| HY-183660 | F-SLOH | / | Unkown | |
| HY-183665 | GBR-13119 | Inhibitor | / | Unkown |
| HY-183666 | NS3956 | Activator | / | Unkown |
| HY-183711 | Antibacterial agent 344 | Inhibitor | / | Unkown |
| HY-183855 | WF-2421 | Inhibitor | / | Unkown |
| HY-183919 | ACC2-IN-1 | Inhibitor | / | Unkown |
| HY-183924 | SYK-IN-14 | Inhibitor | / | Unkown |
| HY-183933 | K812 | Inhibitor | / | Unkown |
| HY-183946 | NVP-TAC544 | Inhibitor | / | Unkown |
| HY-184287 | Antibacterial agent 352 | Inhibitor | / | Unkown |
| HY-185050 | Antitumor agent-210 | Activator | / | Unkown |
| HY-185223 | A-066 | / | Unkown | |
| HY-185546 | CRBN ligand-900 Gly | / | Unkown | |
| HY-185590 | tri-GalNAc-phosphoric acid | Ligand | / | Unkown |
| HY-185679 | W19-LNP | / | Unkown | |
| HY-185751 | 10A1P16 | / | Unkown | |
| HY-185830 | ADC Control Human IgG1-vcMMAE (DAR8) | Inhibitor | / | Unkown |
| HY-186149 | Phosphate muramyl dipeptide | / | Unkown | |
| HY-18956A | (E/Z)-Icerguastat hydrochloride | Inhibitor | / | Unkown |
| HY-19242 | MX-68 | / | Unkown | |
| HY-19926A | GDC-0425 hydrochloride | Inhibitor | / | Unkown |
| HY-21193R | Perfluoropentanoic acid (Standard) | / | Unkown | |
| HY-23312 | Antiparasitic agent-41 | Inhibitor | / | Unkown |
| HY-23317 | N-Methyl-4-(8-phenoxyoctoxy)aniline | Inhibitor | / | Unkown |
| HY-24238 | DLCI-1 | Inhibitor | / | Unkown |
| HY-76228R | 1H-pyrazole (Standard) | / | Unkown | |
| HY-A0114 | Moexiprilat | / | Unkown | |
| HY-B0168S | Milnacipran-d10 hydrochloride | Inhibitor | 99.85% | Unkown |
| HY-B0281AS | Ranitidine-d6 hydrochloride | Antagonist | 97.00% | Unkown |
| HY-B0448S2 | Phenytoin-d5 | Inhibitor | / | Unkown |
| HY-B0824A | (1R)-cis-Bifenthrin | / | Unkown | |
| HY-B0869 | Bispyribac | / | Unkown | |
| HY-B1202A | Alrestatin sodium | Inhibitor | / | Unkown |
| HY-B1794S | Thiethylperazine-d3 | / | Unkown | |
| HY-N0469A | L-Lysine sulfite | Inhibitor | / | Unkown |
| HY-N0493R | Pectolinarigenin (Standard) | / | Unkown | |
| HY-N0631R | Cornuside (Standard) | Inhibitor | / | Unkown |
| HY-N0976 | 1,11b-Dihydro-11b-hydroxymedicarpin | Activator | / | Unkown |
| HY-N10171 | GB-2a | / | Unkown | |
| HY-N10346 | Gluconapin potassium | / | Unkown | |
| HY-N10346A | Gluconapin | Inhibitor | / | Unkown |
| HY-N10653 | Altemicidin | / | Unkown | |
| HY-N11072 | Tremulacin | Inhibitor | 96.41% | Unkown |
| HY-N1151 | Thunberginol C | Inhibitor | / | Unkown |
| HY-N11872 | Suffruticosol A | Activator | / | Unkown |
| HY-N11972 | β-Maaliene | / | Unkown | |
| HY-N12141 | Flaccidoside II | Inducer | / | Unkown |
| HY-N12169 | Janthitrem A | / | Unkown | |
| HY-N12171 | Isoreserpiline | Inhibitor | / | Unkown |
| HY-N12531 | Molephantin | / | Unkown | |
| HY-N12719 | Isocampneoside I | / | Unkown | |
| HY-N13174 | Peanut procyanidin A | Inhibitor | / | Unkown |
| HY-N13293 | Isopaynantheine | Control | / | Unkown |
| HY-N13715 | Thalicminine | / | Unkown | |
| HY-N13894 | Auramycin A | Inhibitor | / | Unkown |
| HY-N13895 | Auramycin B | Inhibitor | / | Unkown |
| HY-N1393S | 2-Methoxybenzoic acid-13C6 | / | Unkown | |
| HY-N14018 | Glidobactin A | Inhibitor | / | Unkown |
| HY-N14019 | Glidobactin B | Inhibitor | / | Unkown |
| HY-N14020 | Glidobactin C | Inhibitor | / | Unkown |
| HY-N14022 | Glidobactin F | Inhibitor | / | Unkown |
| HY-N14023 | Glidobactin G | Inhibitor | / | Unkown |
| HY-N14093 | Aspulvinone H | / | Unkown | |
| HY-N14193 | Estatin B | Inhibitor | / | Unkown |
| HY-N14200 | Maridomycin II | Inhibitor | / | Unkown |
| HY-N14201 | Maridomycin IV | Inhibitor | / | Unkown |
| HY-N14202 | Maridomycin V | Inhibitor | / | Unkown |
| HY-N14203 | Maridomycin VI | Inhibitor | / | Unkown |
| HY-N14350 | 2'''-Hydroxychlorothricin | Inhibitor | / | Unkown |
| HY-N14571 | Quinomycin B | / | Unkown | |
| HY-N14586 | Roridin J | / | Unkown | |
| HY-N14753 | Juglomycin A | Inhibitor | / | Unkown |
| HY-N14754 | Juglomycin B | Inhibitor | / | Unkown |
| HY-N14887 | Phleomycin E | Inhibitor | / | Unkown |
| HY-N14941 | Phleomycin G | Inhibitor | / | Unkown |
| HY-N15001 | Gabaculine | Inhibitor | / | Unkown |
| HY-N1500A | (S)-Pulegone | Substrate | / | Unkown |
| HY-N1503R | Methyl deacetylasperulosidate (Standard) | / | Unkown | |
| HY-N15180 | Corynantheidine | / | Unkown | |
| HY-N15182 | 4-Trehalosamine | Inhibitor | / | Unkown |
| HY-N15339A | Convolamine hydrochloride | Activator | / | Unkown |
| HY-N15389 | Noformicin | Inhibitor | / | Unkown |
| HY-N15404 | Glaucarubin | Inhibitor | / | Unkown |
| HY-N19844 | 3-Heptadecylcatechol | / | Unkown | |
| HY-N2393A | Kukoamine B mesylate | Inhibitor | / | Unkown |
| HY-N2953 | Borapetoside E | Inhibitor | / | Unkown |
| HY-N3312S | Matairesinol-d6 | / | Unkown | |
| HY-N4031 | Humantenine | Chemical | 98% | Unkown |
| HY-N4243 | Neocurdione | / | Unkown | |
| HY-N6609B | Magnocurarine chloride | Antagonist | / | Unkown |
| HY-N7506 | 13-Hydroxyisobakuchiol | Inhibitor | / | Unkown |
| HY-N7697C | Chitohexaose hexahydrochloride | 95.0% | Unkown | |
| HY-N8107 | Matairesinol monoglucoside | 99.42% | Unkown | |
| HY-N8818 | 3-Acetoxytirucalla-7,24-dien-21-oic acid | / | Unkown | |
| HY-N9484S | Menthofuran-13C2 | / | Unkown | |
| HY-P0009S1 | Cetrorelix-d10 | Antagonist | / | Unkown |
| HY-P10200 | CP7-FP13-2 | Inhibitor | / | Unkown |
| HY-P11634 | KF-22 | Inhibitor | / | Unkown |
| HY-P1624S | Teduglutide-Ala(13C3,15N) sodium | / | Unkown | |
| HY-P3269 | Calciseptine | Inhibitor | / | Unkown |
| HY-P4885 | Glp-amyloid-β (3-40) peptide (human) | / | Unkown | |
| HY-P5550 | Urumin | Inhibitor | / | Unkown |
| HY-R04622 | mmu-miR-486a-5p | / | Unkown | |
| HY-RS20179 | Mical2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20533 | Casp14 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26683 | Mical2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00008 | CP-28888 | Inducer | / | Unkown |
| HY-W007223 | D-5-Hydroxytryptophan | / | Unkown | |
| HY-W008440 | DL-Cycloserine | / | Unkown | |
| HY-W009512S1 | CVT-2738-d6 | / | Unkown | |
| HY-W019704R | N-Acetyl-DL-methionine (Standard) | / | Unkown | |
| HY-W026339 | IMB-XMA0038 | Inhibitor | / | Unkown |
| HY-W035445 | Antiparasitic agent-42 | Inhibitor | / | Unkown |
| HY-W052508R | Norquetiapine (Standard) | Modulator | / | Unkown |
| HY-W062702 | BMS-933043 | Agonist | / | Unkown |
| HY-W099437 | Diethylene glycol monobutyl ether acetate | / | Unkown | |
| HY-W102356 | Phenethyl acetate | 99.27% | Unkown | |
| HY-W102356S1 | Phenethyl acetate-13C2 | / | Unkown | |
| HY-W102356S2 | Phenethyl acetate-d5 | / | Unkown | |
| HY-W1113135A | Carboxymethyl-β-cyclodextrin sodium salt, for capillary electrophoresis | / | Unkown | |
| HY-W1115186 | CRBN ligand-900 | / | Unkown | |
| HY-W133921 | Dipropylene glycol | / | Unkown | |
| HY-W142432R | Perfluoroundecanoic acid (Standard) | / | Unkown | |
| HY-W153159R | N-Methyltyramine hydrochloride (Standard) | Agonist | / | Unkown |
| HY-W182790 | Garsevil | / | Unkown | |
| HY-W188178 | N-Mitrososarcosine | / | Unkown | |
| HY-W197533 | 3-Hydroxymethyl-β-carboline | / | Unkown | |
| HY-W241345 | DOTA-bis(tert-butyl)ester | 99.25% | Unkown | |
| HY-W279140 | Pirlindole hydrochloride | Inhibitor | / | Unkown |
| HY-W335896 | 4-(2-Octylamino)diphenylamine | Inhibitor | / | Unkown |
| HY-W353842 | Octyl decyldimethyl ammonium chloride | Inhibitor | / | Unkown |
| HY-W369099 | HJC0152 free base | / | Unkown | |
| HY-W413619 | Cipargamin enantiomer | Inhibitor | / | Unkown |
| HY-W440913 | DSPE-PEG5000-Cy5 | / | Unkown | |
| HY-W517092 | 1,2,3,4,7,8,9-Heptachlorodibenzofuran | / | Unkown | |
| HY-W517275 | Sulfamethylthiazole | / | Unkown | |
| HY-W587486A | N-Acetyltaurine hemimagnesium | / | Unkown | |
| HY-W591838 | Perfluoropentanesulfonic acid | Activator | 97.23% | Unkown |
| HY-W644305 | Androst-16-en-3-ol | Modulator | / | Unkown |
| HY-W658325 | P-Decyloxyaniline | / | Unkown | |
| HY-W665796 | N-Methyl-N-nitroso-2-propanamine | / | Unkown | |
| HY-W666088 | (2-Phenylethyl)hydrazine dihydrochloride | / | Unkown | |
| HY-W679796 | PBITC | / | Unkown | |
| HY-W680886 | 6-APDB | / | Unkown | |
| HY-W681659 | Flutoprazepam | Inhibitor | / | Unkown |
| HY-W711852 | Benzamide-d5 | Inhibitor | / | Unkown |
| HY-W714505 | AH 7563 | Ligand | / | Unkown |
| HY-W714509 | AH 8507 | / | Unkown | |
| HY-W721480 | HC-067047 hydrochloride | Antagonist | / | Unkown |
| HY-W721596 | Pentadecanoyl ethanolamide | / | Unkown | |
| HY-W721611 | Terbucarb | / | Unkown | |
| HY-Y0496S | 1,4-Dichlorobenzene-d4 | 99.0% | Unkown | |
| HY-Z16784 | PX-478 free base | / | Unkown | |
| HY-109506S10 | DPPC-13C3 | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(125)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99126 | Anti-Mouse/Human CD44 Antibody (IM7) | Inhibitor | 99.07% | Unkown |
| HY-P990117 | Anti-Mouse/Rat/Human Osteopontin/SPP1 Antibody (MPIIIB10) | Inhibitor | 95.00% | Unkown |
| HY-P990545 | Tanruprubart | Inhibitor | 99.047% | Unkown |
| HY-P99124 | Anti-Mouse CD3 Antibody (17A2) | Inhibitor | 99% | Unkown |
| HY-P990116 | Anti-Mouse osteopontin/SPP1 Antibody (103D6) | Inhibitor | 99.76% | Unkown |
| HY-P99123 | Anti-Mouse CD28 Antibody (37.51) | 95.00% | Unkown | |
| HY-P99148 | Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) | Inhibitor | 99.24% | Unkown |
| HY-P990107 | Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) | Inhibitor | 97.44% | Unkown |
| HY-P99136 | Anti-Mouse IFN gamma Antibody (H22) | Inhibitor | 95.00% | Unkown |
| HY-P990685 | Romiplostim | Agonist | ≥99.0% | Unkown |
| HY-P99908 | Efineptakin alfa | Activator | 99.70% | Unkown |
| HY-P990203 | Anti-Mouse LPAM-1/Integrin α4β7 Antibody (DATK32) | Inhibitor | 99.08% | Unkown |
| HY-P99408 | Oxelumab | Inhibitor | 99.31% | Unkown |
| HY-P99976 | Anti-Mouse CD19 Antibody (1D3) | Inhibitor | 98.778% | Unkown |
| HY-P990094 | Trabikibart | 99.17% | Unkown | |
| HY-P99129 | Anti-Mouse CD8a Antibody (53-6.7) | Inhibitor | 98.18% | Unkown |
| HY-P990254 | Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173) | Inhibitor | 99% | Unkown |
| HY-P990245 | Anti-Mouse FAP Antibody (73.3) | Inhibitor | 95.00% | Unkown |
| HY-P991728 | Zarutatug | Inhibitor | 99.11% | Unkown |
| HY-P990129 | Anti-Mouse CD71/TfR1 Antibody (8D3) | Inhibitor | / | Unkown |
| HY-P990282 | Anti-Mouse CD24 Antibody (M1/69) | Inhibitor | ≥95.0% | Unkown |
| HY-P990980 | Cizutamig | Inhibitor | 95% | Unkown |
| HY-P991886 | ANX-M1 (Human IgG1) | Inhibitor | 99.0% | Unkown |
| HY-P990552A | huATN-658 | Antagonist | 99.67% | Unkown |
| HY-P990181 | Anti-Mouse myeloperoxidase/MPO Antibody (6G4) | Inhibitor | 95.00% | Unkown |
| HY-P990215 | Anti-Mouse IL-27 p28 Antibody (MM27.7B1) | Inhibitor | 95.00% | Unkown |
| HY-P992033 | Anti-Mouse IL-4Rα Antibody (REGN1103) | Antagonist | 99.12% | Unkown |
| HY-P991128 | Cliramitug | 97.0% | Unkown | |
| HY-P991480 | ONC-841 | Inhibitor | 95.03% | Unkown |
| HY-P99620 | Firivumab | Inhibitor | 95.00% | Unkown |
| HY-P991797 | Anti-Mouse IL-17A Antibody (BZN035) | Inhibitor | 97.90% | Unkown |
| HY-P990060 | Denecimig | Inhibitor | 95.90% | Unkown |
| HY-P991200 | OM-7D3-B3 | 97.98% | Unkown | |
| HY-P99653A | Ianalumab (FUT8-KO) | Inhibitor | 99.85% | Unkown |
| HY-P99948 | Etevritamab | Ligand | 97.00% | Unkown |
| HY-P991112 | Anti-Mouse CD8α Antibody (YTS169.4) | Inhibitor | 98.99% | Unkown |
| HY-P99922 | Encelimab | Inhibitor | 95.25% | Unkown |
| HY-P991570 | Zaptuzumab | 99.0% | Unkown | |
| HY-P992146 | Zevontabart | Inhibitor | 99.46% | Unkown |
| HY-P99680 | Keliximab | Inhibitor | 98.23% | Unkown |
| HY-P991864 | Annexuzlimab | Inhibitor | 98.67% | Unkown |
| HY-P991004 | Itanistomig | 95.84% | Unkown | |
| HY-P990264 | Anti-Mouse CD70 Antibody (FR70) | Inhibitor | 95.00% | Unkown |
| HY-P990812 | Anti-Mouse myeloperoxidase/MPO Antibody (6D1) | Inhibitor | 98.82% | Unkown |
| HY-P991208 | Flt-3L-Ig (hum/hum) | 98% | Unkown | |
| HY-P992159 | Anti-ZnT8 Antibody (mAb43) | Inhibitor | 99.40% | Unkown |
| HY-P991294 | MGTA-117 Antibody | / | Unkown | |
| HY-P991966 | Anti-Human/Mouse EGFR Antibody (7A7) | 99.45% | Unkown | |
| HY-P991999 | OM-RCA-01 | ≥99.0% | Unkown | |
| HY-P992060 | Anti-Mouse CD20 Antibody (18B12) | / | Unkown | |
| HY-P992074 | Zemlikafusp alfa | Ligand | / | Unkown |
| HY-P992151 | Sphingomab | Inhibitor | / | Unkown |
| HY-P992488 | ZV05 | Inhibitor | / | Unkown |
| HY-P992513 | Anti-Mouse TREM2 Antibody (4D9) | Inhibitor | / | Unkown |
| HY-P99529 | Valziflocept | 99.00% | Unkown | |
| HY-P991550 | RFB4 | Inhibitor | 96.93% | Unkown |
| HY-P991584 | HuGAL-FR21 | Inhibitor | 97.80% | Unkown |
| HY-P991769 | Anti-Dengue virus type 2 E protein DIII Antibody (DV2-96) | Inhibitor | 98.24% | Unkown |
| HY-P991881 | KY1070 | / | Unkown | |
| HY-P991922 | AKIR001 | Inhibitor | / | Unkown |
| HY-P992063 | Anti-Mouse CD8α Antibody (YTS 105.18) | / | Unkown | |
| HY-P992201 | Anti-CD160 Antibody (MAT 302) | / | Unkown | |
| HY-P992512 | ANX-M1 (Mouse IgG1) | Inhibitor | / | Unkown |
| HY-P99354 | Bavunalimab | 99.408% | Unkown | |
| HY-P991243 | MP-RM-1 | Inhibitor | 96.29% | Unkown |
| HY-P991433 | BIIB036 | Activator | / | Unkown |
| HY-P991542 | GBR-401 | Inhibitor | / | Unkown |
| HY-P991590 | 1D09C3 | / | Unkown | |
| HY-P991602 | NI-1201 | Inhibitor | / | Unkown |
| HY-P991609 | ABX-MA1 | Inhibitor | / | Unkown |
| HY-P991760 | Anti-IL-10 Antibody (JES3-19F1) | Inhibitor | / | Unkown |
| HY-P991772 | Anti-WNV E protein DIII-LR Antibody (E16) | Inhibitor | / | Unkown |
| HY-P991853 | Anti-MSMP/PSMP Antibody (3D5) | Inhibitor | / | Unkown |
| HY-P991902 | NAV006 | Inhibitor | / | Unkown |
| HY-P991918 | KHK2840 | Agonist | / | Unkown |
| HY-P991924 | CO-1 | Inhibitor | / | Unkown |
| HY-P991935 | ANT1034 | Inducer | / | Unkown |
| HY-P991947 | ELB041 | Inhibitor | / | Unkown |
| HY-P991969 | LR004 | Inhibitor | / | Unkown |
| HY-P992000 | F8-IL-4 | / | Unkown | |
| HY-P992004 | KHK2805 | Inhibitor | / | Unkown |
| HY-P992059 | Anti-Mouse CD1d Antibody (1B1) | Antagonist | / | Unkown |
| HY-P992072 | Anti-Human/Mouse CD95 Antibody (HFE7A) | / | Unkown | |
| HY-P992080 | Anti-Flu A (H7N9) HA/Hemagglutinin Antibody (m826) | Inhibitor | / | Unkown |
| HY-P992081 | Anti-H3L Antibody (NAL_A185) | Inhibitor | / | Unkown |
| HY-P992086 | Anti-Mouse VEGF Antibody (G6-31) | Inhibitor | / | Unkown |
| HY-P992152 | Vatreptacog alfa | / | Unkown | |
| HY-P992153 | Serrumab | Inhibitor | / | Unkown |
| HY-P992172 | ADEL-Y01 | Inhibitor | / | Unkown |
| HY-P992223 | Anti-DAG1/Dystroglycan Antibody (DAG-6F4) | / | Unkown | |
| HY-P992291 | Anti-PL2L60 Antibody (KAO3) | Inducer | / | Unkown |
| HY-P992333 | CLT030 Antibody | Inhibitor | / | Unkown |
| HY-P992336 | CRB0017 | Inhibitor | / | Unkown |
| HY-P992339 | cT84.66 | / | Unkown | |
| HY-P992352 | ES005 | / | Unkown | |
| HY-P992356 | GENA-104A16 | Inhibitor | / | Unkown |
| HY-P992357 | GNUV201 | Inhibitor | / | Unkown |
| HY-P992376 | huXBR1-402 | Inhibitor | / | Unkown |
| HY-P992379 | IB001 | Inhibitor | / | Unkown |
| HY-P992380 | IBC-Ab002 | Inhibitor | / | Unkown |
| HY-P992381 | IBI352g4a | / | Unkown | |
| HY-P992384 | IMG-008 | Inhibitor | / | Unkown |
| HY-P992401 | M802 | / | Unkown | |
| HY-P992410 | MEDI-579 | Inhibitor | / | Unkown |
| HY-P992423 | NIAID RSVF2-5 | Inhibitor | / | Unkown |
| HY-P992424 | NMB04 | Inhibitor | / | Unkown |
| HY-P992426 | NS101 | Inhibitor | / | Unkown |
| HY-P992430 | OI-3 | Inhibitor | / | Unkown |
| HY-P992445 | PRO131921 | Inhibitor | / | Unkown |
| HY-P992455 | SAR442085 | / | Unkown | |
| HY-P992462 | SHR-1806 | / | Unkown | |
| HY-P992465 | SIWA318H | / | Unkown | |
| HY-P992482 | VIR-2482 | / | Unkown | |
| HY-P992483 | VIS832 | Inhibitor | / | Unkown |
| HY-P992484 | VY7523 | Inhibitor | / | Unkown |
| HY-P99648A | Gosuranemab (powder) | Inhibitor | / | Unkown |
| HY-P991318 | AR20.5 | Inhibitor | / | Unkown |
| HY-P991477 | HFB-100204 | Inhibitor | / | Unkown |
| HY-P991751 | Anti-Mouse MHC Class I (H-2Db) Antibody (28-14-8S) | Inhibitor | / | Unkown |
| HY-P991869 | Aquaporumab | Inhibitor | / | Unkown |
| HY-P991896 | AT1412 | Modulator | / | Unkown |
| HY-P991957 | PRN100 | / | Unkown | |
| HY-P991958 | GIGA-564 | Inhibitor | / | Unkown |
| HY-P992108 | Efadirelaxin alfa | Activator | / | Unkown |
| HY-P992156 | Anti-Human/Mouse/Bovine LAG-3 Antibody (ADI-31853) | Inhibitor | / | Unkown |